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2. Abstract	
Aims	and	Objectives:	Patient	reported	outcome	measures	(PROMs)	are	tools	which	seek	
to	ascertain	patients’	views	of	their	symptoms,	their	functional	status	and	their	health-
related	quality	of	life,	without	interruption	from	a	healthcare	professional.	Usually	PROMs	
are	questionnaires,	they	may	include	multiple	choice	components	and/or	free	text	answers.	
In	order	for	the	use	of	these	tools	to	be	considered	reliable	and	valid	in	clinical	practice,	
psychometric	testing	to	provide	evidence	of	reliability,	validity	and	functionality	should	be	
undertaken.	Electronic	PROMs	or	ePROMs	are	such	tools	which	are	delivered	electronically	
and	completed	on	a	computer	or	handheld	device,	often	with	responses	uploaded	onto	the	
internet	allowing	remote	completion	and	access	of	results.		
The	ePAQ	system	is	an	ePROM	platform	which	utilises	an	online	electronic	response	
system	for	completion	of	PROMs.	The	original	ePROM	for	which	the	ePAQ	system	was	
developed	is	ePAQ-Pelvic	Floor	(ePAQ-PF).	This	is	a	pelvic	floor	questionnaire	widely	used	
in	clinical	practice	with	excellent	evidence	foe	reliability,	validity	and	functionality.		
This	thesis	aims	to	present	a	narrative	on	the	development	and	utility	of	electronic	patient	
reported	outcome	measures	in	gynaecology,	including	systematic	literature	reviews	of	
existing	tools	prior	to	development/utilisation	of	ePROMs	(papers	1	and	2),	development	
and	initial	psychometric	testing	of	two	novel	gynaecology	ePROMs	using	the	ePAQ	system	
(papers	3	and	4)	and	discussion	of	the	utility	of	ePROMs	in	gynaecology	both	as	tools	for	
clinical	practice	and	in	research	(papers	5,	6	and	7).		
Methods:	Two	systematic	reviews	following	PRISMA	guidelines	and	registered	
prospectively	on	the	PROSPERO	database	(CRD42017082508	and	CRD42017084710)	
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were	undertaken.	Paper	1	was	a	systematic	review	of	non-invasive	modalities	used	to	
identify	women	with	anal	incontinence	following	childbirth;	to	assess	the	existing	PROMs	
for	this	purpose	with	a	view	to	deploying	the	ePROM	ePAQ-PF	for	this	purpose	in	a	future	
study.		Paper	2	was	a	systematic	review	of	PROMs,	and	their	psychometric	properties,	
used	to	assess	body	image	in	a	urogynaecology	patients.	This	was	done	to	evaluate	existing	
tools	available,	to	inform	development	of	a	domain	(area	within	a	questionnaire)	in	ePAQ-
PF	to	assess	body	image.		
The	development	and	initial	psychometric	testing	of	a	two	novel	gynaecology	ePROMs	
based	on	the	ePAQ	system	is	described	in	papers	3	and	4.		
Three	ethically	approved	retrospective	cohort	studies	using	data	collected	from	ePAQ-PF	as	
part	of	routine	clinical	practice	are	described	in	papers	5-7.	Each	of	these	papers	deals	with	
different	 symptom	 complexes	 and	 issues	 occurring	 in	 urogynaecology	 with	 the	 aim	 of	
presenting	the	utility	of	ePROMs	in	gynaecology	both	as	clinical	tools	and	research	tools.		
In	paper	5	the	aim	was	to	measure	the	prevalence	of	coital	urinary	incontinence	(leakage	
of	urine	during	sexual	intercourse).	In	this	study	2312	women	completed	ePAQ-PF	in	
advance	of	their	urogynaecology	consultation.	Logistic	regression	and	Spearman’s	rank	
correlation	evaluated	associations	between	types	of	coital	incontinence	and	different	types	
of	urinary	incontinence	(urgency	incontinence	and	stress	incontinence).	Mann-Witney	test	
evaluated	the	relationship	between	coital	incontinence	and	self-reported	quality-of–sex-life	
and	self	-avoidance	and	partner-avoidance	of	sex	using	data	from	ePAQ-PF.	A	subgroup	
analysis	was	undertaken	to	analyse	outcomes	in	84	women	with	coital	incontinence	
undergoing	tension	free	vaginal	tape	(an	operation	to	treat	stress	incontinence).	
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In	paper	6	the	aim	was	to	use	data	from	ePAQ-PF	to	assess	the	relationship	between	pelvic	
organ	prolapse	symptoms,	subjective	outcomes	of	surgery	and	body	mass	 index	(BMI)	 in	
women	undergoing	vaginal	hysterectomy	for	treatment	of	prolapse.	Pre-	and	post-operative	
data	 from	 ePAQ-PF	 were	 collected	 prospectively	 from	 60	 women	 undergoing	 vaginal	
hysterectomy	 for	 prolapse.	Of	 these,	 20	were	normal	weight	 (BMI	 18.5	 –	 24.9),	 20	were	
overweight	 (BMI	 25	 –	 29.9)	 and	 20	 were	 women	 with	 obesity	 (BMI	 30	 –	 34.9).	 	 The	
relationship	between	BMI	and	symptom	scores	for	prolapse,	impact	on	vaginal	symptoms	on	
quality	 of	 life	 and	 ‘overall	 change	 in	 condition’	 was	 assessed.	 Pre-	 and	 post-operative	
symptom	scores	were	compared	using	repeated	mixed	ANOVA	test	for	BMI	as	a	categorical	
variable	 (Normal,	 Overweight	 and	 Obese).	 Spearman’s	 rank	 order	 correlation	 test	 was	
carried	 out	 to	 evaluate	 BMI	 as	 a	 continuous	 variable.	 All	 women	 underwent	 vaginal	
hysterectomy	using	a	standardised	technique.	
	
ePAQ-PF	uses	a	free	test	question	to	assess	the	concerns	and	treatment	goals	of	patients	
completing	this	ePROM.	All	patients	are	asked:	‘Considering	the	issues	that	currently	concern	
you	the	most,	what	do	you	hope	to	achieve	from	any	help,	advice	or	treatment?’.	The	
objectives	of	the	study	presented	in	paper	7	were	to	undertake	a	content	analysis	of	the	
free-text	concerns	and	goals	recorded	by	patients	completing	this	item	in	ePAQ-PF	and	
measure	how	these	related	to	self-reported	symptoms	and	health-related	quality-of-life	
(HRQOL)	data	also	recorded	using	ePAQ-PF.	In	total,	1996	consenting	patients	completed	
ePAQ-PF.	Content	analysis	was	undertaken	of	the	free-text	item	responses.		Key	content	
themes	were	identified	by	the	lead	researcher,	and	three	researchers	read	and	coded	all	
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recorded	responses.	Student’s	t	test	was	used	to	compare	ePAQ-PF	domain	scores	for	
patients	reporting	concerns	in	the	relevant	domain	with	those	who	did	not.	
	
Results:	Paper	1:	109	studies	were	included	from	1602	screened	articles.	36	studies	
utilising	15	different	PROM	instruments	were	identified.	Mean	response	rates	were	92%	up	
to	six	weeks	after	childbirth.	Non-personalised	assessment	modalities	(PROMs)	were	
associated	with	reporting	of	higher	rates	of	anal	incontinence	compared	to	patient	
interview	at	all	periods	of	follow	up	after	childbirth,	this	was	statistically	significant	
between	six	weeks	and	one	year	after	childbirth	(p<0.05).			
Paper	2:	17	studies	were	included	from	3207	screened	articles.	Seven	different	PROMs	
used	to	assess	body	image	in	a	urogynaecological	population	were	identified.	Two	of	these	
PROMs	(Genital	Self-Image	Scale-20	and	Body	Image	in	Pelvic	Organ	Prolapse	
questionnaire)	had	good	psychometric	evidence	for	use	but	this	was	only	in	the	context	of	
women	with	prolapse.	Evidence	for	validity	and	reliability	was	limited	for	the	other	five	
PROMs	identified.	
Paper	3	(development/testing	of	ePAQ-Vulva):	Factor	analysis	identified	five	principal	
components.	These	were	reviewed	and	amended	to	provide	a	putative	domain	structure	of	
six	domains.	Internal	reliability	of	these	domains	was	assessed	using	Cronbach’s	alpha,	
producing	values	of	0.715	to	0.917.	Inter-rater	reliability	of	the	picture	items	produced	a	
Kappa	statistic	of	0.405.	Spearman’s	rank	showed	moderate	correlation	between	multiple	
choice	answers	and	free-text	concerns	(r=0.364	–	0.462)	in	three	of	the	six	domains	(Pain,	
Sex	and	Dyspareunia).	
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Paper	 4	 (development/testing	 of	 ePAQ-Menstrual,	 Pain	 and	 Hormonal	 (ePAQ-MPH)):	
Exploratory	 factor	 analysis	 identified	18	domains	 (Cronbach’s	α	>0.7)	 and	30	 redundant	
items.	 Test-retest	 analysis	 found	 acceptable	 intra-class	 correlations	 of	 0.6–0.9	 (p<0.05).	
Eight	domains	were	compared	with	Menstrual	Distress	Questionnaire	showing	moderate	or	
strong	 correlation	 in	 seven	domains.	Ten	domains	were	 compared	with	Women’s	Health	
Questionnaire,	six	of	which	showed	moderate	correlation.	Mean	QQ-10	Value	and	Burden	
scores	were	 76	 and	 25,	 respectively	 (SD=15.8	 and	 15.5).	 The	mean	 completion	 time	 for	
ePAQ-MPH	was	31	minutes.	Confirmatory	factor	analysis	of	the	revised	version	2	instrument	
with	15	domains	showed	good	model	fit.	
Paper	5:	Prevalence	of	coital	incontinence	in	the	cohort	was	30%.	Symptoms	of	both	
urgency	incontinence	(p<0.005)	and	stress	incontinence	(p<0.005)	were	significantly	and	
independently	associated	with	both	types	of	coital	incontinence	(orgasm	&	penetration).	In	
women	with	coital	incontinence	compared	with	those	without,	there	was	significant	self-
avoidance	of	sex	(p<0.0005),	partner-avoidance	of	sex	(p<0.0005)	and	impaired	quality-of-
sex-life	due	to	sexual	problems	(p<0.005).	Subgroup	analysis	of	84	women	undergoing	TVT	
showed	significant	improvement	in	all	coital	incontinence	symptoms	three	months	post-
operatively.	
	
Paper	6:	Overall,	93%	of	women	reported	improvement	in	their	condition.	The	main	finding	
was	that	‘Overall	change	in	condition’	was	negatively	correlated	with	increasing	BMI	(rs=	-
0.324,	p=0.028).	Irrespective	of	BMI,	significant	improvements	were	observed	in	symptoms	
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of	prolapse	and	vaginal	symptoms	impact	on	health-related	quality	of	life	at	three-months	
post	operation.			
	
Paper	7:	63%	of	participants	who	completed	the	questionnaire,	recorded	at	least	one	free-
text	item.	Content	analysis	identified	1560	individual	concerns	coding	into	the	19	ePAQ-PF	
domains.	Symptom	scores	were	significantly	higher	for	patients	reporting	free-text	
concerns	in	18	domains	(p<0.05)	indicating	convergent	validity	of	ePAQ-PF.	Additional	
concerns	relating	specifically	to	body	image	were	recorded	by	11%	of	patients.		
	
Conclusions:	 This	 narrative	 thesis	 presents	 good	 evidence	 for	 the	 use	 of	 ePROMs	 in	
gynaecology,	 both	 as	 clinical	 and	 research	 tools.	 Electronic	 patient	 reported	 outcome	
measures	 in	 gynaecology	 have	 an	 important	 role	 in	 supporting	 self-	 expression	 and	
increasing	disclosure	of	potentially	taboo	or	embarrassing	symptoms.	Their	use	as	research	
tools	 is	 valuable	 allowing	 symptom	 complexes	 to	 be	 explored	 and	 outcomes	 after	
interventions	 measured	 accurately.	 Further	 research	 and	 development	 of	 ePROMs	 in	
gynaecology	will	be	needed	to	support	the	NHS	Long	Term	Plan.	
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ePAQ-Vulva	 	 	 Electronic	Personal	Assessment	Questionnaire-	Vulva	 	
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authors,	Ms	Strickland	and	Ms	Pooranawattanakul	also	undertook	collection	of	free	text	
data.	I	wrote	the	manuscript.	My	Co-authors	edited	the	manuscript.	
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5. Commentary	
5.1 							Introduction,	background	and	systematic	literature	reviews	
5.1.1 Patient	reported	outcome	measures	
Patient	reported	outcome	measures	(PROMs)	are	tools	which	seek	to	ascertain	patients’	
views	of	their	symptoms,	their	functional	status	and	their	health-related	quality	of	life	
(HRQoL)1.	An	individual’s	beliefs	and	perspective	on	his	or	her	condition,	including	
personal	goals	and	concerns	are	important	to	understand	in	any	medical	field.	This	is	
particularly	true	for	intimate	gynaecological	and	urogenital	disorders,	which	may	be	taboo,	
embarrassing	and	have	significant	psychological	and	psychosocial	components.	
PROMs	are	completed	by	the	patient	without	interpretation	of	the	patient’s	response	by	a	
clinician	or	anyone	else2.	Their	function	as	an	outcome	measure	refers	to	the	ability	of	
these	tools	to	compare	patients’	health	at	different	times,	measuring	the	effect	a	treatment	
or	intervention	has	had	on	symptoms,	functional	status	or	HRQoL.	PROMs	are	usually	
questionnaires,	ideally	completed	by	the	patient,	which	allow	for	subjective	data	to	be	
collected	and	measured	in	an	objective	way3.	
The	use	of	PROMs	in	all	areas	of	healthcare	has	become	increasingly	widespread4,5	and	their	
use	 in	 sensitive	 conditions,	 where	 patients	may	 not	 disclose	 embarrassing	 symptoms	 is	
potentially	invaluable6-8.	Since	2009	the	NHS	has	made	it	a	requirement	to	collect	PROM	data	
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from	patients	before	and	after	surgery	for	hip	and	knee	replacements,	varicose	veins	and	
groin	hernias5.	Increasingly,	their	use	is	being	recommended	in	clinical	practice	and	they	are	
being	integrated	as	part	of	standard	clinical	care	in	many	areas.			
PROMs	were	originally	developed	as	tools	for	use	in	research	studies,	but	their	value	and	
utility	in	clinical	care	is	increasingly	understood	and	development	of	PROM	tools	and	usage	
thereof	is	steadily	increasing.	
	
5.1.2 Patient	reported	outcome	measures	in	gynaecology	
Gynaecology	concerns	disease	of	the	female	reproductive	and	genitourinary	systems.	
Almost	all	the	conditions	in	gynaecology	have	symptoms	which	are	considered	to	be	
embarrassing	or	taboo	in	nature.	Gynaecological	conditions,	such	as	heavy	menstrual	
bleeding,	pelvic	pain,	urinary	incontinence	and	pelvic	organ	prolapse	can	have	a	profound	
and	significant	impact	on	HRQoL.	There	is	good	evidence	that	many	patients	do	not	seek	
help	for	intimate	and	potentially	embarrassing	symptoms,	resulting	in	decreased	HRQoL	
and	delays	in	accessing	care7-9.	Using	PROMs	as	a	tool	for	assessment	in	gynaecological	
conditions,	especially	if	administered	indirectly	(by	post	or	by	the	internet),	can	potentially	
result	in	increased	disclosure	of	embarrassing	symptoms	and	their	impact	on	HRQoL;	
allowing	for	a	better	assessment	of	health	than	a	conventional	history	may	be	able	to	
achieve.	PROMs	have	been	used	in	gynaecological	disorders	since	the	1960s10	and	since	the	
1990s	many	tools	(150+)	have	been	developed	and	validated	within	urogynaecology,	
which	concerns	female	pelvic	floor	dysfunction	including	urinary	incontinence,	pelvic	
organ	prolapse,	anal	incontinence	and	sexual	dysfunction.		
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5.1.3 Electronic	Patient	Reported	Outcome	Measures	(ePROMs)	and	ePAQ-Pelvic	
Floor	
One	of	the	key	disadvantages	of	paper	based	PROMs	is	the	ability	to	review	the	data	easily	
and	look	at	patterns	and	trends	across	multiple	groups	of	patients.	In	order	to	achieve	this	
with	paper	based	PROMs,	the	data	needs	to	be	entered	by	hand	into	a	database	which	is	
time	consuming	and	costly.		
ePROMs	offer	patients	the	opportunity	to	complete	the	assessment	when	it	is	convenient	
for	them	and	in	their	own	home.	This	may	mean	that	the	answers	to	the	questions	asked	
are	more	honest	and	open	as	the	patient	may	feel	more	comfortable	in	a	non-medical	
setting	and	have	a	better	opportunity	to	reflect	on	their	symptoms11	and	the	impact	of	
these	on	function	and	HRQoL,	compared	to	completing	the	PROM	on	paper	in	an	outpatient	
clinic	waiting	room.		
ePROMs	also	offer	clinicians	the	opportunity	to	assess	the	patient	remotely,	via	a	virtual	
clinic.	This	has	considerable	benefits	for	follow-up	patients	who	may	be	able	to	have	a	
telephone	consultation	after	completion	of	an	ePROM	at	home	to	assess	progress,	rather	
than	having	to	re-attend	the	outpatient	department12.	ePROM	data	could	also	be	utilised	to	
give	tailored	advice	to	patients	on	self-management,	as	well	as	providing	healthcare	
professionals	with	detailed	symptom	and	HRQoL	data	between	scheduled	appointments13.	
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Previous	research	has	found	that	electronic	systems	can	gain	better	response	rates	and	
patients	may	find	them	easier	and	more	satisfying	to	complete14.	
	
The	first	ePROM	developed	for	use	in	gynaecology	was	the	electronic	Personal	Assessment	
Questionnaire-	Pelvic	Floor	(ePAQ-PF)15.	This	was	previously	a	paper	based	tool,	
comprising	a	battery	of	validated	paper	based	PROMS:	the	Birmingham	Bowel	and	Urinary	
Symptoms	Questionnaire	(BBUS-Q)16,	Sheffield	Prolapse	Symptoms	Questionnaire	(SPS-
Q)17	and	Female	Sexual	Function	Index	(FSFI)18.	In	development	of	ePAQ-PF,	an	expert	
panel	reviewed	the	items	included	and	revised	the	format	of	the	instrument	as	well	as	
adding	items	assessing	impact,	patients	concerns,	patient	goals	and	patient	questions.		
	
ePAQ-PF	is	now	utilised	as	a	web-based	instrument	that	provides	a	comprehensive	
assessment	of	a	patient’s	pelvic	floor	symptoms	and	their	impact	on	HRQoL.	The	
instrument	is	completed	on-line,	prior	to	clinic	attendance	by	80%	of	users,	or	
alternatively,	using	a	touchscreen-computer	or	tablet	in	a	private	room	in	the	
urogynaecology	clinic.	Patients	may	choose	to	have	their	partner/family	member	present	
with	them	when	they	complete	the	questionnaire	and	if	they	complete	it	in	the	hospital	a	
nurse	can	sit	with	them	to	support	them	if	they	wish.	The	majority	of	patients	complete	the	
questionnaire	alone,	unaided.	Previous	studies	have	shown	that	most	patients	find	the	
questionnaire	easy	to	use	and	a	useful	process	which	helps	them	to	reflect	and	prepare	for	
their	consultation6.	The	mean	completion	time	of	ePAQ-PF,	including	the	free-text	
components,	is	26	minutes15.	A	questionnaire	report	may	be	printed	or	viewed	
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electronically	for	use	by	the	attending	clinician,	supporting	consultation,	diagnosis	and	
management19.		
	
The	core	element	of	ePAQ-PF	comprises	of	standardised	multiple-choice	questions,	which	
assess	 both	 the	 frequency	 and	 impact	 of	 pelvic	 floor	 symptoms	 across	 four	 dimensions:	
Urinary,	 Bowel,	 Vaginal	 and	 Sexual.	 Each	 item	 is	 presented	 on	 a	 separate	 screen,	 with	
individual	‘help’	pages	and	navigation	buttons.		Response	options	for	all	these	items	are	on	a	
four-point	scale	‘Never’,	‘Occasionally’,	‘Most	of	the	time’	or	‘All	of	the	time’	and	scored	0,	1,	
2	or	3	respectively.	The	impact	attributed	to	each	of	these	symptoms	is	also	recorded,	using	
a	 standard	 sub-question	 ‘How	 much	 of	 a	 problem	 is	 this	 for	 you?’	 and	 graded	 as	 ‘Not	 a	
problem’,	‘A	bit	of	a	problem’,	‘Quite	a	problem’	or	‘A	serious	problem’	and	scored	0,	1,	2	and	
3	respectively.	The	degree	of	frequency	and	bothersomeness	are	thereby	assessed	for	each	
symptom.		
	
The	 electronic	 instrument	 automatically	 generates	 scores	 across	 20	 validated	 domains	
(areas	 assessing	 different	 themes	 within	 a	 PROM	 or	 questionnaire),	 providing	 graphic	
representation	of	these	both	the	severity	and	the	impact	for	each	condition.	Domain	scores	
are	derived	by	dividing	the	sum	of	all	item	scores	in	that	domain	by	the	total	possible	item	
score	and	multiplying	this	by	100	to	produce	a	scale	ranging	from	0	(best	possible	health	
status)	to	100	(worst	possible	health	status)15,	20.	 In	addition	to	the	multiple-choice	items	
within	ePAQ-PF,	the	instrument	also	includes	a	free-text	question	which	asks:	‘Considering	
the	 issues	 that	currently	concern	you	the	most,	what	do	you	hope	to	achieve	 from	any	help,	
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advice	or	treatment?’.	Patients	are	invited	to	record	up	to	three	free-text	responses,	each	of	
up	to	100	characters.	
Five	of	 the	papers	 incorporated	 into	this	narrative	thesis	are	studies	which	use	the	ePAQ	
system	developed	for	ePAQ	Pelvic	Floor.	Two	of	the	studies	describe	the	development	and	
initial	psychometric	testing	of	two	novel	gynaecology	ePROMs	using	the	ePAQ	base	format	
for	 software	 engineering	 and	 PROM	 production.	 Three	 further	 papers	 utilise	 data	 from	
ePAQ-Pelvic	Floor	 for	purposes	of	 research	 in	urogynaecology	and	demonstrate	both	 the	
potential	utility	and	value	of	PROMs	for	this	purpose	as	well	as	within	clinical	practice.		
	
	
5.1.4 Focused	 gynaecology	 PROMs	 systematic	 literature	 reviews:	 paper	 1	 and	
paper	2	
	
In	order	to	inform	development	of	patient	reported	outcome	measures,	it	is	essential	to	have	
a	deep	awareness	of	the	existing	tools	available	for	the	same	or	similar	purposes	and	the	
evidence	of	psychometric	testing	for	these	tools.	Therefore,	before	using	an	existing	tool	for	
a	new	or	different	purpose	or	before	developing	a	completely	new	PROM	literature	reviews	
should	 be	 undertaken.	 Ideally,	 these	 reviews	 should	 be	 systematic	 in	 nature	 using	
standardised	methods	of	data	collection,	analysis	and	reporting	of	results.	Paper	1	and	Paper	
2	of	this	thesis	are	systematic	reviews	undertaken	to	inform	using	an	existing	ePROM	(ePAQ-
PF)	in	a	different	way	(paper	1)	and	developing	new	domain	areas	in	an	existing	ePROM	
(paper	2).	
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Paper	121	of	this	thesis	is	a	systematic	review	of	non-invasive	modalities	(PROMs)	used	to	
identify	women	with	anal	incontinence	problems	following	childbirth.	Anal	incontinence	is	
the	involuntary	leakage	of	faeces	or	flatus.	Anal	incontinence	following	childbirth	is	
prevalent	and	has	a	significant	impact	upon	quality-of-life.	At	the	present	time,	there	is	no	
standard	assessment	for	women	after	childbirth	using	a	PROM	to	identify	these	symptoms.	
This	systematic	review	aimed	to	identify	non-invasive	modalities	including	all	PROMs	that	
have	been	used	to	identify	women	with	anal	incontinence	following	childbirth	and	assess	
response	rates	and	reporting	rates	of	anal	incontinence	for	these	modalities.	The	reason	for	
undertaking	this	systematic	review	was	to	assess	whether	ePAQ-Pelvic-Floor	may	be	a	
suitable	tool	to	deploy	for	this	purpose.		
	Ovid	Medline,	AMED,	CINAHL,	Cochrane	Collaboration,	EMBASE	and	Web	of	Science	
databases	were	searched	for	studies	using	non-invasive	modalities	to	identify	women	with	
anal	incontinence	following	childbirth,	published	from	January	1966	to	May	2018.	Study	
data	including	type	of	modality,	response	rates	and	reported	prevalence	of	anal	
incontinence	were	extracted	and	critically	appraised.	
In	total,	109	studies	were	included	from	1602	screened	articles.	Three	types	of	non-
invasive	modality	were	identified:	validated	PROMs	(n=36	studies	utilising	15	different	
instruments,	including	ePAQ-Pelvic	Floor	in	one	study),	non-validated	PROMs	(n=50	
studies)	and	patient	interviews	(n=23	studies).	Mean	response	rates	were	92%	up	to	six	
weeks	after	childbirth.	Non-personalised	assessment	modalities	(PROMs)	were	associated	
with	reporting	of	higher	rates	of	anal	incontinence	compared	to	patient	interview	at	all	
periods	of	follow	up	after	childbirth,	this	was	statistically	significant	between	six	weeks	
and	one	year	after	childbirth	(p<0.05).			
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This	systematic	review	confirmed	that	PROMs	can	be	used	effectively	after	childbirth	to	
identify	women	with	anal	incontinence	and	these	are	likely	to	be	more	effective	than	
interviews	with	patients.	The	main	strengths	of	this	systematic	review	were	the	rigorous	
search	strategy	employed,	which	has	identified	the	relevant	studies,	allowing	
identification	of	the	PROMs	available	which	have	been	used	successfully	to	identify	women	
with	anal	incontinence	after	childbirth.	The	limitations	of	this	systematic	review	include	
the	heterogeneity	in	the	definitions	used	to	describe	anal	incontinence	symptoms	in	the	
studies	included,	which	is	some	cases	may	have	underestimated	the	prevalence	of	anal	
incontinence.	Disparity	in	the	definition,	or	lack	of	definition,	of	what	constitutes	obstetric	
anal	sphincter	injury	may	also	have	contaminated	the	results.	The	use	of	non-validated	
PROMs	and	patient	interviews	may	have	also	resulted	in	over	or	under-reporting	of	anal	
incontinence	symptoms.		The	small	numbers	of	studies	for	the	three	different	non-invasive	
modalities	at	various	different	points	of	follow-up	may	have	resulted	in	type	2	statistical	
errors	when	comparing	prevalence	rates	using	paired	t	test.	The	use	of	a	search	strategy	
which	excluded	papers	not	published	in	English	may	have	also	resulted	in	missing	non-
invasive	modalities	potentially	relevant	to	this	systematic	review.	Grey	literature	searches	
were	also	not	undertaken,	this	may	have	resulted	in	relevant	conference	abstracts	being	
excluded.	Nevertheless,	this	is	an	up	to	date	systematic	review	which	demonstrates	the	
most	appropriate	PROMs	to	use	for	women	with	anal	incontinence	following	childbirth.	
Further	research	aims	to	evaluate	the	use	of	ePAQ-Pelvic	Floor	(one	of	the	validated	
PROMs	identified	in	this	review)	in	a	large	cohort	of	women	following	childbirth.	
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Paper	222	of	this	thesis	is	a	systematic	review	of	PROMs	which	have	been	used	to	assess	
body	image	concerns	in	women	with	urogynaecology	and	pelvic	floor	problems.	It	is	well	
established	that	urogynaecological	conditions	can	have	a	significant	impact	on	body	
image23-27.	This	systematic	review	aimed	to	identify	currently	available	PROMs	used	to	
assess	body	image	within	a	urogynaecological	population	and	to	identify	the	most	
psychometrically	robust	and	appropriate	PROM	tools	to	use	in	this	context.	This	was	
undertaken	following	a	study	which	identified	that	women	using	ePAQ-Pelvic	Floor	had	
body	image	concerns	which	were	not	addressed	by	this	ePROM	(Paper	7	of	this	thesis)28.	
Ovid	Medline,	AMED,	CINAHL,	Cochrane	Collaboration,	EMBASE	and	Web	of	Science	
databases	were	searched	from	January	1966	to	November	2018,	to	identify	studies	that	
had	administered	a	PROM	to	assess	body	image	to	patients	diagnosed	with	a	
urogynaecological	condition.	The	information	extracted	and	critically	appraised	included;	
study	setting,	PROM	instrument	used	and	the	reported	psychometric	properties	of	the	
PROM.		
In	total,	seventeen	studies	were	included	from	3207	screened	articles.	Seven	different	
PROMs	used	to	assess	body	image	in	a	urogynaecological	population	were	identified.	Two	
of	these	PROMs	(Genital	Self-Image	Scale-2029	and	Body	Image	in	Pelvic	Organ	Prolapse	
questionnaire30)	had	good	psychometric	evidence	for	use	but	this	was	only	in	the	context	of	
women	with	prolapse.	Evidence	for	validity	and	reliability	was	limited	for	the	other	five	
PROMs	identified.		The	main	strength	of	this	systematic	review	was	the	rigorous	and	
transparent	search	strategy	employed,	which	allowed	the	identification	of	all	the	relevant	
studies	and	identifying	seven	PROMs	used	in	a	urogynaecology	population.		The	review	
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was	able	to	identify	the	most	psychometrically	robust	tools	available	for	use	to	assess	body	
image	within	a	urogynaecology	setting.	
	The	limitations	of	this	systematic	review	were	that	the	data	was	only	as	good	as	that	which	
has	been	provided	in	the	included	studies.	Not	all	the	psychometric	testing	for	each	PROM	
may	have	been	included,	especially	details	about	content	validity,	criterion	validity	and	
responsiveness,	which	were	often	not	reported.	To	minimise	the	risk	of	bias	and	
subjectivity	with	using	the	Oxford	PROM	group’s	appraisal	system	which	was	used	to	
complete	this	systematic	review31,	each	reviewer	independently	extracted	data	on	the	
quality	of	the	psychometric	properties	and	functionality	of	the	included	PROMs.	The	use	of	
a	search	strategy	which	excluded	papers	not	published	in	English	may	have	also	resulted	in	
missing	both	instruments	and	related	studies	potentially	relevant	to	this	systematic	review.	
This	review	has	identified	that	further	development	and	psychometric	testing	of	PROMs	to	
assess	body	image	in	urogynaecology,	both	for	research	purposes	and	clinical	practice,	is	
required.		Likewise,	further	research	to	investigate	the	relationship	between	body	image	
and	urogynaecological	symptomatology	is	required	and	developing	valid,	reliable	and	
functional	PROMs	will	be	integral	to	this.	The	next	stage	is	to	develop	and	undertake	
psychometric	testing	of	a	domain	to	assess	body	image	in	the	ePAQ-PF	ePROM.	
	
5.2 Development	and	psychometric	testing	of	PROMs	in	gynaecology	
	
5.2.1 Overview	of	development	and	testing	of	PROMs	
The	development	of	patient	reported	outcome	measures	should	follow	a	set	pattern.	This	
includes	the	assessment	of	the	views	of	both	healthcare	professionals	and	patients	on	the	
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development	of	the	PROM,	what	items	(questions	or	themes	the	PROM	should	cover)	
should	be	included	and	how	it	should	work.	Drafting	of	PROM	items	is	undertaken	and	this	
process	may	be	reviewed	by	both	healthcare	professionals	and	patients	who	are	
stakeholders	in	the	development	of	the	PROM.	Once	the	PROM	is	completed	it	should	be	
administered	to	a	group	of	patients	large	enough	to	allow	for	psychometric	properties	
which	assess	reliability,	validity	and	functionality	of	the	PROM	to	be	appropriately	
evaluated.		After	initial	testing	of	the	PROM,	further	refinement	of	items	and	structure,	
taking	into	account	the	results	of	the	psychometric	testing,	should	be	undertaken.	A	further	
or	final	version	of	the	PROM	may	then	be	tested	in	a	similar	manner	and	the	PROM	revised	
as	indicated	until	the	reliability,	validity	and	functionality	are	shown	to	be	optimal.	Only	
then	should	the	instrument	be	used	in	clinical	practice	and	as	a	research	tool.		
Paper	222	of	this	thesis	is	a	systematic	which	identified	all	the	currently	available	PROMs	to	
assess	body	image	in	urogynaecology.	One	of	the	main	findings	of	this	systematic	review	
was	that	of	the	seven	tools	identified	by	the	review,	only	two	had	been	appropriately	tested	
in	a	urogynaecology	population	and	had	good	evidence	of	reliability,	validity	and	
functionality.	The	other	five	tools	had	all	been	used	in	a	research	setting	without	adequate	
evidence	of	their	ability	to	do	the	task	they	have	been	designed	to	do.	The	most	frequently	
used	instrument	identified	in	this	systematic	review	was	the	modified	Body	Image	Scale	
(mBIS)23,	which	was	used	in	11	studies23,24,32-40.	This	PROM	was	initially	developed	to	
assess	body	image	concerns	in	relation	to	medical	conditions	or	treatment	in	cancer	
patients	and	was	adapted	for	use	in	patients	with	pelvic	organ	prolapse.	This	was	done	by	
simply	changing	questions	regarding	‘disease	or	treatment’	from	Hopwood’s	original	body	
image	scale41	to	questions	regarding	‘prolapse’.	No	evidence	at	all	was	provided	for	the	
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content	validity	of	this	tool	in	a	urogynaecology	population	and	the	available	evidence	for	
its	reliability	and	construct	validity	was	very	limited,	despite	it	being	the	most	widely	used	
PROM	to	assess	body	image	in	a	urogynaecology	setting.	For	this	tool	to	be	considered	
valuable	for	research	and	use	in	clinical	practice,	further	psychometric	testing	within	a	
urogynaecology	population	would	be	required.	This	paper	helps	to	underline	the	
importance	of	robust	PROM	development	and	testing	to	ensure	that	the	results	it	produces	
are	not	biased	or	inaccurate.		
	
5.2.2	Patient	involvement	in	the	development	of	ePROMs	
In	order	to	ensure	that	a	PROM	truly	captures	the	perspectives	of	patients,	it	is	essential	
that	patients	are	directly	involved	in	the	development	of	a	PROM42.	This	is	mainly	because	
only	patients	will	be	able	to	determine	which	elements	of	health	outcomes	are	important	to	
them	and	if	the	PROM	is	able	to	access	this	information.		
A	large	scoping	review	which	aimed	to	review	the	different	ways	that	patients	are	involved	
in	PROM	development,	the	extent	to	which	patients	are	involved	and	whether	patient	
involvement	has	increased	over	time	found	that	in	just	over	a	quarter	of	the	189	included	
studies	did	not	actively	utilise	any	involvement	from	patients43.	Of	the	PROM	development	
studies	which	did	include	patients,	58%	involved	patients	in	item	development,	51%	
involved	patients	in	testing	the	comprehensibility	or	reading	level	of	the	PROM.	In	only	7%	
of	the	studies	included	were	patients	involved	in	each	step	of	PROM	development.	The	
scoping	review	also	found	that	patient	involvement	did	not	improve	over	time.		
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Paper	 344	 of	 this	 thesis	 is	 a	 PROM	 development	 study	 describing	 the	 development	 and	
primary	psychometric	testing	of	an	electronic	PROM	to	assess	patients	with	vulval	disorders.	
During	the	development	of	the	ePROM	concerned	(ePAQ-Vulva),	patients’	views	were	sought	
on	ePROM	development	in	this	area.	A	survey	of	six	free	text	questions	was	completed	by	62	
patients	with	vulval	disorders	attending	the	vulval	clinic	at	Sheffield	Teaching	Hospitals	over	
a	three-week	period.	Of	the	patients	who	completed	the	survey,	75%	were	positive	about	the	
idea	 of	 an	 electronic	 PROM	 to	 aid	with	 the	 assessment	 of	with	 vulval	 disorders,	 74%	of	
patients	 listed	 advantages	 ePROMs	 in	 this	 context,	 compared	 to	 26%	 who	 listed	
disadvantages.	 There	were	 two	 emerging	 key	 themes	 from	advantages	 listed	by	patients	
completing	the	survey.	These	were	the	ability	to	express	their	feelings	or	concerns	via	the	
ePROM	(35%)	and	the	ability	to	receive	information	and	knowledge	about	vulval-disorders	
via	the	ePROM	(33%).	 	The	responses	to	the	survey	helped	to	inform	the	development	of	
items	within	the	PROM,	alongside	the	expert	panel	and	national	guidelines.	Patients	were	
not	 involved	 in	 assessments	 of	 reading	 level	 for	 the	 ePAQ-Vulva	 PROM	 and	 were	 only	
involved	at	the	very	start	of	PROM	production.	Given	the	evidence	for	the	benefits	of	patient	
involvement	 in	 PROM	 production,	 this	 lack	 of	 patient	 involvement	 could	 be	 seen	 as	 a	
limitation	of	paper	3	of	this	thesis.				
	
Paper	445	of	this	thesis	is	also	an	ePROM	development	paper,	concerning	the	development	
and	initial	psychometric	testing	of	ePAQ-MPH	(Menstrual,	Pain	and	Hormonal).	This	is	an	
ePROM	 designed	 to	 assess	 menstrual	 disorders,	 gynaecological	 pain	 syndromes	 and	
gynaecological	 hormone	 disorders.	 In	 order	 to	 guide	 development	 of	 PROM	 items,	 semi-
structured	interviews	with	25	patients	were	conducted	by	a	social	scientist	working	as	part	
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of	the	ePROM	development	team.	These	interviews	were	voice-recorded,	transcripts	made	
and	then	subjected	to	thematic	content	analysis46.	The	thematic	content	analysis	identified	
the	themes	which	were	salient	to	the	patients	participating,	including	assessments	of	pain,	
the	 ability	 to	 say	 how	 much	 symptoms	 impacted	 on	 HRQoL	 and	 the	 inclusion	 of	
perimenopausal	symptoms.		
Measures	of	ePROM	acceptability	were	assessed	using	another	questionnaire	based	tool.	In	
total,	279	women	completing	the	ePAQ-MPH	ePROM	during	the	pilot	phase	also	completed	
a	validated	questionnaire	called	Questionnaire	Quotient	10-item	(QQ-10).	This	is	a	tool	
which	measures	face	validity	(the	degree	to	which	the	ePROM	appears	to	measure	what	it	
is	purporting	to	measure,	from	the	patient’s	perspective	in	this	case),	feasibility	and	utility	
of	the	PROM	(all	from	the	patients’	perspective)47.	The	QQ-10	tool	produces	a	value	score	
and	a	burden	score,	the	greater	the	value	score	then	the	more	acceptable	the	ePROM	
appears	to	be	to	patients.	Conversely,	the	greater	the	burden	score	then	the	ePROM	
appears	less	acceptable	to	patients.		Mean	scores	for	Value	and	Burden	in	this	ePROM	
development	study	for	ePAQ-MPH	were	76	(SD	=	15.8)	and	25	(SD	=	15.5),	respectively,	
suggesting	high	Value	and	low	Burden	for	the	majority	of	patients.	Of	the	six	items	relating	
to	Value,	‘ease	of	use’	and	‘happy	to	complete	again’	were	the	most	highly	rated	responses	
(92%	and	90%,	respectively).	Of	the	four	Burden	items;	‘The	questionnaire	is	too	long’	was	
the	most	frequently	reported	response	(25%	of	subjects).	Therefore,	patients	were	
involved	in	both	the	development	of	the	ePROM	and	in	assessing	acceptability.	They	were	
not	involved	in	the	revision	and	further	psychometric	testing	of	ePAQ-MPH,	which	may	be	a	
limitation	of	its	development.	This	is	of	concern,	because	if	an	ePROM	does	not	adequately	
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represent	the	patients’	perspective,	it	can	lead	to	patients	failing	to	complete	the	ePROM,	
resulting	in	a	negative	impact	on	the	validity48.		
	
5.2.3 Psychometric	testing	of	patient	reported	outcome	measures	
Testing	of	psychometric	properties	of	a	PROM	provides	evidence	that	the	instrument	is	
working	correctly	and	measuring	what	it	purports	to	measure	(validity)	and	doing	this	in	a	
consistent	and	reproducible	way	(reliability).	The	ability	of	a	PROM	to	accurately	collect	
symptom	data	and	HRQoL	data	is	dependent	on	the	strength	of	the	psychometric	
properties	of	the	instrument.	The	two	most	important	psychometric	properties	are	
reliability	and	validity	and	the	evidence	for	these	two	properties	sits	along	a	continuum	
whereby	there	can	be	no	evaluation	of	these	properties	at	all,	up	to	full	evaluation	in	the	
relevant	study	population.	This	means	that	it	is	not	correct	or	proper	to	claim	that	a	PROM	
is	absolutely	valid	or	reliable,	as	this	is	a	continuous	process49.	This	also	means	that	to	state	
that	an	instrument	is	‘validated’,	meaning	psychometric	testing	has	been	completed	and	
good	evidence	for	validity,	is	incorrect.	This	statement	simply	means	that	the	psychometric	
performance	has	been	tested	and	may	show	promise.	The	more	psychometric	testing	is	
done,	then	the	more	that	patients	and	healthcare	professionals	can	have	confidence	in	the	
reliability,	validity	and	functionality	of	the	tool	being	considered.		
Reliability	assesses	the	extent	to	which	a	PROM	tool	yields	consistent	and	reproducible	
results50.	Internal	reliability	is	the	extent	to	which	items	within	an	instrument	measure	the	
same	concepts51.	It	also	ensures	that	no	two	items	in	a	PROM	are	measuring	exactly	the	
same	concept	and	may	therefore	be	used	as	a	tool	for	item	reduction	during	PROM	
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development;	with	the	aim	of	reducing	the	burden	of	completing	the	instrument.	The	
Cronbach’s	α	statistic	is	used	to	measure	internal	reliability.	Scores	greater	than	0.7	
indicate	that	items	are	measuring	related	constructs.	Likewise,	scores	greater	than	0.94	
suggest	a	degree	of	item	redundancy,	and	provide	a	basis	for	item	reduction44.	A	further	
measure	of	reliability	is	test-retest	reliability,	which	provides	evidence	of	stability	of	the	
PROM.		In	test-retest	reliability	the	patient	completes	the	PROM	on	two	separate	occasions	
at	least	one	week	apart.	Typically,	Wilcoxon	signed-rank	test	is	used	to	measure	any	
differences	between	Cronbach’s	alpha	values	for	the	two	completions	and	then	inter-class	
correlations	are	calculated.		
	
	
Validity	is	the	extent	to	which	a	PROM	measures	what	it	purports	to	measure52.	This	has	to	
be	absolutely	specific	to	the	population	and	setting22.	For	example,	as	in	paper	two	of	this	
thesis,	a	PROM	designed	to	assess	body	image	in	cancer	patients	may	not	be	reliable	in	a	
urogynaecology	population.	Broadly,	there	are	three	main	types	of	validity.	These	are	
content	validity,	criterion	validity	and	construct	validity.		
	
Content	validity	is	extent	to	which	a	PROM	measures	appropriate	content	and	includes	a	
variety	of	attributes	which	make	up	the	measured	construct	of	the	instrument49.	This	is	
represented	by	evidence	of	the	adequacy	and	appropriateness	of	development	of	the	
material	included	in	the	PROM.	Ideally,	a	plan	for	the	content	of	the	PROM	should	be	made	
before	the	instrument	is	developed	and	the	source	of	the	content	should	be	from	focus	
groups	or	cognitive	interviewing	(with	patients	who	would	be	using	the	PROM,	but	also	
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with	experts	in	the	field).	A	group	of	experts	in	the	field	can	then	further	examine	items	and	
endorse	the	content	validity	and	identify	any	gaps	in	content49.	Face	validity	is	where	the	
content	of	a	PROM	is	assessed	in	terms	of	how	it	is	perceived	by	patients	and	experts	with	
regard	to	its	ability	to	measure	what	it	is	supposed	to	be	measuring.	If	the	PROM	appears	to	
measure	what	it	is	supposed	to	be	measuring,	this	is	evidence	of	face	validity.	It	is	a	
subjective	judgement	and	there	are	different	means	of	assessing	this	including	interviews	
with	patients/experts	completing	the	PROM	or	questionnaire	tools,	such	as	QQ-1047.			
	
Criterion	validity	is	when	the	extent	to	which	the	PROM	agrees	with	an	external	standard	
measure,	usually	another	PROM	which	has	undergone	psychometric	testing	and	is	used	in	
clinical	practice	or	research49.	Correlation	between	the	PROM	and	another	(usually	
validated	and	well-established)	PROM	is	usually	measured	using	Spearman’s	rank	
correlation22.	Often,	during	PROM	development,	if	the	concept	of	the	tool	is	novel	(as	in	
paper	3	of	this	thesis)	there	may	not	be	an	appropriate	measure	of	criterion	validity	
available.		
	
Construct	validity	describes	the	relationship	of	a	construct	to	other	variables52.	Convergent	
construct	validity	is	the	degree	to	which	two	measures	of	constructs	that	should	be	related,	
are	in	fact	related.	For	example,	the	relationship	between	women	who	report	urinary	
incontinence	and	quality	of	life,	which	would	be	anticipated	to	be	related.	This	is	often	
explored	using	correlation	coefficients,	whereby	>0.5	indicates	adequate	convergent	
validity	and	<0.5	indicates	adequate	divergent	validity	(two	concepts	which	should	be	
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unrelated,	are	proven	to	be)53.	Responsiveness	of	a	PROM	measures	the	instrument's	
ability	to	measure	change,	for	example,	before	and	after	treatment54.		
	
Functionality,	refers	to	the	practical	properties	of	a	PROM	and	includes	things	such	as	
acceptability,	feasibility	and	reading	level	of	the	administration	of	the	PROM.	Strictly	
speaking,	these	are	not	psychometric	properties	per	se.	However,	these	details	are	often	
important	in	practical	terms;	ensuring	that	it	is	feasible	for	patients	to	complete	the	PROM	
and	the	it	is	user	friendly.	Details	such	as	the	completion	rate	(levels	of	missing	data),	
number	of	items	in	the	PROM,	completion	time	and	scored	reading	level	provide	evidence	
of	the	functionality	of	a	PROM.		
	
Paper	344	of	this	thesis	describes	the	initial	psychometric	testing	of	ePAQ-Vulva,	an	ePROM	
developed	for	the	assessment	of	patients	with	vulval	disease.		Initial	psychometric	testing	
of	this	novel	ePROM	was	undertaken.	Factor	analysis	is	a	statistical	procedure	which	
enables	the	underlying	domains,	or	scales,	of	a	patient-reported	outcome	measure/patient	
questionnaire	to	be	determined	and	for	appropriate	measures	of	reliability	and	validity	to	
be	measured	thereof50.	In	order	to	identify	the	domains	of	ePAQ-Vulva,	factor	analysis	
using	Varimax	rotation	(a	statistical	procedure	to	identify	domains	in	a	PROM	or	
questionnaire)	was	carried	out.	Cronbach’s	α	was	used	to	measure	internal	reliability.	
Convergent	validity	was	partially	assessed	by	comparing	the	multiple-choice	PROM	
responses	with	the	free-text	items	in	the	PROM	recording	patient	concerns	and	goals.	The	
free	text	comments	were	each	reviewed	to	assess	if	the	concern	recorded	by	the	patient	
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was	assessed	by	a	questionnaire	item	in	a	particularly	domain.	Free-text	data	for	concerns	
were	then	categorized	according	to	domain	and	the	rank	correlation	coefficient	with	the	
relevant	domain	scores	for	quality	of	life	calculated	(Spearman's	rank	correlation).	
During	the	evaluation	period	98	vulval	clinic	patients	completed	the	instrument	either	on-
line	prior	to	clinic	attendance	or	in	the	vulval	clinic	at	a	touch	screen	computer	in	a	private	
room.	The	average	time	to	complete	the	questionnaire	was	32	minutes.	
Factor	 analysis	 indicated	 the	 presence	 of	 five	 components	 or	 domains.	 The	 expert	 panel	
reviewed	and	intuitively	amended	these	components	to	provide	a	structure	comprising	of	
six	clinically	meaningful	domains.	Internal	reliability	of	the	six	domains	was	assessed	using	
Cronbach’s	α;	all	six	domains	achieved	an	alpha	 level	of≥	0.7.	 Inter-rater	reliability	of	 the	
picture	items	showed	agreement	between	clinician	and	patient	54%	of	the	time	regarding	
the	 presence	 of	 symptoms.	 	 Agreement	 regarding	 absence	 of	 symptoms	 was	 85%.	 The	
Cohen’s	 Kappa	measure	 of	 agreement	 for	 this	 was	moderate	 at	 0.405.	 Spearman’s	 rank	
showed	significant	moderate	correlation	between	multiple-choice	components	and	free-text	
items	 in	 three	 of	 the	 five	 domains.	 The	 initial	 testing	 and	 validation	 of	 ePAQ-Vulva	 has	
provided	some	evidence	of	reliability	and	validity	but	the	data	analysed	so	far	represent	a	
relatively	 small	 sample	 in	 a	 single-centre	 specialist	 vulval	 clinic.	 ePAQ-Vulva	 therefore	
requires	 further	 testing,	 including	confirmatory	 factor	analysis	of	 its	domain	structure	 in	
larger	numbers	of	women.	Changes	will	be	made	to	the	 instrument	to	remove	redundant	
items,	 though	 with	 some	 caution	 to	 ensure	 that	 clinical	 detail	 is	 not	 lost	 through	 item	
reduction.	 Further	 psychometric	 testing	 will	 then	 be	 undertaken	 in	 further	 ethically	
approved	studies.	
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Paper	445	of	this	thesis	regards	the	initial	psychometric	testing	of	ePAQ-MPH,	a	novel	
ePROM	assessing	menstrual	disorders,	gynaecological	pain	and	gynaecological	hormonal	
disorders.	Again,	psychometric	testing	consisted	of	exploratory	factor	analysis	with	
Varimax	rotation	to	identify	a	domain	structure.	The	internal	reliability	of	items	that	
intuitively	constituted	a	domain	was	also	evaluated,	whether	loading	collectively	in	the	
factor	analysis	or	not.	Items	failing	to	be	included	in	any	domain	were	reviewed	by	the	
expert	panel	regarding	their	value	and	possible	removal,	this	was	in	order	not	to	prioritise	
statistical	significance	over	clinical	significance	(and	is	a	measure	of	face	validity	from	the	
clinicians’	perspective).		
To	measure	criterion	validity,	a	sample	of	213	patients	also	completed	two	validated	
PROMs	(Women’s	Health	Questionnaire	(WHQ)55	and	the	Menstrual	Distress	Questionnaire	
(MDQ)10.	These	two	PROMs	were	used	as	there	is	evidence	for	their	validity	and	both	
instruments	cover	almost	all	the	content	incorporated	in	ePAQ-MPH.	Scores	from	ePAQ-
MPH	were	compared	with	salient	domain	scores	from	WHQ	and	MDQ	using	rank	
correlation	to	assess	the	degree	of	correlation.	Test-retest	reliability	to	evaluate	stability	
over	time	was	undertaken	with	30	participants	who	completed	ePAQ-MPH	on	two	
occasions,	at	least	one	week	apart.	Wilcoxon	signed-rank	test	was	used	to	measure	
differences	between	Cronbach’s	alpha	values	for	the	two	completions	and	inter-class	
correlations	were	calculated.		
Complete	 questionnaire	 data	 were	 obtained	 from	 291	 completions	 of	 ePAQ-MPH.	 Mean	
completion	 time	was	31	minutes.	Eighteen	domains	of	ePAQ-MPH	with	Cronbach’s	alpha	
values	of	>0.7	were	identified.	Factor	analysis	demonstrated	that	the	Menstrual	dimension	
had	 two	redundant	 items	and	 identified	six	domains;	 the	Pelvic	Pain	dimension	had	 four	
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redundant	items	and	five	domains;	the	Hormonal	dimension	had	seven	redundant	items	and	
four	domains.	Within	the	hormonal	dimension	a	putative	polycystic	ovary	syndrome	domain	
including	 items	relating	 to	hair	 loss,	acne	and	hirsutism	was	evaluated;	 these	 items	were	
tested	for	internal	reliability	and	produced	a	Cronbach’s	alpha	value	of	0.42	suggesting	that	
this	was	not	a	reliable	domain.	The	final	dimension	of	Non-menstrual	Bleeding	&	Discharge	
(NMBD)	had	5	redundant	items	and	three	domains	were	identified.	All	redundant	items	were	
removed	from	Version	1	of	ePAQ-MPH	(102	items	reduced	to	72	items).	Test	retest	reliability	
of	ePAQ-MPH	was	undertaken	with	30	participants	using	Version	1	of	ePAQ-MPH.	Intra-class	
correlation	coefficient	values	ranged	from	0.45	to	0.9;	the	minimum	accepted	value	of	0.5,	
was	not	achieved	 in	 the	hormonal	/	sexual	 function	domain	(0.45).	 Interclass	correlation	
>0.5	was	seen	 in	all	other	domains.	For	criterion	validity	of	Version	1	of	ePAQ-MPH,	180	
patients	 completed	 the	MDQ	 PROM	 and	 213	 completed	 the	WHQ	 PROM.	 Two	 of	 the	 18	
domains	 of	 ePAQ-MPH	 (Version	 1)	 had	 a	 relevant	 domain	 in	 both	MDQ	 and	WHQ.	 Eight	
domains	 were	 compared	 with	 MDQ	 showing	 moderate	 or	 strong	 correlation	 in	 seven	
domains.	 Ten	 domains	 were	 compared	 with	 WHQ,	 six	 of	 which	 showed	 moderate	
correlation.		
Following	this	initial	psychometric	testing,	all	redundant	items	were	removed	from	version	
1	of	ePAQ-MPH	and	the	PROM	restructured.	To	confirm	the	conceptual	model	of	ePAQ-MPH,	
a	confirmatory	factor	analysis	(CFA)	using	Mplus	version	8.0	(Muthen	&	Muthen,	2017,	Los	
Angeles,	CA)	was	undertaken	by	on	254	completed	questionnaires	(ePAQ-MPH	Version	2)56.	
Overall,	the	findings	suggested	that	that	the	ePAQ-MPH	structure	fits	the	data	moderately	
well57.	Having	confirmed	the	conceptual	framework	for	ePAQ-MPH,	the	PROM	structure	for	
patient	administration	was	reorganised.	The	single	NMBD	domain	(intermenstrual	bleeding)	
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was	relocated	into	the	Menstrual	dimension	and	the	five	domains	relating	to	sexual	function	
(menstruation	and	sexual	function,	dyspareunia,	pain	and	sexual	function	and	hormones	and	
sexual	function)	were	moved	into	a	new	Sexual	dimension,	thus	version	3	of	ePAQ-MPH	was	
finalised.	Initial	psychometric	testing	of	ePAQ-MPH	has	shown	good	internal	reliability,	test-
retest	 reliability	 and	 criterion	validity.	The	 results	of	 the	 initial	psychometric	 testing	has	
enabled	 remodelling	 of	 the	 instrument.	 The	 confirmatory	 factor	 analysis	 of	 the	 revised	
instrument	has	shown	that	the	domain	structure	of	ePAQ-MPH	fits	the	data	it	is	intended	to	
collect	 moderately	 well	 and	 good	 model	 fit	 was	 also	 demonstrated,	 confirming	 the	
conceptual	 framework	 of	 the	 instrument.	 Whilst	 this	 paper	 reports	 the	 development	 of	
version	3	of	ePAQ-MPH,	to	allow	other	research	groups	to	scrutinise	and	review	the	data	
generated	 thus	 far,	wider	 evaluation	 and	 psychometric	 testing	 of	 this	 latest	 and	 current	
version	of	ePAQ-MPH	is	now	required	in	larger	samples	and	in	different	settings,	including	
tests	of	stability,	tests	of	data	quality,	sensitivity	and	responsiveness	to	change.	So	far,	ePAQ-
MPH	shows	good	potential	as	an	ePROM;	providing	objective	patient-based	data	which	could	
be	utilised	for	assessment,	service	evaluation	and	research.		
	
5.3 The	utility	of	ePROMs	as	research	tools	in	gynaecology	
	
5.3.1 Quantitative	research	using	ePROMs	in	gynaecology	
PROMs	in	gynaecology	were	first	developed	as	research	tools	to	measure	the	outcome	
following	an	intervention	(or	control)	as	part	of	a	study.	The	value	of	using	patient	focussed	
tools	as	part	of	routine	clinical	care	has	become	apparent	over	time,	although	there	is	still	
little	agreement	on	which	tools	should	be	used	in	which	settings.		
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Good	quality	research	assessing	patient	outcomes	depends	on	using	PROMs	which	have	
good	evidence	for	reliability	and	validity.	Studies	which	use	non-validated	tools	are	at	risk	
of	creating	biased	and	unreliable	results.	The	tool	used	in	the	three	gynaecology	ePROM	
original	research	papers	forming	part	of	this	thesis	(Paper	5,	Paper	6	and	Paper	7)	all	
utilise	ePAQ-Pelvic	Floor	which	has	excellent	evidence	for	reliability	and	validity6,	15,	20.		
A	key	advantage	of	using	an	ePROM	as	part	of	routine	clinical	care,	both	at	initial	
assessment	and	follow	up	after	interventions,	is	that	a	large	amount	of	data	is	prospectively	
collected	and	available	for	analysis.	However,	in	order	to	ensure	good	research	governance,	
it	is	essential	that	appropriate	consent	for	use	of	the	data	in	research	is	obtained	from	each	
patient,	each	time	they	complete	the	ePROM.	In	addition,	each	research	project	should	be	
appropriately	registered	and	approved.	The	final	item	in	ePAQ-Pelvic	Floor	asks	patients:	
“Are	you	willing	to	allow	confidential	use	of	your	answers	to	this	questionnaire	for	
appropriate	approved	and	regulated	research,	audit	or	service	evaluation	projects?”.	Only	
data	from	patients	who	answer	‘yes’	to	this	question	is	then	able	to	be	used	in	approved	
studies.	Separate	ethical	approval	for	each	of	the	three	original	research	studies	using	
ePAQ-Pelvic	Floor	data	in	this	thesis	was	obtained	in	addition	to	the	patients’	individual	
permissions.			
ePAQ-Pelvic	Floor	presents	132	items	across	four	symptom	dimensions.	It	is	able	to	assess	
urinary	symptoms,	bowel	symptoms,	vaginal	symptoms	and	sexual	symptoms;	all	of	these	
symptom	areas	are	important	in	urogynaecology.	The	twenty	scored	domains	each	consist	
of	three	to	five	questions	assessing	symptoms	and	their	impact	on	HRQoL.	Thus,	a	very	
large	amount	of	data	is	collected	and	processed.	Each	individual	symptom	question	is	
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scored	out	of	four	and	each	domain	(comprising	three-six	questions	in	related	areas)	is	
scored	out	of	100	using	an	algorithm.	This	system	of	quantitative	data	and	scoring	allows	
for	symptoms	occurring	in	different	domains	to	be	compared	using	statistical	tests	to	
measure	associations.	It	also	allows	for	symptom	scores	to	be	compared	before	and	after	
an	intervention.	The	datasets	accumulated	by	ePAQ-Pelvic	Floor	are	large,	demonstrating	
statistical	significance	of	associations	and	changes	after	intervention	is	both	feasible	and	
potentially	very	valuable.	
	
Paper	 58	 of	 this	 thesis	 is	 a	 retrospective	 cohort	 study	 assessing	 the	 prevalence	 and	
associations	of	coital	urinary	incontinence	in	women	attending	the	urogynaecology	teaching	
clinic	at	Sheffield	Teaching	Hospitals,	using	data	from	ePAQ-Pelvic	Floor.	Coital	incontinence	
is	the	complaint	of	involuntary	loss	of	urine	associated	with	sexual	intercourse	(coitus).	This	
can	be	 further	divided	 into	 coital	 incontinence	occurring	with	penetration	at	 the	 start	 of	
intercourse	and	that	occurring	at	orgasm58.	The	aim	of	the	study	was	to	accurately	measure	
the	 prevalence	 of	 coital	 incontinence	 in	women	 attending	 the	 urogynaecology	 clinic	 and	
evaluate	the	association	between	different	types	of	coital	incontinence	and	different	types	of	
urinary	incontinence	(stress	incontinence	and	overactive	bladder)	and	HRQoL.	Previously	it	
was	 thought	 that	 coital	 incontinence	 at	 orgasm	 was	 due	 to	 overactive	 bladder	 (OAB)	
(inappropriate	bladder	contractions	causing	leakage)	and	that	incontinence	at	penetration	
was	 due	 to	 stress	 incontinence	 (SUI)	 (leakage	 with	 raised	 intra-abdominal	 pressure	
secondary	to	weakness	of	the	muscles	at	the	bladder	neck.	Data	from	2212	patients	who	had	
completed	ePAQ-Pelvic	Floor	and	consented	for	use	of	their	data	was	analysed.	The	results	
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showed	 that	 the	 prevalence	 of	 coital	 incontinence	 in	 the	 cohort	was	 30%.	 Symptoms	 of	
overactive	 bladder	 (p<0.005)	 and	 stress	 urinary	 incontinence	 (p<0.005)	 were	 both	
significantly	and	independently	associated	with	both	types	of	coital	incontinence	(orgasm	&	
penetration).	This	was	 in	 contrast	 to	 the	previously	held	view	 that	 coital	 incontinence	at	
orgasm	was	 only	 associated	with	 overactive	 bladder.	 In	women	with	 coital	 incontinence	
compared	 with	 those	 without,	 there	 was	 significant	 self-avoidance	 of	 sex	 (p<0.0005),	
partner-avoidance	of	sex	(p<0.0005)	and	impaired	quality-of-sex-life	due	to	sexual	problems	
(p<0.005).	The	impact	of	this	was	significant	in	each	group.	Therefore,	the	symptom	of	coital	
incontinence	 may	 be	 a	 significant	 factor	 in	 sexual	 dysfunction	 in	 women	 with	 coital	
incontinence.		
	
Paper	659	of	this	thesis	was	a	retrospective	cohort	study	using	quantitative	data	from	ePAQ-
Pelvic	 Floor.	 The	 aim	 of	 this	 study	was	 to	 assess	 the	 relationship	 between	 pelvic	 organ	
prolapse	(POP)	symptoms	as	assessed	by	ePAQ	pelvic	floor,	subjective	outcomes	of	surgery	
and	the	patients’’	body	mass	 index	(BMI)	 in	women	undergoing	vaginal	hysterectomy	for	
POP.	The	rationale	for	undertaking	this	study	is	that	obesity	is	a	significant	risk	factor	for	
pelvic	organ	prolapse	(POP),	but	the	effects	of	obesity	on	outcomes	of	surgery	for	POP	are	
poorly	understood60-63.		
Pre-	and	post-operative	data	from	ePAQ-Pelvic	floor	were	collected	prospectively	from	60	
women	undergoing	vaginal	hysterectomy	for	POP.	Of	these	women,	20	were	normal	weight	
(BMI	18.5	–	24.9),	20	were	overweight	(BMI	25	–	29.9)	and	20	were	women	with	obesity	
(BMI	30	–	34.9).		The	relationship	between	BMI	and	symptom	scores	for	prolapse,	impact	on	
vaginal	symptoms	on	quality	of	life	and	‘overall	change	in	condition’	was	assessed.	Pre-	and	
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post-operative	symptom	scores	were	compared	using	repeated	mixed	ANOVA	test	for	BMI	
as	 a	 categorical	 variable	 (Normal,	 Overweight	 and	 Obese).	 Spearman’s	 rank	 order	
correlation	 test	 was	 carried	 out	 to	 evaluate	 BMI	 as	 a	 continuous	 variable.	 All	 women	
underwent	 vaginal	 hysterectomy	 using	 a	 standardised	 technique	 undertaken	 by	 four	
surgeons.	
The	results	showed	that	93%	of	women	reported	improvement	in	their	condition.	The	main	
finding	was	that	‘Overall	change	in	condition’	was	negatively	correlated	with	increasing	BMI	
(rs=	 -0.324,	 p=0.028).	 Irrespective	 of	 BMI,	 significant	 improvements	 were	 observed	 in	
symptoms	of	prolapse	and	the	impact	of	vaginal	symptoms	on	quality	of	life	at	three-months	
post	operation.		Therefore,	with	increasing	BMI,	women	may	be	more	likely	to	report	lower	
levels	of	satisfaction	following	prolapse	surgery,	despite	reporting	equivalent	improvements	
in	symptoms	compared	to	those	with	normal	BMI.	Previous	studies	have	shown	that	BMI	is	
known	 to	affect	how	 individuals	perceive	 their	general	health	and	well-being	with	obese	
individuals	reporting	poorer	levels	of	subjective	health	status64-66.		Therefore,	women	with	
obesity	may	actually	perceive	change	in	their	condition	after	prolapse	surgery	differently	to	
women	of	normal	weight.		Reduction	of	weight	prior	to	prolapse	surgery	could	be	considered	
in	obese	women	to	improve	subjective	outcomes	of	surgery.		
The	main	 limitations	 of	 this	 study	were	 the	 short	 follow	 up	 period	 after	 surgery	 (three	
months)	and	lack	of	pre-	and	post-operative	objective	data,	including	pelvic	organ	prolapse	
quantification	(POP-Q)	scores,	although	this	would	have	looked	at	objective	outcomes	which	
are	now	widely	recognized	to	be	less	important	than	subjective	outcomes67,	68.		Of	course,	it	
is	possible	 that	patients	who	were	 	not	satisfied	with	 their	surgery	may	have	disengaged	
from	the	follow	up	process	and	not	completed	the	post-op	questionnaire	that	was	requested,	
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thereby	introducing	reporting	bias.	 	However,	the	comprehensive	pre-	and	post-operative	
questionnaire	data	collected	with	ePAQ-Pelvic	Floor	 from	60	patients	undergoing	vaginal	
hysterectomy	 for	 prolapse	 has	 permitted	 a	 detailed	 comparison	 of	 subjective	 outcomes	
between	different	BMI	groups	in	this	small	study.		The	main	recommendation	following	this	
small	study	could	be	that,	because	women	with	increasing	BMI	are	likely	to	be	satisfied	to	a	
lesser	 degree	with	 the	 outcome	 of	 prolapse	 surgery,	 they	 should	 perhaps	 be	 counselled	
about	 this	 pre-operatively;	 or	 else	 weight	 loss	 prior	 to	 surgery	 be	 recommend.	 Future	
studies	 in	 this	 area	 should	 investigate	 the	 impact	 of	 obesity	 on	 outcomes	 of	 surgery	 for	
anterior	 and	 posterior	 compartment	 prolapse,	 assessing	 both	 subjective	 and	 objective	
outcomes,	with	long	term	follow	up	to	assess	the	impact	of	BMI	on	prolapse	recurrence	in	
addition.			
	
5.3.2 Qualitative	research	using	ePROMs	in	gynaecology	
Most	PROMS	used	in	gynaecology	use	multiple	choice	questions	(MCQs)	to	assess	for	the	
presence	of	symptoms	and	their	impact	on	function	and	HRQoL.	Data	collected	using	these	
types	of	questions	provides	quantitative	data,	but	in	reality	it	may	lack	both	sensitivity	and	
acuity	required	to	individualise	each	patient’s	concerns	and	goals.	This	is	especially	
important	with	regard	to	treatment	which	is	often	highly	individualised	and	dependent	on	
many	different	factors,	such	as	personal	preference	and	previous	treatments69.		
The	use	of	free	text	responses	within	PROMs,	which	allow	the	patient	to	provide	their	own	
written	response	to	a	question,	can	help	to	provide	a	qualitative	component	to	the	data	
collected	and	provides	an	important	opportunity	for	the	patient	to	express	themselves.	
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ePAQ-Pelvic	Floor	uses	free	text	components	in	this	way.	The	penultimate	item	in	ePAQ-
Pelvic	Floor	is	a	free-text	question:	‘Considering	the	issues	that	currently	concern	you	the	
most,	what	do	you	hope	to	achieve	from	any	help,	advice	or	treatment?’.	The	patient’s	free-
text	responses	to	this	question	are	then	presented	at	the	very	top	of	the	structured	report	
which	the	clinician	uses	to	review	the	results	prior	to	and	during	the	consultation	(face	to	
face	or	virtual)	with	the	patient.	The	purpose	of	using	this	free-text	information	is	to	give	
an	additional	qualitative	and	personalised	component	to	patient	assessment,	alongside	
quantitative	data	from	the	closed	MCQ	elements	of	the	ePAQ-Pelvic	Floor.		
Although	free-text	data	are	commonly	included	in	patient	reported	outcome	measures	
alongside	quantitative	components,	these	types	of	data	are	rarely	used	in	research	as	
components	of	free-text	responses	may	vary	in	relevance	to	the	research	question	posed70	
and	analysis	of	qualitative	data	presents	methodological	challenges.	Reading	through	free	
text	comments	and	analysing/categorising	them	can	be	very	time	consuming	and	difficult	
to	approach	in	a	standardised	way.	As	a	result,	free-text	data	are	often	neglected	even	
though	they	may	represent	a	potentially	rich	source	of	data,	which	can	supplement,	
augment	and	compliment	more	traditional	quantitative	data71.		
	
Paper	728	of	this	thesis	is	a	content	analysis46	of	free-text	data	from	ePAQ-Pelvic	Floor.	The	
objective	of	this	study	was	to	analyse	themes	and	content	of	free-text	concerns	and	goals	
recorded	in	response	the	free-text	concerns	and	goals	item	and	measure	how	these	
responses	related	to	the	quantitative	data	recorded	in	MCQ	items	in	ePAQ-PF.	A	further	
objective	was	to	identify	any	elements	of	urogynaecology	care	not	currently	addressed	by	
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the	ePROM.	The	main	findings	were	the	free-text	component	of	ePAQ-PF	was	used	by	over	
60%	of	patients	completing	the	ePROM.	The	majority	(x=90%)	of	themes	which	were	
identified	from	the	content	analysis	fitted	into	the	existing	domain	structure	of	ePAQ-Pelvic	
Floor.	An	important	finding	was	that	specific	body-image	concerns	were	recorded	by	10%	
(n=136)	of	patients	responding	to	the	free-text	question.	Body	image	in	urogynaecology	is	
an	issue	which	is	not	currently	addressed	by	the	MCQ	items	of	ePAQ-Pelvic	Floor.		The	most	
commonly	reported	patient	goals	identified	by	the	content	analysis	related	to	seeking	
improvement	or	cure	of	urogynaecology	conditions	and	improved	physical	or	sexual	
function.	As	a	result	of	this	study	a	new	domain	to	assess	body	image	within	ePAQ-Pelvic	
Floor	has	been	developed	and	is	currently	undergoing	psychometric	testing	which	will	be	
submitted	for	publication.	Paper	121	of	this	thesis	assessed	the	existing	tools	which	can	do	
this	in	a	urogynaecology	setting	and	was	used	to	inform	content	validity	of	the	new	domain.		
	
	
5.4 Using	ePROMs	to	increase	reporting	of	sensitive	symptoms	
	
It	has	previously	been	shown	that	ePROMs	can	increase	discussion	rates	in	consultations	
about	sensitive	symptoms.	This	was	because	patients	had	completed	the	ePROM	in	private	
and	therefore	felt	better	able	to	disclose	potentially	embarrassing	symptoms.	This	then	
allowed	the	clinician	to	initiate	a	discussion	with	the	patient	about	these	sensitive	
symptoms	and	therefore	devise	a	management	strategy	which	aimed	to	address	these	
issues.	Using	ePROMs	therefore	should	be	considered	in	symptom	areas	with	sensitive,	
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taboo	and	potentially	embarrassing	symptoms,	as	patients	may	not	disclose	these	
symptoms,	even	when	direct	questioning	is	employed.		
	
A	good	example	of	this	is	in	paper	58	of	this	narrative	thesis.	The	reported	prevalence	of	
coital	urinary	incontinence	(leaking	urine	during	sexual	intercourse)	in	this	study	was	47%	
in	women	reporting	urinary	incontinence.		This	is	the	largest	study	to-date	relating	to	coital	
incontinence	in	women	attending	a	urogynaecology	clinic.	These	results	are	comparable	to	
a	previous	study	in	an	earlier	cohort	of	women	from	the	same	unit,	which	found	a	coital	
incontinence	prevalence	of	60%	in	women	undergoing	urodynamic	studies	for	urinary	
incontinence72.	
A	review	of	the	literature	shows	that	six	previous	studies	have	shown	rates	of	coital	
incontinence	in	women	with	urinary	incontinence	to	vary	between	10%	-	66%72-77.	
Including	this	study,	three	of	these	seven	studies	have	assessed	coital	incontinence	in	
women	attending	a	urogynaecology	clinic.	The	prevalence	was	10%74	when	direct	
questioning	was	used	to	assess	prevalence	and	36%73	and	47%8	when	a	validated	
questionnaire	was	used.	Four	studies	assessed	the	prevalence	of	coital	incontinence	in	
women	undergoing	urodynamics,	these	women	are	likely	to	have	a	more	severe	degree	of	
coital	incontinence.	Two	of	these	studies	used	direct	questioning	to	assess	this	and	both	
found	a	prevalence	of	11%77,	78.	The	other	two	studies	used	validated	(ePAQ-Pelvic	Floor)	
or	non-validated	(author’s	own)	PROMs	to	assess	prevalence	and	found	it	to	be	60%72	and	
66%76	respectively.	The	substantially	higher	prevalence	of	coital	incontinence	in	women	
undergoing	urodynamics,	compared	with	women	attending	a	urogynaecology	clinic,	is	
likely	to	be	a	reflection	of	more	severe	symptoms	in	women	undergoing	urodynamics.	It	is	
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apparent	that	using	a	PROM,	does	significantly	increase	the	disclosure	of	coital	urinary	
incontinence	and	therefore	the	reported	prevalence	of	coital	incontinence,	compared	with	
direct	questioning.	This	is	likely	to	be	due	to	embarrassment	and	the	taboo	nature	of	this	
intimate	problem.		
	
Similarly,	in	paper	121	of	this	narrative	thesis,	which	assessed	tools	(including	PROMs	and	
ePROMs)	available	to	identify	women	with	anal	incontinence	symptoms	following	
childbirth,	the	type	of	tool	(PROM	or	patient	interview)	was	shown	to	be	a	significant	factor	
in	the	reported	prevalence	of	anal	incontinence	symptoms	in	studies	included.	Lower	rates	
of	anal	incontinence	were	observed	when	personalised	data	collection	methods	(i.e.	face	to	
face	interview	or	telephone	interview)	were	used,	compared	with	non-personalised	
methods	(PROM	or	ePROM).	This	important	finding	was	demonstrated	at	both	short	and	
long-term	periods	of	follow	up	and	was	found	to	be	statistically	significant	at	the	six	weeks	
to	one	year	follow-up	period.	Interestingly,	this	finding	mirrored	those	of	systematic	
reviews	of	the	prevalence	of	faecal	incontinence	where	reporting	of	faecal	incontinence	
symptoms	was	found	to	be	lower	when	face-to-face	and	telephone	interviews	were	used	to	
assess	these	embarrassing	symptoms,	when	compared	to	PROMs79.	
In	a	previous	study,	two	of	the	main	barriers	to	accessing	care	for	anal	incontinence	were	
shown	to	be	embarrassment	and	stigma	which	were	manifested	as	deeply	felt	shame	in	
violating	a	social	taboo	to	not	talk	about	bowel	symptoms80.	This	means	that	many	women	
living	with	anal	incontinence	symptoms	after	childbirth	may	not	seek	healthcare,	despite	a	
number	of	healthcare	contacts	during	the	post-natal	period,	such	as	routine	postnatal	
follow	up,	infant	vaccinations	and	development	assessments;	which	lead	to	interactions	
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with	healthcare	professionals	including	midwives,	health	visitors	and	general	
practitioners.	These	contacts	could	present	a	number	of	opportunities	where	a	PROM	or	
ePROM	could	be	administered	routinely	to	identify	women	with	anal	incontinence	
symptoms;	potentially	enabling	access	to	care	for	such	affected	women.	Using	ePAQ-Pelvic	
Floor	in	this	context	will	be	the	subject	of	a	further	study.		
As	there	is	good	evidence	that	ePROMs	result	in	increased	disclosure	of	taboo	and	
embarrassing	symptoms,	it	could	be	argued	that	their	routine	use	in	gynaecology	should	
be	mandatory;	to	enhances	self-expression	and	improve	access	to	care.	This	would	require	
consensus	and	recommendations	from	governing	bodies,	making	recommendations	based	
on	the	available	evidence.		
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Abstract	
Aim:	Anal	incontinence	following	childbirth	is	prevalent	and	has	a	significant	impact	upon	
quality-of-life.	Currently,	there	is	no	standard	assessment	for	women	after	childbirth	to	
identify	these	symptoms.	This	systematic	review	aimed	to	identify	non-invasive	modalities	
that	have	been	used	to	identify	women	with	anal	incontinence	following	childbirth	and	
assess	response	rates	and	reporting	rates	of	anal	incontinence	for	these	modalities.	
Methods:	Ovid	Medline,	AMED,	CINAHL,	Cochrane	Collaboration,	EMBASE	and	Web	of	
Science	databases	were	searched	for	studies	using	non-invasive	modalities	to	identify	
women	with	anal	incontinence	following	childbirth,	published	from	January	1966	to	May	
2018.	Study	data	including	type	of	modality,	response	rates	and	reported	prevalence	of	
anal	incontinence	were	extracted	and	critically	appraised.	
Results:	109	studies	were	included	from	1602	screened	articles.	Three	types	of	non-
invasive	modality	were	identified:	validated	questionnaires/symptom	scales	(n=36	studies	
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utilising	15	different	instruments),	non-validated	questionnaires	(n=50	studies)	and	
patient	interviews	(n=23	studies).	Mean	response	rates	were	92%	up	to	six	weeks	after	
childbirth.	Non-personalised	assessment	modalities	(validated	and	non-validated	
questionnaires)	were	associated	with	reporting	of	higher	rates	of	anal	incontinence	
compared	to	patient	interview	at	all	periods	of	follow	up	after	childbirth,	this	was	
statistically	significant	between	six	weeks	and	one	year	after	childbirth	(p<0.05).			
Conclusion:	This	systematic	review	confirms	that	questionnaires	can	be	used	effectively	
after	childbirth	to	identify	women	with	anal	incontinence.	Given	the	
methodological	limitations	associated	with	non-validated	questionnaires;	the	role	of	
providing	assessment	for	all	women	following	childbirth	using	validated	questionnaires	to	
assess	pelvic-floor	symptomatology,	including	anal	incontinence,	should	be	considered.	
	
Keywords:	Anal	incontinence,	faecal	incontinence,	postnatal,	patient	reported	outcomes,	
questionnaires	
	
Brief	Summary	
	This	systematic	review	identified	14	validated	patient	reported	outcome	measures	which	
could	potentially	be	used	routinely	to	identify	women	with	anal	incontinence	symptoms	
after	childbirth.		
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Introduction		
Anal	incontinence	is	a	common	condition	affecting	up	to	20%	of	adult	women	[1].	It	has	a	
profound	and	significant	effect	on	quality	of	life	[2]	and	is	associated	with	significant	
healthcare	costs	[3].	The	joint	International	Urogynaecological	Association/International	
Continence	Society	definition	of	anal	incontinence	symptoms	include	faecal	incontinence;	
defined	as	involuntary	loss	of	faeces	(solid	and/or	liquid	stool)	and	flatus	incontinence;	
defined	as	involuntary	loss	of	flatus	[4].		
	
The	main	aetiological	factor	in	the	development	of	anal	incontinence	in	women	is	
childbirth;	causing	injury	either	to	the	anal	sphincter	complex,	pelvic	nerves	or	both	[5].	
The	condition	often	goes	unrecognised	at	the	time	of	delivery	and,	even	when	managed	
appropriately,	can	lead	to	lasting	problems,	which	are	also	frequently	unreported	to	
healthcare	providers	[6].		
	
Many	women	may	perceive	anal	incontinence	symptoms	such	as	flatus	incontinence	to	be	
normal	following	childbirth	and	barriers	to	accessing	care	in	this	context	include	shame	
and	embarrassment,	as	well	as	a	lack	of	knowledge	of	potential	treatments;	many	of	which	
are	minimally	invasive	[7].	Many	general	practitioners	are	also	unaware	of	treatments	and	
local	care	pathways	for	women	with	anal	incontinence	following	childbirth	[8].	In	the	UK	
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and	many	other	countries,	there	is	currently	no	standardised	assessment	for	women	in	the	
postnatal	period	to	identify	those	who	are	affected	by	anal	incontinence	symptoms.	This	is	
despite	a	number	of	routine	healthcare	contacts	during	this	time,	including	with	midwives,	
general	practitioners	and	health	visitors;	potentially	yielding	an	opportunity	for	the	
condition	to	be	assessed	and	appropriate	access	to	care	provided	if	indicated.	There	are	a	
number	of	patient	reported	outcome	measures	and	symptom	scales	available	which	could	
potentially	be	used	in	this	context.	
	
If	women	with	anal	incontinence	symptoms	are	identified	in	a	timely	fashion	after	
childbirth,	there	is	an	opportunity	to	offer	them	access	to	appropriate	care.	This	may	
include	physiotherapy	and	assessment	in	a	functional	bowel	clinic	under	the	care	of	a	
colorectal	team	with	access	to	endoanal	ultrasound	scanning	and	manometry,	followed	by	
appropriate	treatment.		
	
The	primary	aim	of	this	systematic	review	was	to	identify	non-invasive	modalities	used	to	
detect	women	with	anal	incontinence	symptoms	following	childbirth.		Secondary	aims	
were	comparison	of	response	rates	and	prevalence	rates	of	anal	incontinence	symptoms	
using	the	different	types	of	modalities	identified.		It	was	anticipated	that	the	non-invasive	
modalities	would	include	tools	such	as	questionnaires	and	patient-reported	outcome	
measures,	which	are	increasingly	used	in	clinical	practice	to	identify	patients	with	sensitive	
and	potentially	embarrassing	symptoms.		
		
Methods		
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This	systematic	review	of	the	literature	followed	the	PRISMA	guidelines	[9]	and	was	
designed	to	capture	studies	where	a	population	of	women	had	been	studied	after	childbirth	
and	a	non-invasive	modality	or	tool	was	used	to	identify	anal	incontinence	symptoms.	This	
systematic	review	was	registered	prospectively	on	the	PROSPERO	database	(registration	
number:	CRD42017082508).	
	
The	study	population	was	women	following	childbirth.	The	intervention	studied	was	any	
non-invasive	modality	which	enabled	the	identification	of	anal	incontinence	symptoms.		
	
Ovid	Medline,	AMED,	CINAHL,	Cochrane	library,	EMBASE	and	Web	of	Science	databases	
were	searched	using	medical	subject	heading	(MeSH)	theme	‘faecal	incontinence’	and	the	
keyword	‘anal	incontinence’	(which	is	not	currently	a	MeSH	theme).	These	were	combined	
using	Boolean	AND	operators	with	the	following	MeSH	themes:	‘prevalence’,	‘incidence’,	
‘communication’,	‘decision	making’,	‘surveys	and	questionnaires’,	‘access’,	‘pathway’,	‘care’,	
‘antenatal’,	‘postnatal’,	‘computer/internet’	for	studies	published	between	January	1966	
and	May	2018	(inclusive).	Studies	included	were	limited	to	adult	female	human	subjects	
and	were	restricted	to	English	language	publications.	Conference	abstracts	were	excluded.		
The	rationale	for	restricting	to	English	language	was	to	identify	tools	suitable	for	use	in	the	
UK	population	and	also	because	the	research	team	lacked	the	language	skills	and	resources	
to	translate	those	papers	published	in	languages	other	than	English.	
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Only	studies	that	specifically	assessed	women	following	childbirth,	or	studies	in	which	this	
group	was	identified	separately	within	the	results	of	the	study	were	included.	The	
following	were	excluded:	
• Studies	assessing	prevalence	in	community-based	adults	
• Studies	in	which	women	had	already	been	identified	with	anal	incontinence	
following	childbirth	(interventional	studies	including	women	with	known	
incontinence	after	childbirth)	
• Studies	which	used	invasive	modalities,	such	as	endoanal	ultrasound	or	manometry	
The	primary	outcome	was	the	type	of	modality	used	to	identify	women	with	anal	
incontinence	after	childbirth.	Secondary	outcomes	included	response	rates	to	the	identified	
modalities	and	prevalence	rates	of	anal	incontinence	reported	following	childbirth	
(including	rates	of	incontinence	to	flatus,	liquid	stool	and	solid	stool	where	reported)	in	
order	that	the	prevalence	reported	for	the	different	types	of	modalities	could	be	compared.	
	
Two	reviewers	(TGG	and	SCR)	independently	reviewed	all	the	abstracts	identified	by	the	
literature	search	to	identify	papers	of	potential	interest.	All	papers	of	potential	interest	to	
the	review	were	obtained	and	read	by	two	reviewers	(TGG	and	HV)	to	identify	those	that	
were	relevant.	Studies	were	included	only	with	the	agreement	of	both	reviewers	following	
evaluation	of	full	manuscripts.	Any	disparities	were	resolved	by	consensus	and,	if	required,	
arbitration	by	a	third	reviewer	(SJ).	A	manual	search	of	the	reference	list	of	each	
manuscript	was	also	conducted	by	both	reviewers	to	identify	further	studies	of	relevance	
to	the	systematic	review.	
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The	same	two	reviewers	independently	extracted	data	from	the	included	studies	onto	an	
electronic	data	collection	form.	These	were	compared	and	a	summary	table	of	consensus	
data	was	compiled.	Critical	appraisal	of	study	quality	was	undertaken	according	to	the	
principles	of	the	STROBE	statement	for	observational	studies	and	Centre	for	Evidence	
Based	Medicine	questionnaires	for	cross-sectional	surveys	[10,	11],	to	assess	the	data	
quality	of	included	studies	similarly	to	methods	used	in	previous	comparable	systematic	
reviews.	Studies	were	scored	out	of	four	for	data	quality-	one	point	being	given	for	use	of	
representative	sampling,	one	point	for	response	rate	greater	than	50%,	one	point	for	use	of	
a	self-administered	and	robustly	validated	assessment	tool	(administered	in	its	original	
format	and	language	of	validation	and	not	altered	by	the	authors	of	the	relevant	study)	and	
one	point	for	95%	confidence	interval	for	the	estimated	prevalence	of	anal	incontinence	of	
no	more	than	2%.	Studies	scoring	3+	were	deemed	to	be	of	high	quality.		
Differences	in	the	mean	prevalence	of	anal	incontinence	were	compared	for	the	different	
modalities	identified	using	paired	t-	test.	A	p	value	of	less	than	0.05	was	considered	
statistically	significant.		
	
Results	
A	total	of	1602	studies	(excluding	any	duplicates)	were	identified	for	screening	with	1296	
discarded	on	title	and	abstract	alone.	Of	the	remaining	studies,	306	manuscripts	were	
reviewed	in	full	with	109	studies	ultimately	being	included	for	final	analysis	(figure	1).	A	
total	of	80,935	women	were	included	in	this	systematic	review.	In	total	33	of	the	109	
studies	scored	three	or	higher	for	data	quality	(	Supplementary	Tables	1,	2	and	3).	
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Three	types	of	modality	were	used	to	identify	anal	incontinence	symptoms	in	women	
following	childbirth:	validated	patient-reported	outcome	measures	or	symptom	scales	(i.e.	
instruments	that	have	undergone	an	element	of	psychometric	testing)	(36	studies-	
Supplementary	Table	1)	[2,	12-46],	non-validated	questionnaires	(50	studies-	
Supplementary	Table	2)	[47-96]	and	patient	interview,	both	face	to	face	and	telephone	(23	
studies-	Supplementary	Table	3)	[97-119].	Of	the	36	studies	using	a	validated	patient-
reported	outcome	measure	or	symptom	scale,	15	different	instruments	were	used	(Table	
1).		
	
The	duration	of	follow	up	in	the	109	studies	varied	between	38	days	and	34	years.	Eleven	
studies	conducted	follow-up	within	six	weeks	of	delivery	[12,	47-49,	64-66,	82,	97,	108-
109],	fifty	two	conducted	follow	up	after	six	weeks	and	up	to	one	year	[13-21,	28-33,	40-
41,	46,	50-58,	67-72,	83-86,	98-107,	110-115,119],	sixteen	studies	conducted	follow	up	
between	two	and	five	years	[22,	32,	42-45,	59-60,	73,	87-91,	94-95],	and	twenty	six	studies	
conducted	follow	up	at	greater	than	five	years	[2,	23-27,	33-38,61-63,	74-79,	92-93,	116-
118	].	Four	included	studies	did	not	collect	data	on	length	of	time	to	follow	up	after	
childbirth	[39,	80-81,	96].	
	
Seven	studies	did	not	report	response	rates	to	the	modality	used	to	assess	anal	
incontinence	symptoms	in	postnatal	women	[47,	57,	84,	93,	and	99,111,119].	The	mean	
response	rate	was	84%	when	follow	up	was	at	six	weeks	or	less,		72%	when	follow	up	was	
between	six	weeks	and	one	year,	70%	when	follow	up	was	between	two	and	five	years	and	
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68%	when	follow	up	was	at	greater	than	five	years.	Reported	response	rates	for	
questionnaires	and	patient	interviews	were	similar	(Supplementary	Table	4).	
	
The	populations	of	women	in	the	studies	included	different	characteristics,	with	four	
broadly	different	population	types	being	identified:	(1)	Forty	four	studies	included	only	
primiparous	women	following	different	modes	of	delivery,	including	spontaneous	vaginal	
delivery,	instrumental	delivery	and		caesarean	section	[12-27,	47-63,	97-107],)	(2).	Thirty	
seven	studies	included	women	with	mixed	parities	and	mixed	modes	of	delivery	[28-39,	
64-81,	96,	108-112]	(3).	Twenty	four	studies	included	only	women	who	had	been	
diagnosed	with	obstetric	anal	sphincter	injury	(OASI)	[42-45,	82-93,	113-118]	(4).	Four	
studies	included	only	women	who	had	undergone	instrumental	delivery	with	forceps	or	
ventouse	[46,94-95,119].		
A	variety	of	different	definitions	were	used	for	anal	incontinence	in	the	studies.	Generally,	
definitions	were	based	on	functional	bowel	symptom	criteria	or	symptom	severity	scales.	
The	reported	rates	for	overall	anal	incontinence	at	different	points	of	follow-up	is	shown	
in	Table	2.	Supplementary	Tables	1-3	show	anal	incontinence	prevalence	for	each	study,	
including	different	rates	for	flatus	incontinence,	incontinence	to	liquid	stool,	incontinence	
to	solid	stool	and	overall	anal	incontinence	(as	per	Sultan	et	al,	2017[4])	where	reported	in	
each	study.		
	
Overall	reported	rates	of	different	types	of	anal	and	faecal	incontinence	varied	between	
study	populations	and	follow-up	period.	Reported	prevalence	of	anal	incontinence	was	
higher	when	non-personalised	assessment	tools	(questionnaires	and	patient-reported	
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outcome	measures,	both	validated	and	non-validated)	were	used,	compared	with	patient	
interview	(Table	2).	There	were	statistically	significant	differences	in	the	prevalence	of	
anal	incontinence	at	follow	up	between	six	weeks	and	one	year	when	validated	and	non-
validated	questionnaires	were	used,	compared	to	patient	interview	(Table	3	and	4).	At	all	
other	points	of	follow-up	there	was	no	statistically	significant	difference	in	prevalence	of	
anal	incontinence		identified	by	the	three	different	non-invasive	modalities	(Table	3-5).	
	
Discussion	
This	is	an	up-to-date	systematic	review	of	non-invasive	modalities	which	have	been	used	
to	identify	women	with	anal	incontinence	symptoms	following	childbirth	and	is	the	first	to	
specifically	assess	the	tools	used	for	this	purpose;	identifying	fourteen	validated	
instruments	that	appear	to	be	suitable.	The	present	systematic	review	has	also	confirms	
that	the	prevalence	of	anal	incontinence	symptoms	in	women	following	childbirth	is	high,	
affecting	up	to	50%	of	first-time	mothers	in	the	first	year	after	childbirth	in	studies	
published	in	2014	and	2016	[16,19].		
	
The	strengths	of	this	systematic	review	are	the	rigorous	search	strategy	employed,	which	
has	identified	the	relevant	studies,	allowing	identification	of	the	non-invasive	modalities	
available	which	have	been	used	successfully	to	identify	women	with	anal	incontinence	
after	childbirth.	The	limitations	of	this	systematic	review	include	the	heterogeneity	in	the	
definitions	used	to	describe	anal	or	faecal	incontinence	symptoms	in	the	studies	included,	
which	is	some	cases	may	have	underestimated	the	prevalence	of	anal	incontinence.	
Disparity	in	the	definition,	or	lack	of	definition,	of	what	constitutes	obstetric	anal	sphincter	
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injury	may	also	have	contaminated	the	results.	The	use	of	non-validated	questionnaires	
and	patient	interviews	(supplementary	tables	2	and	3)	may	have	also	resulted	in	over	or	
under-reporting	of	anal	incontinence	symptoms.		The	small	numbers	of	studies	for	the	
three	different	non-invasive	modalities	at	various	different	points	of	follow-up	may	have	
resulted	in	type	2	statistical	errors	when	comparing	prevalence	rates	using	paired	t	test.	
The	use	of	a	search	strategy	which	excluded	papers	not	published	in	English	and	the	grey	
literature	may	have	also	resulted	in	missing	non-invasive	modalities	potentially	relevant	
to	this	systematic	review.		
	
Whilst	there	was	a	degree	of	heterogeneity	in	the	definitions	used	to	report	anal	
incontinence	in	the	studies	included	in	this	review,	these	definitions	were	based	on	
functional	bowel	symptom	criteria	or	symptom	severity	scales.	Some	studies	had	sought	to	
only	assess	faecal	incontinence	(excluding	flatus	incontinence),	potentially	
underestimating	anal	incontinence	rates,	and	some	had	reported	as	‘faecal	incontinence’	
rates	which	actually	included	flatus	incontinence.	When	extracting	data	from	all	papers,	
the	current	IUGA/ICS	definition	of	anal	incontinence	[4]	was	used	(supplementary	tables	
1,	2	and	3).	Flatus	incontinence	is	the	most	common	symptom	in	the	spectrum	of	anal	
incontinence.	Frank	faecal	incontinence	of	liquid	or	solid	stool	is	less	common,	but	has	a	
greater	impact	on	quality	of	life	[120].	However,	studies	assessing	patient	preferences	for	
end	points	in	anal	incontinence	treatment	have	indicated	that	flatus	incontinence,	faecal	
frequency	and	faecal	urgency	are	among	the	most	bothersome	symptoms,	having	a	
significant	impact	on	quality	of	life	[121]	and	are	therefore	it	is	important	to	include	and	
assess	for	flatus	incontinence	in	addition	to	faecal	incontinence.		
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A	number	of	studies	(n=31)	in	this	systematic	review	were	published	before	Sultan’s	
classification	system	for	obstetric	anal	sphincter	injury	(OASI)	was	published	and	became	
well	established	in	clinical	practice	[122].	The	populations	identified	in	this	systematic	
review	include	studies	which	may	contain	a	larger	number	of	patients	with	either	
unrecognised	or	inadequately	repaired	third	or	fourth	degree	perineal	tears,	resulting	in	a	
higher	rate	of	anal	incontinence	symptoms	than	would	be	expected	with	current	practices.	
However,	the	reported	rates	of	third	and	fourth	degree	perineal	tears	(obstetric	anal	
sphincter	injury)	have	actually	risen	in	the	last	ten	years	[123,124].	This	has	previously	
been	attributed	in	part	to	increased	detection	and	reporting	of	third	and	fourth	degree	
tears,	however,	this	is	also	now	considered	to	be	due	to	inconsistencies	in	preventing	OASI	
in	different	units,	inconsistencies	in	midwifery	and	obstetric	training	and	skills,	lack	of	
awareness	of	risk	factors	and	the	long-term	impact	of	OASI	and	variations	in	practice	
between	midwives	and	obstetricians	[124].		Measures	to	help	reverse	this	trend	are	being	
put	in	place	with	a	current	trial	of	a	national	care	bundle	devised	by	the	Royal	College	of	
Obstetricians	and	Gynaecologists	(UK)	and	supported	by	the	Royal	College	of	Midwives	
(UK)	[125],	which	makes	use	of	the	increasing	evidence	for	specific	manual	perineal	
protection	maneuvers	[126].	It	is	clear	that	women	are	currently	at	risk	of	anal	
incontinence	following	childbirth	and	there	is	currently	a	lack	of	interventions	to	identify	
such	affected	women	following	childbirth	and	help	them	to	access	care	and	treatment.	
	
The	type	of	modality	used	(validated	questionnaire/symptom	scale,	non-validated	
questionnaire	and	patient	interview)	was	shown	to	be	a	significant	factor	in	the	reported	
prevalence	of	anal	incontinence	symptoms	in	studies	included	in	this	systematic	review	
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(Table	2).	Lower	rates	of	anal	incontinence	symptoms	were	observed	when	personalised	
data	collection	methods	(face	to	face	interview	or	telephone	interview)	were	used,	
compared	with	non-personalised	self-completed	questionnaires	(both	validated	and	non-
validated)(Tables	2-5).	This	was	demonstrated	at	both	short	and	long-term	periods	of	
follow	up	(Table	2)	and	was	statistically	significant	at	the	six	weeks	to	one	year	follow-up	
period	(Tables	3	and	4).	This	finding	mirrors	those	of	systematic	reviews	of	the	prevalence	
of	faecal	incontinence	[1]	where	reporting	of	faecal	incontinence	symptoms	was	found	to	
be	lower	when	face-to-face	and	telephone	interviews	were	used	to	assess	these	
embarrassing	symptoms,	when	compared	to	self-completed	questionnaires.	Differences	in	
the	prevalence	rates	of	anal	incontinence	between	the	different	modalities	did	not	reach	
statistical	significance	at	the	other	points	of	follow	up.	This	may	be	due	to	a	type	two	
statistical	error	due	to	the	small	sample	sizes	for	these	periods	of	follow	up,	compared	to	
the	six	week-one	year	follow	up	period	where	the	sample	sizes	were	large	enough	to	
demonstrate	a	statistically	significant	effect.			
	
It	has	previously	been	shown	that	using	non-personalised	methods	(self-completed	
questionnaires),	which	may	be	perceived	as	less	intimidating,	results	in	increased	rates	of	
disclosure	for	urinary	incontinence	compared	to	patient	interview	[127,	128].	We	would	
anticipate	that	this	would	also	be	the	case	for	reporting	of	anal	incontinence	symptoms.	
		
Two	of	the	main	barriers	to	accessing	care	for	faecal	incontinence	in	a	recently	published,	
well-designed	qualitative	study	were	embarrassment	and	stigma	which	were	manifested	as	
deeply	felt	shame	in	violating	a	social	taboo	to	not	talk	about	bowel	symptoms	[7].	This	is	
	
71	
often	compounded	by	normative	thinking,	with	patients	feeling	that	faecal	incontinence	
may	be	a	normal	symptom	following	childbirth	and	a	lack	of	knowledge	about	the	
condition	and	fear	of	investigation	or	treatment.	Therefore,	many	women	living	with	anal	
incontinence	symptoms	after	childbirth	may	not	seek	healthcare.	This	is	despite	a	number	
of	healthcare	contacts	during	the	post-natal	period,	such	as	routine	postnatal	follow	up,	
infant	vaccinations	and	development	assessments;	which	lead	to	interactions	with	
healthcare	professionals	including	midwives,	health	visitors	and	general	practitioners.	
These	contacts	present	a	number	of	opportunities	where	a	self-completed	questionnaire	
could	be	administered	routinely	to	identify	women	with	anal	incontinence	symptoms;	
potentially	enabling	access	to	care	for	affected	women.	The	relatively	high	response	rates	
to	the	modalities	evaluated	in	this	systematic	review	(Table	1)	suggest	that	using	an	
appropriate	questionnaire	to	assess	pelvic	floor	symptoms,	including	anal	incontinence	in	
the	first	year	after	childbirth	would	result	in	good	response	rates	in	clinical	practice.	
	
The	fifteen	validated	patient-reported	outcome	measures/symptom	scales	identified	by	
this	systematic	review	have	all	undergone	psychometric	testing	in	populations	of	women	
with	anal	incontinence.	The	comparison	of	psychometric	properties	of	these	instruments	
is	outside	the	scope	of	this	systematic	review.	Fourteen	of	these	tools	would	appear	to	be	
suitable	for	identifying	anal	incontinence	symptoms	following	childbirth.	The	Faecal	
Incontinence	Quality	of	Life	(FIQoL)	questionnaire	[129]	is	used	to	assess	health	related	
quality	of	life	in	patients	previously	identified	as	having	faecal	incontinence,	rather	than	as	
a	means	to	identify	those	with	the	symptom	and	is	therefore	not	suitable	for	
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administration	to	women	following	childbirth,	unless	they	are	known	to	have	anal	
incontinence.	
	
The	Jorge	and	Wexner	score	[5],	Vaizey	incontinence	score	[130],	Colorectal	Anal	Distress	
Inventory	[131],	Danish	Anal	Sphincter	Rupture	Questionnaire	[132],	St	Mark’s	Score	
[133],	Park’s	score	[134],	Bowel	Symptom	questionnaire[135],Fecal	Incontinence	
questionnaire	[136]	,	Anal	Incontinence	score	[137]	and	Manchester	Health	Questionnaire	
[138](now	modified	Manchester	Health	questionnaire	[139])	are	all	paper-based	
instruments	which	assess	anal	incontinence	and	bowel	symptoms.		
The	Australian	Pelvic	Floor	Questionnaire	[140],	Epidemiology	of	Prolapse	and	
Incontinence	Questionnaire	[141]	and	the	Personal	Assessment	Questionnaire	(PAQ)	
[142]	are	comprehensive	pelvic-floor	questionnaires	which	are	also	paper-based,	
assessing	prolapse,	vaginal	symptoms	and	urinary	incontinence	in	addition	to	anal	
incontinence	symptoms.	The	Personal	Assessment	Questionnaire	(PAQ)	[142]	has	
subsequently	been	further	validated	in	an	electronic	format	(ePAQ)	[143].		
The	validated	questionnaires	in	this	systematic	review	were	administered	to	populations	
including	ten	different	languages	(Supplementary	Table	1).	All	of	the	identified	
instruments	had	been	previously	validated	in	the	language	in	which	they	were	used	for	in	
this	study.	The	majority	of	the	symptom	scales	and	validated	questionnaires	identified	in	
this	systematic	review		have	also	been	validated	in	translated	forms	into	multiple	
languages	(Table	1).			
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When	using	patient	reported	outcome	measures	including	questionnaires	and	symptom	
scales,	it	is	important		to	use	instruments	that	are	psychometrically	robust	with	evidence	of	
their	validity,	reliability	and	functionality.	This	reduces	bias	and	ensures	the	validity	of	
results.	Studies	which	use	questionnaires	that	have	not	been	validated	for	use	in	the	
population	of	interest	may	potentially	be	subject	to	measurement	error	and	lack	ability	to	
measure	changes	in	health	status	accurately	[144].	Therefore,	any	conclusions	drawn	
cannot	be	made	with	confidence.	Where	a	validated	instrument	is	available,	it	should	be	
used	in	preference	to	a	non-validated	instrument.		
	
In	conclusion,	this	systematic	review	has	identified	three	types	of	non-invasive	modality	
which	can	be	used	to	identify	women	with	anal	incontinence	following	childbirth.	The	key	
clinical	message	is	that	using		non-personalised	assessment	methods	(validated	and	non-
validated	questionnaires/symptom	scales)	is	likely	to	be	more	effective	than	patient	
interview	when	assessing	intimate	and	embarrassing	symptoms	such	as	anal	
incontinence;	which	is	a	prevalent	symptom	following	childbirth,	with	a	significant	
potential	for	impact	on	health	related	quality	of	life.	Therefore,	the	role	of	a	national	
standard	assessment	for	all	women	following	childbirth	using	validated	questionnaires	to	
assess	for	pelvic	floor	symptoms,	including	anal	incontinence,	should	be	considered.	
Validated	questionnaires	and	symptoms	scales	should	be	used	in	preference	to	non-
validated	tools	owing	to	the	methodological	limitations	of	using	non-validated	
instruments.	Further	psychometric	validation	of	the	validated	measures	identified	in	this	
systematic	review	is	required,	in	populations	of	postnatal	women,	before	recommending	
their	use	as	part	of	routine	clinical	practice	in	this	context.	The	value	and	cost	of	using	
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appropriate	validated	tools	to	identify	affected	women,	and	subsequently	providing	access	
to	care	and	support,	also	warrants	further	research.		
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Table	1:	List	of	validated	patient	reported	outcome	measures	or	symptom	scales	identified	
in	this	systematic	review,	including	other	languages	of	validation	these	measures	are	
available	in	
	
Validated	patient	
reported	outcome	
measure/symptom	scale	
used	
Validation	
paper	
reference	
Format	of	
PROM/Symptom	
scale	
Number	of	
studies	using	
PROM/scale	in	
present	
systematic	
review	
Original	
language	of	
validation	
Subsequent	
Language(s)	
of	validation	
Jorge	and	Wexner	score	 Jorge	and	
Wexner,	1993	
Paper-based	 17	 English	 Swedish,	
Danish,	
French,	
German,	
Spanish,	
Italian,	Dutch,	
Turkish	
Anal	incontinence	score	 Pescatori	et	al,	
1992	
Paper-based	 5	 Italian	 English,	
French,	
Norwegian	
Colorectal	Anal	Distress	
Inventory	(CRADI)	
Barber	et	al,	
2001	
Paper-based	 2	 English	 Finnish,	
Korean,	Greek,	
Brazilian	
Portuguese,	
Spanish,	
Hebrew,	
Turkish,	
Chinese	
Epidemiology	of	prolapse	
and	incontinence	
questionnaire	(EPIQ)	
Lukacz	et	al,	
2005	
Paper-based	 2	 English	 Spanish	
Fecal	incontinence	
questionnaire	
Reilly	et	al,	
2000	
Paper-based	 1	 English	 -	
Australian	Pelvic	floor	
symptom	questionnaire	
Baesssler	et	al,	
2009	
Paper-based	 1	 English	 Serbian,	
French,	
German	
Bowel	symptom	
questionnaire	(BSQ)	
Talley	et	al,	
1995	
Paper-based	 1	 English	 -	
St	Marks	Score	 Maeda	at	el,	
2007	
Paper-based	 1	 English	 Norwegian,	
French,	
German,	
Spanish,	
Italian,	Dutch,	
Turkish	
Vaizey	incontinence	score	 Vaizey	et	al,	
1999	
Paper-based	 1	 English	 French,	
German,	
Spanish,	
Italian,	Dutch,	
Norwegian,	
Turkish	
Park’s	score	 Browning	and	
Parks,	1983	
Paper-based	 1	 English	 Dutch	
Personal	Assessment	
Questionnaire	(PAQ,	now	
revised	to	ePAQ-Pelvic	
Floor)	
Hiller	et	al,	
2002	
Radley	et	al,	
2006	
Electronic	 1	 English	 Italian	
Manchester	Health	
Questionnaire	
Bugg	et	al,	
2001	
Paper-based	 1	 English	 -	
Modified	Manchester	
Health	Questionnaire	
Kwon	et	al,	
2005	
Paper-based	 1	 English	 -	
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Danish	Anal	Sphincter	
Rupture	Questionnaire	
(DASRQ)	
Due	and	
Ottensen,	
2009	
Paper-based	 1	 Danish	 -	
Faecal	incontinence	
quality	of	life	survey	
(FIQoL)	
Rockwood	et	
al,	2000	
Paper-based	 1	 English	 Spanish,	
Japanese,	
French,	
Turkish,	
Norwegian,	
German	
	
Table 2 
 
Modality used Number 
of 
studies  
Response 
rate     
(mean±2SD) 
Overall anal 
incontinence 
(mean±2SD) 
Studies	with	follow	up	at	6/52	or	less	after	childbirth 
Validated questionnaire/PROM 1 100% 21% 
Non-validated questionnaire 7 92%±0.2% 22%±0.2% 
Patient interview (telephone/face to face) 3 66%±0.4% 16%±0.1% 
Studies	with	follow	up	after	6/52	up	to	1	year	after	childbirth 
Validated questionnaire/PROM 16 65%±0.4% 27%±0.3% 
Non-validated questionnaire 18 76% 0.3% 21% 0.4% 
Patient interview (telephone/face to face) 17 74%±0.2% 12%±0.2% 
Studies	with	follow	up	between	2-5	years	after	childbirth 
Validated questionnaire/PROM 6 66%0.5% 33%±0.2% 
Non-validated questionnaire 10 74%±0.2% 38%±0.3% 
Patient interview (telephone/face to face) 0 No Data No Data 
Studies	with	follow	up	at	greater	than	5	years	after	childbirth 
Validated questionnaire/PROM 12 62%±0.3% 26%±0.3% 
Non-validated questionnaire 11 68%±0.3% 31%±0.4% 
Patient interview (telephone/face to face) 3 91%±0.1% 22%±0.1% 
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Table 3: Comparison of mean prevalence rates reported for anal incontinence using validated 
questionnaires/symptom scales or patient interview 
 
Follow up 
Period after 
childbirth 
Validated 
questionnaire 
(Mean prevalence 
of anal 
incontinence±2SD) 
Patient interview 
(Mean prevalence 
of anal 
incontinence±2SD) 
T value P	value	 95%		
Confidence	
interval	
6 weeks or less 21% 
(1 study) 
16%±0.1% 
(3 studies) 
1.0 0.500	 -64.38	to	
75.38	
	
6/52 to 1 year 27%±0.3% 
(16 studies) 
12%±0.2% 
(17 studies) 
3.700 0.0021*	 6.04	to	22.46	
	
2-5 years 33%±0.2% 
(6 studies) 
No data - -	 -	
>5 years 26%±0.3% 
(12 studies) 
22%±0.1% 
(3 studies) 
1.162 0.365	 -30.57	to	
17.57	
 
 
Table 4: Comparison of mean prevalence rates reported for anal incontinence using non-validated 
questionnaires/symptom scales or patient interview 
 
Follow up 
Period after 
childbirth 
Non-validated 
questionnaire 
(Mean prevalence 
of anal 
incontinence±2SD) 
Patient interview 
(Mean prevalence 
of anal 
incontinence±2SD) 
T value P	value	 95%	
Confidence	
interval	
6 weeks or less 22%±0.2% 
(7 studies) 
16%±0.1% 
(3 studies) 
1.672 0.236	 -8.07	to	18.34	
	
6/52 to 1 year 21% 0.4% 
(18 studies) 
12%±0.2% 
(17 studies) 
2.391 0.029*	 1.123	to	18.67	
	
2-5 years 38%±0.3% 
(10 studies) 
No data - -	 -	
>5 years 31%±0.4% 
(11 studies) 
22%±0.1% 
(3 studies) 
1.311 0.320	 -15.74	to	
29.54	
	
 
 
Table 5: Comparison of mean prevalence rates reported for anal incontinence using validated 
questionnaires/symptom scales or non-validated questionnaires 
 
Follow up 
Period after 
childbirth 
Validated 
questionnaire 
(Mean prevalence 
of anal 
incontinence±2SD) 
Non-validated 
Questionnaire 
(Mean prevalence 
of anal 
incontinence±2SD) 
T value P	value	 95%	
Confidence	
interval	
6 weeks or less 21%  
(1 study) 
22%±0.2% 
(7 studies) 
2.011 0.295	 	-10.71to	
14.71	
6/52 to 1 year 27%±0.3% 
(17 Studies) 
21% 0.4% 
(18 studies) 
0.901 0.382	 -7.41	to	18.23	
	
2-5 years 33%±0.2% 
(6 studies) 
38%±0.3% 
(10 studies) 
1.571 0.178	 	-24.70	to	6.00	
	
>5 years 26%±0.3% 
(12 studies) 
31%±0.4% 
(11 studies) 
0.621 0.552	 -29.90	to	
17.20	
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Table	1	
	
	 Type	of	modality:	Validated	patient	reported	outcome	measures	
Study	
	
Study	quality	 Patient	group	 Participants	
	
Follow-up	
	
Modality	 Language	of	
questionnaire	
used	in	study	
Response	rate	to	
modality	
Flatus	
incontinence	
Faecal	
incontinence	
(liquid	stool)	
Faecal	
incontinence	(solid	
stool)	
Overall	anal	
incontinence	in	
study	(Sultan	et	al,	
2017)	
	 Primiparous	women	(all	modes	of	delivery)	
	 Follow	up	6/52	or	less	
Fynes	et	al,	1998	
	
4	 Primiparous	
women	(all	modes	
of	delivery)	
200	 6	weeks	 Anal	incontinence	
score	
English	 100%	 11.5%	 Not	reported	 1.5%	 21%	
	 Follow	up	>6/52	to	1	year	
Solans-Domènech	
et	al,	2010	
	
3	 Primiparous	
women	(all	modes	
of	delivery)	
876	 7	weeks	 Jorge	and	Wexner	
Score	
Spanish	 88.2%	 Not	reported	
separately	
Not	reported	
separately	
Not	reported	
separately	
7.3%	
Frudinger	et	al,	
2003	
3	 Primiparous	
women	(all	modes	
of	delivery)	
156	 3	months	 Jorge	and	Wexner	
questionnaire	
	
English	 95%	 Not	reported	 Not	reported	 Not	reported	 27.6%	
Donnelly	et	al,	
1998	
3	 Primiparous	
women	(all	modes	
of	delivery)	
168	 6	months	 Anal	incontinence	
score	
English	 76%	 13%	 Not	reported	 4%	 13%	
Rogers	et	al,	2014	 3	 Primiparous	
women	(all	modes	
of	delivery)	
474	 6	months	 Jorge	and	Wexner	
score	
English	 71%	 Not	reported	
separately	
Not	reported	
separately	
9.4%	 50.4%	
Hatem	et	al,	2007	 3	 Primiparous	
women	(all	modes	
of	delivery)	
1355	 6	months	 Vaizey	
incontinence	score	
English	 55%	 Not	reported	 Not	reported	 Not	reported	 10.2%	
Leeman	et	al,	2016	
	
3	 Primiparous	
women	(all	modes	
of	delivery)	
335	 6	months	 Jorge	and	Wexner	
questionnaire	
English	 74%	 Not	reported	
separately	
Not	reported	
separately	
Not	reported	
separately	
49.7%	
Johannessen	et	al,	
2014	
	
3	 Primiparous	
women	(all	modes	
of	delivery)	
1030	 1	year	 St	Mark’s	score	 Norwegian	 66%	 5.8%	 8.9%	 4.5%	 19%	
Chan	et	al,	2013	
	
3	 Primiparous	
women	(all	modes	
of	delivery)	
328	 1	year	 CRADI	 Chinese	 74.2%	 18.3%	 4%	 0.3%	 18%	
Durnea	et	al,	2014	 3	 Primiparous	
women	(all	modes	
of	delivery)	
872	 1	year	 Australian	Pelvic	
floor	questionnaire	
English	 72%	 44.8%	 7.2%	 1.9%	 44.8%	
	 Follow	up	2-5	years	
Gartland	et	al,	
2016	
3	 Primiparous	
women	(all	modes	
of	delivery)	
1102	 4	years	 Bowel	Symptom	
Questionnaire	
(BSQ)	
English	 82%	 43.4%	 Not	reported	
separately	
1.5%	 43.3%	
	 Follow	up	>	5	years	
Damon	et	al,	2005	 3	 Primiparous	
women	(all	modes	
of	delivery)	
74	 6	years	 Jorge	and	Wexner	
questionnaire	
French	 73%	 13.5%	 Not	reported	
separately	
Not	reported	
separately	
14.8%	
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Evers	et	al,	2012	
	
2	 Primiparous	
women	(all	modes	
of	delivery)	
937	 7.5	years	 Epidemiology	of	
prolapse	and	
incontinence	
questionnaire	
(EPIQ)	
English	 41%	 19.3%	 8.3%	 1%	 19.3%	
Dolan	et	al,	2010	 4	 Primiparous	
women	(all	modes	
of	delivery)	
1861	 20	years	 Personal	
Assessment	
Questionnaire	
(PAQ)	
English	 62%	 Not	reported	 Not	reported	 Not	reported	 11%	
Nilsson	et	al,	2016	
	
3	 Primiparous	
women	(all	modes	
of	delivery)	
4203	 21.5	years	 Jorge	and	Wexner	
questionnaire	
Swedish	 65.2%	 Not	reported	
separately	
Not	reported	
separately	
13.7%	 13.7%	
Gyhagen	et	al,	
2013	
	
4	 Primiparous	
women	(all	modes	
of	delivery)	
5118	 22	years	 Jorge	and	Wexner	
Questionnaire	
Swedish	 65.2%	 47%	 8.9%	 4.7%	 47%	
	 Postnatal	women	(all	parities	and	modes	of	delivery)		
	 Follow	up	6/52	to	1	year	
Soligo	et	al,	2016	 3	 Postnatal	women	
(all	parities	and	
modes	of	delivery)		
685	 3	months	 Jorge	and	Wexner	
questionnaire	
Italian	 53%	 Not	reported	 Not	reported	 Not	reported	 10.4%	
Torrisi	et	al,	2012	
	
3	 Postnatal	women	
(all	parities	and	
modes	of	delivery)	
744	 3	months	 Jorge	and	Wexner	
questionnaire	
Italian	 70.9%	 12%	 3.2%	 1.1%	 16.3%	
Pinta	et	al,	2004	
	
2	 Postnatal	women	
(all	parities	and	
modes	of	delivery)	
99	 4	months	 Jorge	and	Wexner	
score	
Finnish	 10%	 26.2%	 3%	 3%	 26.2%	
Guise	et	al,	2007	 2	 Postnatal	women	
(all	parities	and	
modes	of	delivery)	
8774	 6	months	 Fecal	incontinence	
survey	
English	 40%	 26.5%	 9.4%	 8.3%	 29.2%	
	 Follow	up	2-5	years	
Wagenius	et	al,	
2003		
	
3	 Postnatal	women	
(all	parities	and	
modes	of	delivery)	
534	 4	years	 Anal	incontinence	
score	
Swedish	 82%	 21.3%	 12.7%	 3%	 21.3%	
	 Follow	up	>	5	years	
Mous	et	al,	2008	
	
3	 Postnatal	women	
(all	parities	and	
modes	of	delivery)	
209	 5	years	 Park’s	classification	 Dutch	 84%	 27%	 5.7%	 5.2%	 27%	
Baud	et	al,	2011	
	
2	 Postnatal	women	
(all	parities	and	
modes	of	delivery)	
258	 6	years	 Jorge	and	Wexner	
Score	
French	 36%	 39.9%	 12%	 3.9%	 39.9%	
Handa	et	al,	2011	
	
2	 Postnatal	women	
(all	parities	and	
modes	of	delivery)	
1011	 7.5	years	 Epidemiology	of	
prolapse	and	
incontinence	
questionnaire	
(EPIQ)	
English	 48.2%	 Not	reported	
separately	
Not	reported	
separately	
Not	reported	
separately	
11%	
Altman	et	al,	2007	
	
3	 Postnatal	women	
(all	parities	and	
modes	of	delivery)	
395	 10	years	 Jorge	and	Wexner	 Swedish	 69%	 27.6%	 5.3%	 1%	 27.6%	
Samarasekera	et	
al,	2008	
4	 Postnatal	women	
(all	parities	and	
modes	of	delivery)		
175	 14	years	(mean)	 Jorge	and	Wexner	
questionnaire	
Faecal	
incontinence	
quality	of	life	scale	
(FIQoL)	
English	 60.9%	 26%	
	
15.4%	
	
12%	 26%	
Faltin	DL	et	al,	
2006	
	
3	 Postnatal	women	
(all	parities	and	
modes	of	delivery)	
540	 18	years	 Jorge	and	Wexner	
score	
French	 77%	 41%	 7.6%	 1.6%	 41%	
Soerensen	et	al,	
2013.	
	
3	 Postnatal	women	
(all	parities	and	
modes	of	delivery)	
363	 22.2	years	 Jorge	and	Wexner	
Questionnaire	
Danish	 62.9%	 21.1%	 10.7%	 2.5%	 35%	
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	 Variable	follow	up	
Fritel	et	al,	2007	
	
3	 Postnatal	women	
(all	parities	and	
modes	of	delivery)	
2640	 Variable,	not	
reported	
Anal	incontinence	
score	
French	 85%	 28.6%	 Not	reported	
separately	
9.5%	 28.6%	
	 Postnatal	women	with	obstetric	anal	sphincter	injury	
	 Follow	up	>	6/52	to	1	year	
Vaccaro	et	al,	2008	
	
3	 Postnatal	women	
with	obstetric	anal	
sphincter	injury	
47	 12	weeks	 Jorge	and	Wexner	
score	
English	 60%	 38%	 11%	 4%	 43%	
Andrews	et	al,	
2009	
	
3	 Postnatal	women	
with	obstetric	anal	
sphincter	injury		
43	 1	year		 Manchester	Health	
Questionnaire	
	
English	 73%	 5%	 Not	reported	 Not	reported	 5%	
	 Follow	up	2-5	years	
Norderval	et	al,	
2004	
	
3	 Postnatal	women	
with	obstetric	anal	
sphincter	injury	
150	 2	years	 Anal	incontinence	
score	
Norwegian	 87%	 35.3%	 15.3%	 8%	 35.3%	
Richter	et	al,	2015	
	
2	 Postnatal	women	
with	obstetric	anal	
sphincter	injury	
138	 2	years	 Modified	
Manchester	Health	
questionnaire	
English	 40.2%	 19%	 16%	 13%	 24%	
Tin	et	al,	2010	 2	 Postnatal	women	
with	obstetric	anal	
sphincter	injury	
325	 2-5	years	 Colorectal	Anal	
Distress	Inventory	
(CRADI)	
English	 25%	 38.2%	 19.7%	 7.7%	 38.2%	
Jangö	et	al,	2016	
	
3	 Postnatal	women	
with	obstetric	anal	
sphincter	injury	
1987	 5	years	 Danish	anal	
sphincter	rupture	
questionnaire	
Danish	 77%	 22%	 10.5%	 2.9%	 36.6%	
	 Postnatal	women	after	instrumental	delivery	
Fitzpatrick	et	al,	
2003	
4	 Postnatal	women	
after	instrumental	
delivery	
130	 12	weeks	 Jorge	and	Wexner	
questionnaire	
	
English	 55%	 Not	reported	 Not	reported	 Not	reported	 45%	
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Table 2 
 
 
Type of modality: Non-validated questionnaires 
 
Study 
 
Study quality Patient group Participants 
 
Follow-up 
 
Modality Response rate 
in study 
Flatus 
incontinence 
Faecal 
incontinence 
(liquid stool) 
Faecal 
incontinence 
(solid stool) 
Anal 
incontinence 
(Sultan et 
al, 2017) 
Primiparous women (all modes of delivery) 
Follow up to 6/52 or less 
Rieger et al, 
1998 
1 Primiparous 
women (all 
modes of 
delivery) 
50 38 days 
(median), range 
20-65 days 
Self-
administered 
questionnaire 
(author’s own) 
Non-reported 6% Not reported Not reported 20% 
Zetterström et al, 
1999 
2 Primiparous 
women (all 
modes of 
delivery) 
38 6 weeks Self-
administered 
questionnaire 
(authors own) 
100% 18.4% 10.5% 2.6% 18.4% 
Donnelly et al, 
1998 
3 Primiparous 
women (all 
modes of 
delivery) 
312 6 weeks Self-
administered 
questionnaire 
(authors own) 
100% 15.4% Not reported 10.2% 24% 
Follow up > 6/52 to 1 year 
Faltin et al, 2001 
 
2 Primiparous 
women (all 
modes of 
delivery) 
92 3 months Self-
administered 
questionnaire 
(authors own) 
92% 17% Not reported 3% 17% 
Chaliha et al, 
2001 
 
3 Primiparous 
women (all 
modes of 
delivery) 
161 3 months Self-
administered 
questionnaire 
(authors own) 
56% 12.4% 1.8% 0.6% 12.4% 
Faltin et al, 2000 2 Primiparous 
women (all 
modes of 
delivery) 
144 4.5 months Self-
administered 
questionnaire 
(authors own) 
96% 13.8% 4.1% 4.1% 15% 
Hatem et al, 
2007 
2 Primiparous 
woman (all 
modes of 
delivery) 
1291 6 months Self-
administered 
questionnaire 
(author’s own) 
52% Not reported Not reported Not reported 20.6% 
Fenner et al, 
2003 
 
1 Primiparous 
women (all 
modes of 
delivery) 
831 6 months Self-
administered 
questionnaire 
(authors own) 
29% Not reported Not reported Not reported 21.7% 
Zetterstrom et al, 
1999 
 
2 Primiparous 
women (all 
modes of 
delivery) 
278 9 months Self-
administered 
questionnaire 
(authors own) 
80% 26% Not reported Not reported 26% 
Van Brummen et 
al, 2006 
2 Primiparous 
women (all 
modes of 
delivery) 
407 1 year Self-
administered 
questionnaire- 
authors own 
93% 30.5% Not reported 
separately 
Not reported 
separately 
30.5% 
Svare et al, 2016 2 Primiparous 
women (all 
modes of 
delivery) 
617 1 year Self-
administered 
questionnaire- 
authors own 
85% 48% 18% 5% 48% 
Follow up 2-5 years 
Koops et al, 
2003 
2 Primiparous 
women (all 
modes of 
delivery) 
430 3-4 years Self 
administered 
questionnaire 
(authors own) 
70% 27.4% 18.8% 10.2% 27.4% 
Pollack et al, 
2004 
 
2 Primiparous 
women (all 
modes of 
delivery) 
242 5 years Self-
administered 
questionnaire- 
authors own 
69% 34.2% Not reported 
separately 
4.9% 35.5% 
Follow up > 5 years 
Nordenstam et 
al, 2009 
2 Primiparous 
women (all 
modes of 
delivery) 
231 10 years Self-
administered 
questionnaire- 
authors own 
81% 31% Not reported 
separately 
5.6% 46% 
Gyhagen et al, 
2015 
 
2 Primiparous 
women (all 
modes of 
delivery) 
5236 20 years Self-
administered 
questionnaire- 
authors own 
65.2% Not reported Not reported Not reported 13.3% 
Halle et al, 2016 
 
2 Primiparous 
women (all 
modes of 
delivery) 
1122 15-23 years Self-
administered 
questionnaire- 
authors own 
52.8% 26% 8.6% 1.6% 26% 
Postnatal women (all parities and modes of delivery) 
Follow up to 6/52 or less 
Rajeshkannan at 
al, 2013 
2 Postnatal women 
(all parities and 
540 6 weeks Self-
administered 
95.2% Not reported 
separately 
Not reported 
separately 
Not reported 
separately 
16.5% 
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modes of 
delivery) 
questionnaire- 
authors own 
Hall et al, 2003 
 
2 Postnatal women 
(all parities and 
modes of 
delivery) 
50 6 weeks Self-
administered 
questionnaire 
(authors own) 
96% 24% Not reported 10% 24% 
Abramowitz et 
al, 2000 
3 Postnatal women 
(all parities and 
modes of 
delivery) 
233 6-8 weeks Self-
administered 
questionnaire 
(authors own) 
90% 10.4% 1.4% 1.8% 10.4% 
Follow up > 6/52 to 1 year 
Hannah et al, 
2002 
 
2 Postnatal women 
(all parities and 
modes of 
delivery) 
1596 3 months Self-
administered 
questionnaire 
(authors- own) 
82% 7.8% Not reported 0.9% 7.8% 
Haadem et al, 
1990 
2 Postnatal women 
(all parities and 
modes of 
delivery) 
36 3 months Self-
administered 
questionnaire 
(authors own) 
!00% 25% Not reported 2.7% 25% 
MacArthur et al, 
2001 
2 Postnatal women 
(all parities and 
modes of 
delivery) 
7879 3 months Self-
administered 
questionnaire 
(author’s own) 
71.7% 45.3% Not reported 9.6% 45.3% 
Eason et al, 2002 2 Postnatal women 
(all parities and 
modes of 
delivery) 
948 3 months Self-
administered 
questionnaire- 
authors own 
79% 25.5% Not reported 3.1% 25.5% 
Obioha et al, 
2015 
 
2 Postnatal women 
(all parities and 
modes of 
delivery) 
230 3 months Self-
administered 
questionnaire- 
authors own 
92% 10.4% Not reported 
separately 
3% 13.5% 
Glazener et al, 
1995 
 
2 Postnatal women 
(all parities and 
modes of 
delivery) 
438 1 year Self-
administered 
questionnaire 
(author’s own)- 
faecal 
incontinence not 
asked about 
specifically 
86% Not reported Not reported Not reported 0.2% 
Follow up 2-5 years 
Palm et al, 2013 
 
2 Postnatal women 
(all parities and 
modes of 
delivery) 
 
417 5 years Self-
administered 
questionnaire- 
authors own 
69.2% 59% 18.4% 6% 59% 
Follow up > 5 years 
Ryhammer et al, 
1995. 
 
2 Postnatal women 
(all parities and 
modes of 
delivery) 
242 Eight years Self-
administered 
questionnaire 
(author’s own) 
80% 4.95% Not reported 0.8% 4.95% 
Fornell et al, 
2005 
2 Postnatal women 
(all parities and 
modes of 
delivery) 
59 10 years Self-
administered 
questionnaire 
(authors own) 
71% 13% 14.6% 21.9% 13% 
Glazener et al, 
2014 
 
2 Postnatal women 
(all parities and 
modes of 
delivery) 
471 12.7 years 
(mean) 
Self-
administered 
questionnaire 
(authors own) 
63% Not reported Not reported Not reported 16.5% 
MacArthur et al, 
2011 
 
1 Postnatal women 
(all parities and 
modes of 
delivery) 
3763 12 years Self-
administered 
questionnaire 
(authors own) 
49% Not reported Not reported Not reported 12.9% 
Nygaard et al, 
1997 
 
2 Postnatal women 
(all parities and 
modes of 
delivery) 
151 30 years Self-
administered 
questionnaire 
(author’s own) 
67% 68% Not reported 41% 68% 
Bollard et al, 
2003 
2 Postnatal women 
(all parities and 
modes of 
delivery) 
92 34 years Self-
administered 
questionnaire- 
authors own 
64% 31% 6% 4.4% 64% 
Variable follow up 
McKinnie et al, 
2005 
2 Postnatal women 
(all parities and 
modes of 
delivery) 
978 Variable  Self-
administered 
questionnaire- 
authors own 
97.4% Not reported 
separately 
Not reported 
separately 
Not reported 
separately 
13% 
Goldberg et al, 
2003 
 
2 Postnatal women 
(all parities and 
modes of 
delivery) 
All had multiple 
pregnancy 
733 Variable  Self-
administered 
questionnaire- 
authors own 
95.3% 25.2% 5.9% 1.6% 25.2% 
Kunduru et al, 
2015 
2 Postnatal women 
(all parities and 
modes of 
delivery) 
1373 N/A Self-
administered 
questionnaire- 
authors own 
100% Not reported Not reported Not reported 14.2% 
Postnatal women with obstetric anal sphincter injury 
Follow up 6/52 or less 
Sultan, Kamm, 
Hudson, 
Bartram,1994 
 
2 Postnatal women 
with obstetric 
anal sphincter 
injury 
34 49 days 
(median) 
Range 42-651 
days 
Self-
administered 
questionnaire 
(authors own) 
68% 41% 8.8% Not reported 41% 
Follow up > 6/52 to 1 year 
Haadem et al, 
1988 
2 Postnatal women 
with obstetric 
59 3 months Self- 
administered 
54% 28% Not reported Not reported 15% 
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anal sphincter 
injury 
questionnaire 
(authors own) 
Chaliha et al, 
1999 
 
1 Postnatal women 
with obstetric 
anal sphincter 
injury 
549 3 months Self-
administered 
questionnaire 
(authors own) 
 
Not reported 4.9% 0.5% 0.4% 5% 
Uustal Fornell et 
al, 1996  
2 Postnatal women 
with obstetric 
anal sphincter 
injury 
51 6 months Self-
administered 
questionnaire 
(authors own) 
 
94% 24% 16% 0% 40% 
Mazouni et al, 
2005 
2 Postnatal women 
after instrumental 
delivery 
159 1 year Self-
administered 
Questionnaire 
(author’s own) 
75% 7.5% Not reported Not reported 8.8% 
Follow up 2-5 years 
Tetzschner et al, 
1997 
 
2 Postnatal women 
with obstetric 
anal sphincter 
injury 
72 2-4 years Self-
administered 
questionnaire 
(authors own) 
77% 25% Not reported 17% 25% 
Haadem et al, 
1987 
2 Postnatal women 
with obstetric 
anal sphincter 
injury 
59 3.4 years Self-
administered 
questionnaire 
(author’s own) 
95% 25.4% Not reported 6.7% 50.9% 
Gjessing et al , 
1998 
 
2 Postnatal women 
with obstetric 
anal sphincter 
injury 
35 3.5 years Self-
administered 
questionnaire- 
authors own 
75% 34% 11.4% 11.4% 57% 
Kumar, 2012 2 Postnatal women 
with obstetric 
anal sphincter 
injury 
41 4-6 years Self-
administered 
questionnaire 
(authors own) 
60% 26% 19.5% 4.9% 37% 
Poen et al, 1998 
 
2 Postnatal women 
with obstetric 
anal sphincter 
injury 
117 5 years Self-
administered 
questionnaire 
(author’s own) 
75% 19.6% 5.1% 7% 40%  
Follow up > 5 years 
Sørensen et al, 
1988 
2 Postnatal women 
with obstetric 
anal sphincter 
injury 
24 6.5 years Self-
administered 
questionnaire 
(author’s own) 
96% 25% 13% 4% 42% 
de Leeuw et al, 
2002 
1 Postnatal women 
with obstetric 
anal sphincter 
injury 
34 19 years Self-
administered 
questionnaire- 
authors own 
Not reported 35% 21% 24% 35% 
Postnatal women following instrumental delivery 
Sultan et al, 
1998 
 
2 Postnatal women 
following 
instrumental 
delivery 
44 5 years Self-
administered 
questionnaire 
(authors own) 
73.8% 22.7% 11.3% 3.6% 22.7% 
Johanson et al, 
1999 
2 Postnatal women 
following 
instrumental 
delivery 
228 5 years Self-
administered 
questionnaire- 
form another 
author 
74.5% 12.2% 4.4% 3% 20.2% 
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Table	3	
	
Type	of	modality:	Patient	interviews	
	
	
Study	
	
Study	quality	 Patient	group	 Participants	
	
Follow-up	
	
Modality	 Response	rate	to	
modality	
Flatus	incontinence	 Faecal	
incontinence	
(liquid	stool)	
Faecal	
incontinence	(solid	
stool)	
Anal	incontinence	
(Sultan	et	al,	2017)	
Primiparous	women	(all	modes	of	delivery)	
Follow	up	6/52	or	less	
Belmonte-Montes	C	
et	al,	2001	
	
1	 Primiparous	
women	(all	modes	
of	delivery)	
98	 6	weeks	 Patient	interview	 42%	 	 	 	 21%	
Follow	up	>6/52	to	1	year	
Meyer	et	al,	1998	 2	 Primiparous	
women	(all	modes	
of	delivery)	
149	 9-11	weeks	 Patient	interview	 80%	
	
Not	reported	 Not	reported	 Not	reported	 5%	
Groutz	et	al,	1999	 2	 Primiparous	
women	(all	modes	
of	delivery)	
300	 3	months	 Patient	interview	 Not	reported	 6.3%	 Not	reported	 0.7%	 7%	
Farrell	et	al,	2001	 2	 Primiparous	
women	(all	modes	
of	delivery)	
315	 6	months	 Patient	interview	 45.7%	 22.2%	 Not	reported	
separately	
Not	reported	
separately	
22%	
Borello-France	D	et	
al,	2006	
	
2	 Primiparous	
women	(all	modes	
of	delivery)	
759	 6	months	 Telephone	
interview	
82%	 21.2%	 8.3%	 4.7%	 21.2%	
Yang	et	al,	2010	
	
2	 Primiparous	
women	(all	modes	
of	delivery)	
1889	 6	months	 Telephone	
interview	
77%	 0.32%	 0.11%	 0.05%	 0.69%	
Jelovsek	et	al,	2013	 2	 Primiparous	
women	(all	modes	
of	delivery)	
759	 6	months	 Patient	interview	
(telephone)	
82%	 Not	reported	 Not	reported	 Not	reported	 12%	
Crawford	et	al,	1993	
	
2	 Primiparous	
women	(all	modes	
of	delivery)	
70	 9-12	months	 Patient	interview	
(telephone)	
37%	 10%	 3%	 1.5%	 10%	
Lal	et	al,	2003	
	
2	 Primiparous	
women	(all	modes	
of	delivery)	
284	 1	year	 Patient	interview	
(telephone)	
85%	 3%	 Not	reported	 3.7%	 3.7%	
Brincat	et	al,	2009	 2	 Primiparous	
women	(all	modes	
of	delivery)	
151	 1	year	 Patient	interview	
(telephone)	
63%	 Not	reported	
separately	
Not	reported	
separately	
Not	reported	
separately	
5.3%	
Lipschuetz	et	al,	
2015	
	
2	 Primiparous	
women	(all	modes	
of	delivery)	
198	 1	year	 Patient	interview	
(telephone)	
94%	 Not	reported	
separately	
Not	reported	
separately	
Not	reported	
separately	
10.1%	
Postnatal	women	(all	parities	and	modes	of	delivery)	
Follow	up	6/52	or	less	
Sultan,	Kamm,	
Hudson	et	al,	1993	
	
2	 Postnatal	women	
(all	parities	and	
modes	of	delivery)	
150	 49	days	postnatal	
(median)	Range	
35-105	days.	
Patient	interview	 74%	 Not	reported	 Not	reported	 Not	reported	 10%	
Sultan	et	al,	1994	
	
2	 Postnatal	women	
(all	parities	and	
modes	of	delivery)		
105	 6	weeks	 Patient	interview	 82%	 Not	reported	 Not	reported	 Not	reported	 16%	
Follow	up	>6/52	to	1	year	
Tetzschner,	
Sørensen,Jønsson,	
Lose	and	
Christiansen,	1997	
2	 Postnatal	women	
(all	parities	and	
modes	of	delivery)	
146	 3	months	 Patient	interview	 72%	 2%	 1%	 Not	reported	 3%	
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Baydock	et	al,	2009	
	
2	 Postnatal	women	
(all	parities	and	
modes	of	delivery)	
	
632	 4	months	 Patient	interview	
(telephone)	
Not	reported	 Not	reported	
separately	
Not	reported	
separately	
Not	reported	
separately	
4%	
MacArthur	et	al,	
1997	
2	 Postnatal	women	
(all	parities	and	
modes	of	delivery)		
906	 10	months	 Patient	interview	 80%	 Not	reported	 Not	reported	 Not	reported	 1.4%	
Postnatal	women	with	obstetric	anal	sphincter	injury	
Follow	up	>6/52-	1	year	
Sørensen	et	al,	1993	 2	 Postnatal	women	
with	obstetric	anal	
sphincter	injury	
38	 3	months	 Patient	interview	 100%	 Not	reported	 Not	reported	 Not	reported	 23.7%	
Walsh	CJ,	1996	
	
2	 Postnatal	women	
with	obstetric	anal	
sphincter	injury	
81	 3	months	 Patient	interview	 87%	 12%	 Not	reported	 7.4%	 20%	
Laine	et	al,	2011	
	
2	 Postnatal	women	
with	obstetric	anal	
sphincter	injury	
455	 10	months	 Patient	interview	 77%	 33%	 Not	reported	
separately	
6%	 38%	
Follow	up	>	5	years	
Sze	EH,	et	al,	2005	
(A)	
	
2	 Postnatal	women	
with	with	obstetric	
anal	sphincter	
injury	
148	 5-10	years	 Patient	interview	
(telephone)	
98%	 Not	reported	
separately	
Not	reported	
separately	
Not	reported	
separately	
29.7%	
Sangalli	et	al,	2000	
	
3	 Postnatal	women	
with	with	obstetric	
anal	sphincter	
injury	
177	 13	years	 Patient	interview	
(telephone)	
86%	 5.6%	 7.3%	 2.3%	 15.2%	
Size	EH,	2005	(B)		 2	 Postnatal	women	
with	with	obstetric	
anal	sphincter	
injury	
172	 Variable	2.5-14	
years	
Patient	interview	
(telephone)	
90%	 Not	reported	 Not	reported		 Not	reported	 19.7%	
Postnatal	women	following	instrumental	delivery	
Sultan,	Kamm,	
Bartram	et	al,	1993	
1	 Primiparous	
women	undergoing	
instrumental	
delivery		
43	 5.3	months		 Patient	interview	 Not	reported	 Not	reported	 Not	reported	 Not	reported	 20.9%	
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Supplementary Table 4 
Follow up 
period 
Number of 
studies in 
review 
reporting 
follow-up 
period 
Total number of 
patients in 
studies reporting 
follow-up period 
Median response 
rate 
Mean response 
rate ± 2SD 
Validated questionnaire/symptom scale (validated patient reported outcome measures) 
6 weeks or less 1 200 100% 100% 
>6 weeks to 1 
year 
17 17473	
 
71% 64.5%±0.4 
2-5 years 6 4236 66% 80%±0.5 
>5 years 12 15144 64% 62%±0.1 
Non-validated questionnaires 
6 weeks or less 7 1257 96% 92%±0.2 
>6 weeks to 1 
year 
18 15766 81% 76%±0.4 
2-5 years 10 1685 75% 74%±0.2 
>5 years 11 11425 66% 69%±0.3 
Patient interview 
6 weeks or less 3 353 74% 66%±0.4 
>6 weeks to 1 
year 
17 7175 80% 74%±0.3 
2-5 years     
>5 years 3 497 90% 91%±0.1 
 
 
 
 
 
	
7.2	Paper	2:	Gray	TG,	Sneyd	R,	Scurr	K,	Jones	GL,	Iles	D,	Jha	S,	Radley	SC.	Patient-
reported	outcome	measures	which	assess	body	image	in	urogynaecology	patients:	a	
systematic	review.	International	Urogynecology	Journal.	2019;30(5):673-81.	
	
Abstract	
Aim:	Urogynaecological	conditions	can	have	a	significant	impact	on	body	image.	Patient-
reported	outcome	measures	(PROMs)	are	widely	used	in	urogynaecology	to	assess	
symptoms	and	their	impact	on	quality-of-life.		
This	systematic	review	aimed	to	identify	currently	available	PROMs	used	to	assess	body	
image	within	a	urogynaecological	population	and	to	identify	the	most	psychometrically	
robust	and	appropriate	PROM	tools	to	use	in	this	context.		
Methods:	Ovid	Medline,	AMED,	CINAHL,	Cochrane	Collaboration,	EMBASE	and	Web	of	
Science	databases	were	searched	from	January	1966	to	November	2018,	to	identify	studies	
that	had	administered	a	PROM	to	assess	body	image	to	patients	diagnosed	with	a	
urogynaecological	condition.	The	information	extracted	and	critically	appraised	included;	
study	setting,	PROM	instrument	used	and	the	reported	psychometric	properties	of	the	
PROM.		
Results:	Seventeen	studies	were	included	from	3207	screened	articles.	Seven	different	
PROMs	used	to	assess	body	image	in	a	urogynaecological	population	were	identified.	Two	
of	these	PROMs	(Genital	Self-Image	Scale-20	and	Body	Image	in	Pelvic	Organ	Prolapse	
questionnaire)	had	good	psychometric	evidence	for	use	but	this	was	only	in	the	context	of	
women	with	prolapse.	Evidence	for	validity	and	reliability	was	limited	for	the	other	five	
PROMs	identified.	
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Conclusion:	Further	development	and	psychometric	testing	of	PROMs	to	assess	body	
image	in	urogynaecology,	both	for	research	purposes	and	clinical	practice	,	is	required.		
Further	research	is	also	required	to	investigate	the	relationship	between	body	image	and	
urogynaecological	symptomatology	and	developing	valid,	reliable	and	functional	PROMs	
will	be	integral	to	this.	
	
Keywords:	Body	image,	patient	report	outcome	measures,	surveys	and	questionnaires	
	
Brief	Summary	
	This	systematic	review	has	identified	two	patient-reported	outcome	measures	that	could	
be	recommended	for	use	in	assessment	of	body	image	in	women	with	prolapse.	
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Introduction		
Patient-reported	outcome	measures	(PROMs)	are	well	established	in	urogynaecology	and	
are	utilised	both	as	clinical	and	research	tools.	PROMs	provide	patients’	perspectives	on	
their	conditions,	without	interruption	or	influence	from	the	clinician	and	can	include	
assessments	of	condition-specific	symptomatology	and	impact	on	health-related	quality	of	
life	(HRQoL)	[1].	Evaluation	of	PROMs	through	psychometric	testing	is	deemed	important	
for	each	population	the	specific	tool	is	to	be	used,	to	ensure	reliable	and	valid	results.		
	
PROMs	are	particularly	valuable	in	urogynaecology,	where	conditions	are	often	of	a	
sensitive	nature.	PROMs	are	clearly	shown	to	help	self-expression,	discussion	and	the	
disclosure	of	embarrassing	or	intimate	conditions	[2,	3].	Although	the	assessment	of	the	
impact	of	urogynaecological	conditions	on	both	sexual	function	and	HRQoL	is	increasingly	
well	understood,	understanding	the	relationships,	impact	and	outcomes	of	these	conditions	
in	relation	to	body	image	is	a	relatively	new	area	of	research	within	the	subspecialty.	
		
‘Body	image’	refers	to	the	mental	picture	that	an	individual	has	of	themselves,	which	
depicts	not	only	details	available	to	objective	investigation	by	others	(e.g.	height,	weight,	
hair	colour	etc.),	but	also	details	that	have	been	learned	about	themselves,	either	from	
personal	experiences	or	by	internalising	the	judgments	of	others	[4].		
In	addition,	the	term	‘genital	self-image’	has	also	been	used	to	describe	the	internal	mental	
picture	 (body	 image)	 that	 an	 individual	 has	 of	 his	 or	 her	 external	 genitalia	 [4]	 and	may	
include	 components	 such	 as	 appearance,	 attractiveness,	 scarring,	 function	 and	 the	
perceptions	of	others	(including	both	partners,	family	and	healthcare	professionals).	
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Urogynaecological	conditions	including	prolapse,	urinary	incontinence	and	perineal	
trauma	[5	-	9]	have	been	shown	to	have	a	negative	effect	on	body-image	as	a	whole,	and	
specifically	on	genital	self-image	[10,	11].	Previous	qualitative	studies	have	also	found	that	
a	significant	proportion	of	new	patients	attending	urogynaecology	outpatient	clinics	have	
body	image	concerns	[8,	12].		
	
The	aim	of	this	systematic	review	was	to	identify	from	the	existing	literature	the	PROMs	
that	have	been	used	to	assess	body	image	within	a	urogynaecological	population	and	also	
to	identify	the	most	psychometrically	robust	and	appropriate	PROM(s)	to	use	in	this	
context.		
	
Methods		
A	systematic	review	of	the	literature	using	well	established	methodology	[13]	was	
undertaken.	This	followed	the	PRISMA	guidelines	[14]	and	was	designed	to	capture	studies	
where	a	population	of	women	specifically	with	urogynaecology	conditions	had	been	
administered	a	PROM	which	assessed	body	image.	This	systematic	review	was	registered	
prospectively	on	the	PROSPERO	database	(registration	number:	CRD42017084710).	
	
The	study	population	was	women	with	urogynaecological	conditions.	In	particular,	this	
covered	the	following	conditions:	pelvic	organ	prolapse,	urinary	incontinence,	faecal	
incontinence	and	sexual	dysfunction.	
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The	intervention	studied	was	any	PROM	which	assessed	body	image	concerns.	The	
comparison	was	the	reported	psychometric	properties	of	the	identified	instruments	in	the	
included	studies.			
	
Ovid	Medline,	AMED,	CINAHL,	Cochrane	library,	Dissertations	and	theses	(PhD	only),	
EMBASE,	PSYCHInfo	and	Web	of	Science	databases	were	searched	using	medical	subject	
heading	(MeSH)	theme	“body	image”,	combined	with	Boolean	AND	operators	with	the	
MeSH	themes	“patient	reported	outcome	measures”,	“surveys	and	questionnaires”,	
“urinary	incontinence”,	“pelvic	organ	prolapse”,	“sex”,	“fecal	incontinence”	for	studies	
published	between	January	1966	and	November	2018	(inclusive).	Studies	included	were	
limited	to	adult	female	human	subjects	and	were	restricted	to	English	language	
publications.	
In	addition,	the	following	journals	were	hand	searched	for	relevant	studies:	
• International	Urogynaecology	Journal	
• Neurourology	and	Urodynamics	
• American	Journal	of	Obstetrics	and	Gynecology	
• BJOG:	an	international	journal	of	obstetrics	and	gynaecology	
• Quality	of	Life	Research	
	
Three	reviewers	(TGG,	RS	and	KS)	independently	reviewed	all	the	abstracts	identified	by	
the	literature	search	to	identify	papers	of	potential	interest.	All	papers	of	potential	interest	
to	the	review	were	obtained	and	read	by	three	reviewers	(TGG,	RS	and	KS)	to	identify	those	
that	were	relevant.	Studies	were	included	only	with	the	agreement	of	all	three	reviewers	
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following	evaluation	of	full	manuscripts.	Any	disparities	were	resolved	by	consensus	and,	if	
required,	arbitration	by	a	fourth	and	fifth	reviewer	(SCR	and	SJ).	A	manual	search	of	the	
reference	list	of	each	manuscript	was	also	conducted	by	the	reviewers	to	identify	further	
studies	of	relevance	to	the	systematic	review.	
	
The	same	reviewers	(TGG,	RS	and	KS)	independently	extracted	data	from	the	included	
studies	onto	an	electronic	data	collection	form	adapted	from	previous	reviews	of	the	
psychometric	properties	of	PROMs	[13,	15].		The	information	extracted	included	study	
setting,	population,	PROM	instrument	used,	the	domains	included	in	the	PROM	and	the	
psychometric	properties	of	the	PROM.	These	were	compared	and	a	summary	table	of	
consensus	data	compiled.		
	
Only	studies	that	specifically	included	women	with	urogynaecological	conditions,	or	
studies	in	which	this	group	was	identified	separately	within	the	results	of	the	study	were	
included.	The	following	were	excluded:	papers	reporting	clinician	completed	
questionnaires	or	proformas,	review	articles	or	interim	reports	superseded	by	full	reports.	
The	primary	outcome	was	the	number	of	PROM	tools	used	to	assess	body	image	in	
urogynaecological	conditions.	Secondary	outcomes	were	evidence	of	reliability,	validity	
and	responsiveness	of	these	tools	in	a	urogynaecology	population.	
	
Psychometric	properties	including	reliability	and	validity	provide	a	level	of	evidence	that	
an	instrument	works	effectively	and	measures	what	it	has	been	designed	to	measure.	For	
this	systematic	review	the	psychometric	properties	of	the	identified	PROMs	were	assessed	
	
116	
using	data	from	studies	where	the	instrument	had	been	used	within	a	urogynaecology	
population,	providing	evidence	for	its	potential	validity	in	this	setting.		
	
Reliability	assesses	the	extent	to	which	a	PROM	tool	yields	consistent	and	reproducible	
results	[16].	Both	internal	consistency	and	test-retest	reliability	were	assessed	as	measures	
of	reliability	in	this	review.	
	
Validity	describes	the	extent	to	which	an	instrument	(PROM)	measures	what	it	purports	to	
measure	[17].	This	is	absolutely	specific	to	the	population	and	setting.	Therefore,	for	
example,	a	PROM	designed	to	assess	body	image	in	cancer	patients	may	not	be	reliable	in	a	
urogynaecology	population.	Construct	validity	describes	the	relationship	of	a	construct	to	
other	variables	[17].	This	is	often	explored	using	correlation	coefficients,	whereby	>0.5	
indicates	adequate	convergent	validity	and	<0.5	indicates	adequate	divergent	validity	[15,	
17].	Other	methods	used	to	assess	validity	were	evidence	of	criterion	validity,	where	a	
correlation	between	the	PROM	and	another	(usually	validated	and	well-established)	PROM	
had	been	assessed.	Content	validity	assessing	the	extent	to	which	the	PROM	topic	(or	
domain)	had	been	described	by	the	items	(individual	questions)	with	it,	and	usually	
involving	patient	groups,	was	also	measured.	Information	on	responsiveness	(change	
before	and	after	an	intervention)	was	also	collected.	
	
Functionality,	or	details	on	practical	properties,	of	each	PROM	was	assessed	by	data	
reported	on	acceptability,	feasibility	and	reading	level	of	the	administration	of	the	PROM.	
Details	of	the	type,	size	and	range	of	the	populations	in	which	the	identified	PROMs	were	
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administered	was	collected,	as	well	as	domains	and	scoring,	to	identify	the	most	
psychometrically	robust	PROM	tools	available	to	assess	body	image	in	urogynaecology	
patients.		
	
Results	
A	total	of	3207	studies	(excluding	duplicates)	were	identified	for	screening	with	3158	
being	discarded	on	title	and	abstract	alone.	Of	the	remaining	studies,	49	manuscripts	were	
reviewed	in	full	with	17	studies	identified	as	meeting	the	inclusion	criteria	(Figure	1).	This	
resulted	in	seven	PROMs	being	identified	that		had	been	used	in	a	urogynaecology	
population.	A	full	summary	of	the	seven	PROMs	is	presented	in	Table	1	and	a	full	summary	
of	the	psychometric	properties	presented	in	each	of	the	17	studies	is	presented	in	Table	2.		
	
In	terms	of	population,	15	studies	included	women	with	pelvic	organ	prolapse	(5,	6,	10,	18-
29),	one	study	also	included	patients	with	perineal	trauma	following	childbirth	as	well	as	
patients	with	prolapse	[21],	one	study	included	patients	with	overactive	bladder	[30]	and	
one	study	included	patients	attending	a	urogynaecology	clinic	but	did	not	specify	their	
symptomatology	[11].	Two	identified	studies	utilised	two	PROMs	within	their	study	design	
[10,	27].	A	full	summary	of	study	setting	and	participants	is	reported	in	Table	3.		
	
Two	of	the	PROMS	identified	(modified	Body	Image	Scale-	mBIS	and	Body	Image	in	Pelvic	
Organ	Prolapse-	BIPOP)	were	condition	specific,	each	only	able	to	be	used	in	women	with	
pelvic	organ	prolapse	as	the	questions	relate	directly	to	this	condition.	One	PROM	(Body	
Exposure	during	Sexual	Activities	Questionnaire-	BESAQ)	was	specific	to	a	population	of	
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women	who	were	currently	sexually	active.	The	remaining	four	PROMs	(Gential	Self	image	
Scale-20-	GSIS-20,	Body	Esteem	Scale-	BES,	Body	Image	Quality	of	Life	Inventory-	BIQLI	
and	the	Vaginal	changes,	Sexual	and	Body	Esteem	questionnaire-	VSBE)	were	all	generic	
instruments	which	could	be	to	be	used	in	any	population	of	women,	regardless	of	
condition.		
	
The	seven	PROMs	identified	varied	considerably	in	their	length,	the	domains	covered	and	
how	they	were	scored.	The	number	of	items	varied	from	10-30,	resulting	in	variations	in	
the	scope	of	the	PROMs	identified	and	in	different	completion	times,	all	of	which		affect	the	
acceptability,	value	and	burden	of	a	PROM.	
	
Information	on	the	psychometric	properties	of	the	identified	PROMs	was	assessed	
following	the	methodology	of	the	Oxford	PROMS	group	[13]	and	replicated	the	
methodology	employed	in	previous	systematic	reviews	[31].	This	is	a	subjective	method	of	
appraisal,	but	is	arguably	a	useful	and	helpful	indicator	of	how	comprehensively	the	
psychometric	properties	have	been	assessed	and	provides	an	indication	of	the	level	of	
evidence	for	each	PROM	tool	[31].	Table	4	presents	an	appraisal	of	the	psychometric	
properties	and	functionality	of	the	identified	PROMs	which	helps	to	indicate	which	tools	
can	be	best	recommended	for	use	in	clinical	practice	within	a	urogynaecology	setting.	
	
Two	of	the	PROMs	(BIPOP	and	GSIS-20)	identified	had	undergone	formal	psychometric	
testing	in	a	population	with	pelvic	organ	prolapse	and/or	perineal	trauma	[21,	28].	Body	
Image	in	Pelvic	Organ	Prolapse	is	a	10	item	PROM	scored	out	of	50	which	assesses	how	
	
119	
pelvic	organ	prolapse	directly	affects	body	image	perception.	Good	evidence	in	favour	of	
reliability,	content	validity,	construct	validity	and	criterion	validity	was	presented	for	the	
Body	Image	in	Pelvic	Organ	Prolapse	questionnaire	(BIPOP).	However,	no	data	on	
responsiveness	or	acceptability	was	presented.		The	Genital	Self	Image	Scale-20	is	a	longer	
20	item	PROM	scored	out	of	40,	and	relates	to	body	image	in	relation	to	genitalia.	It	has	
undergone	formal	psychometric	testing	in	a	population	of	women	with	pelvic	organ	
prolapse	and/or	perineal	trauma	and	good	evidence	in	favour	of	reliability,	content	
validity,	construct	validity,	criterion	validity,	responsiveness	and	acceptability	was	
presented	[28].		
None	of	the	other	five	instruments	identified	(mBIS,	BESAQ,	BIQLI,	VSBE	and	BES)	had	such	
comprehensive	evidence	of	reliability	or	validity	within	a	urogynaecological	population	
(Table	4).	Two	of	these	instruments	(VSBE	and	BES)	had	no	evidence	of	reliability	in	a	
urogynaecological	population	presented	and	none	of	these	five	instruments	had	evidence	
of	content	validity	for	their	use	within	a	urogynaecological	population.	However,	apart	
from	the	Body	Image	Quality	of	Life	Inventory-	BIQLI,	all	the	tools	identified	had	some	good	
evidence	in	favour	of	construct	validity	in	a	urogynaecological	population	and	all	had	some	
favourable	evidence	for	acceptability	presented.		
	
Discussion	
This	systematic	review	of	PROMs	used	within	a	urogynaecology	population	has	identified	
seven	instruments	used	for	the	assessment	of	body	image.	Of	these,	two	instruments	have	
been	identified	as	suitable	for	use	in	women	with	pelvic	organ	prolapse	(GSIS-20	and	
BIPOP)	[21,	28].	Suitable	PROMS	to	assess	body	image	in	other	areas	of	urogynaecology,	
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including	urinary	and	faecal	incontinence	or	as	part	of	a	comprehensive	PROM	tool,	were	
not	identified.	
	
The	nature	of	urogynaecology,	which	includes	a	spectrum	of	related	conditions	such	as	
urinary	incontinence,	pelvic	organ	prolapse,	faecal	incontinence	and	sexual	dysfunction,	
often	occurring	concurrently,	makes	identifying	a	single	PROM	for	use	to	assess	body	
image	across	the	whole	subspecialty	challenging.	Issues	to	consider	include	the	scope,	
length	(and	therefore	burden)	of	the	tools	available	and	rationale	for	their	administration	
in	a	urogynaecology	population.	Also,	considering	which	aspects	of	body	image	to	assess	
within	a	urogynaecological	population	is	important.	Whether	this	is	an	assessment	of	
global	body	image	satisfaction	or	specifically	in	relation	to	genital	self-image	or	sexual	
function	would	impact	on	the	choice	of	PROM.			
	
The	rationale	for	administration	of	PROMs	in	a	clinical	setting	includes	supporting	
individualised	care	as	part	of	routine	use	in	clinical	practice,	as	well	as	service	evaluation	
and	research	[32].	For	this	reason,	it	is	essential	to	establish	psychometric	evidence	of	
reliability,	validity	and	feasibility	of	use	of	the	tool	intended	for	this	purpose;	especially	if	
data	are	to	be	used	for	research	purposes.	The	seven	instruments	identified	in	this	
systematic	review	have	been	developed	for	use	in	clinical	practice	and	not	purely	as	
research	tools.	Only	one	of	the	PROMs	identified	has	been	developed	specifically	for	a	
urogynaecology	population	(BIPOP)	[28].	
	
	
121	
The	body	image	in	pelvic	organ	prolapse	questionnaire	(BIPOP)	has	been	specifically	
developed	and	validated	in	a	population	of	women	with	pelvic	organ	prolapse	[28].	The	
study	reported	clear	evidence	of	content	validity,	internal	consistency	reliability,	construct	
validity,	criterion	validity	and	acceptability.	Though	no	assessment	of	responsiveness	was	
presented.		
	
The	Genital	Self	Image	Scale-20	(GSIS-20)	was	not	initially	developed	for	use	within	a	
urogynaecological	population,	but	has	now	undergone	formal	validation	in	a	population	of	
women	with	perineal	trauma	or	pelvic	organ	prolapse	[21].	The	study	reports	good	
evidence	for	content	validity,	internal	consistency	reliability,	construct	validity,	criterion	
validity,	responsiveness	and	acceptability.			
	
All	of	the	other	five	PROMs	identified	in	this	systematic	review	have	been	developed	and	
validated	in	different	patient	settings	and	all	their	published	formal	validation	has	been	in	
non-urogynaecological	populations.	The	most	frequently	used	instrument	identified	was	
the	modified	Body	Image	Scale	(mBIS),	which	was	used	in	11	studies	[5,	6,	18-20,	22-26,	
30].	This	PROM	was	Initially	developed	to	assess	body	image	concerns	in	relation	to	
medical	conditions	or	treatment	in	cancer	patients	and	was	adapted		
for	use	in	patients	with	pelvic	organ	prolapse.	This	was	achieved	by	changing	questions	
regarding	‘disease	or	treatment’	from	Hopwood’s	original	body	image	scale	[33]	to	
questions	regarding	‘prolapse’.	This	tool	is	therefore	only	able	to	be	utilised	in	populations	
where	patients	with	pelvic	organ	prolapse	symptoms	are	assessed.	No	evidence	has	been	
provided	for	the	content	validity	of	this	tool	in	a	urogynaecology	population	and	the	
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available	evidence	for	its	reliability	and	construct	validity	is	very	limited,	despite	it	being	
the	most	widely	used	PROM	to	assess	body	image	in	a	urogynaecology	setting.	Following	
its	initial	use	in	a	urogynaecology	population	by	Jelovsek	et	al	in	2006	[5],	ten	further	
studies	have	utilised	mBIS.	However,	in	order	for	this	tool	to	be	considered	valuable	for	
research	and	use	in	clinical	practice,	further	psychometric	testing	within	a	urogynaecology	
population	is	required.		
	
The	other	four	tools	identified	in	this	review,	the	Body	Exposure	during	Sexual	Activities	
Questionnaire	(BESAQ),	Body	Esteem	Scale	(BES),	Body	Image	Quality	of	Life	Inventory	
(BIQLI)	and	Vaginal	changes/Sexual	and	Body	Esteem	(VSBE)	questionnaire	are	each	all	
used	in	only	one	study;	each	time	in	a	population	of	patients	with	pelvic	organ	prolapse.	
None	of	these	four	tools	has	been	developed	in	a	urogynaecology	population	and	there	is	
no	evidence	for	content	validity	for	these	tools	in	a	urogynaecology	setting.	There	is	some	
limited	evidence	for	reliability	for	BESAQ	[27]	and	BIQLI	[27]	and	some	good	evidence	for	
construct	validity	for	BESAQ	[27],	VSBE	[29]	and	BES	[10].	However,	more	comprehensive	
formal	psychometric	testing	in	a	urogynaecology	population	is	recommended	prior	to	
using	these	instruments	in	clinical	practice	or	research.	
	
We	did	not	identify	any	studies	where	a	PROM	tool	has	been	used	to	assess	body	image	in	
patients	with	stress	urinary	incontinence	or	faecal	incontinence	and	only	one	study	in	
which	body	image	was	assessed	in	patients	with	overactive	bladder	[30].	The	relationship	
between	conditions	including	stress	urinary	incontinence,	overactive	bladder,	faecal	
incontinence	and	body	image	is	clearly	an	area	for	further	research.	This	requires	the	
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development	and	psychometric	testing	of	appropriate	PROMs	to	assess	this.	The	interplay	
between	body	image,	sexual	function	and	quality	of	life	within	urogynaecology	populations	
is	also	an	important	area	of	future	research.	
	
Whilst	the	relationship	between	body	image	and	pelvic	organ	prolapse	is	now	becoming	
well	established,	there	are	still	significant	questions	about	how	patients	who	report	
negative	body	image	should	be	advised	and	managed.	There	is	some	evidence	that	body	
image	improves	following	surgical	intervention	for	prolapse	[18,	22,	27]	or	the	use	of	
pessaries	[20,	23],	though	studies	which	evaluate	the	value	of	counselling	or	cognitive	
behavioural	therapy	in	this	context	are	also	needed,	again	demanding	psychometrically	
robust	PROMs	which	assess	body	image	in	the	relevant	urogynaecological	setting.	
	
	
The	main	strength	of	this	systematic	review	is	the	rigorous	and	transparent	search	strategy	
employed,	which	has	identified	the	relevant	studies,	allowing	identification	of	seven	PROM	
tools	used	in	a	urogynaecology	population.		We	have	been	able	to	identify	the	most	
psychometrically	robust	tools	available	for	use	to	assess	body	image	within	a	
urogynaecology	setting.	
		
The	limitations	of	this	systematic	review	are	that	the	data	is	only	as	good	as	that	which	has	
been	provided	in	the	included	studies.	Not	all	the	psychometric	testing	for	each	PROM	may	
be	included,	especially	details	about	content	validity,	criterion	validity	and	responsiveness,	
which	were	often	not	reported.	To	minimise	the	risk	of	bias	and	subjectivity	with	using	the	
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Oxford	PROM	group’s	appraisal	system,	each	reviewer	independently	extracted	data	on	the	
quality	of	the	psychometric	properties	and	functionality	of	the	included	PROMs.	The	use	of	
a	search	strategy	which	excluded	papers	not	published	in	English	may	have	also	resulted	in	
missing	both	instruments	and	related	studies	potentially	relevant	to	this	systematic	review.		
	
	
Conclusions	
This	systematic	review	aimed	to	identify	the	most	psychometrically	robust	patient	
reported	outcome	measures	which	could	be	used	to	assess	body	image	in	a	urogynaecology	
population.	Two	of	the	identified	PROMs	(GSIS-20	and	BIPOP)	[21,	28]	can	be	
recommended	for	use	in	clinical	practice,	service	evaluation	and	research	for	patients	with	
pelvic	organ	prolapse.	Development	of	a	PROM/PROM(s)	to	identify	and	measure	body	
image	issues	in	other	areas	of	urogynaecology	including	urinary	incontinence	and	faecal	
incontinence	is	required.		
Further	research	is	required	to	investigate	the	relationship	between	body	image	and	
urogynaecological	symptomatology,	quality	of	life	and	sexual	function	and	changes	after	
interventions,	which	would	valuably	utilise	such	tools.	
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Tables	and	figures,	including	legends	
Figure	1:	PRISMA	diagram	showing	selection	of	articles	for	review.	
Table	1:	Summary	of	the	content	and	scope	of	the	seven	PROMs	identified	in	this	
systematic	review		
Table	2:	Summary	of	the	psychometric	properties	reported	for	each	PROM	in	the	17	
included	studies	in	this	systematic	review		
Table	3:	Summary	details	of	the	study	populations	for	each	included	study.	
Table	4:	Psychometric	properties	of	PROMS	identified	by	the	systematic	review,	scored	
according	to	Preston	et	al	(2015).	Key	to	scoring:	0	not	reported,	-	no	evidence	in	favour,	+	
some	limited	evidence	in	favour,	++	some	good	evidence	in	favour,	+++	good	evidence	in	
favour.	
	
	
	
	
	
	
	
	
	
	
	
	
	
131	
Table	1	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
PROM	name	 Populati
on	for	
use	
Number	
of	times	
used	in	
review	
Number	
of	items	
Summary	
The	modified	
Body	Image	Scale	
Condition	
specific-	
prolapse	
11	 10	 Uses	the	same	10	questions	as	the	Body	Image	Scale	
but	substitutes	“disease	or	treatment”	to	“vaginal	
prolapse”	to	make	it	more	relevant	to	its	patient	
cohort.	Answers	graded	from	“Not	at	all”	to	“Very	
much”	in	four	steps.		
Genital	Self	
Image	Scale	-	20		
Generic	
to	women	
3	 20	 20	questions	assessing	body	image	regarding	female	
genitalia.	Scored	from	0-40	with	an	increased	score	
indicating	positive	genital	body	image.	10	questions	
are	scored	0-3	(graded)	and	10	are	0-1	(yes/no).		
Body	Exposure	
During	Sexual	
Activities	
Questionnaire	
Condition	
specific-	
sexually	
active	
women	
only	
2	 28	 A	28	item	questionnaire	assessing	body	image	
during	sexual	activities.	Included	genitalia	specific	
questions.	Answers	graded	from	“never”	to	“always	
or	almost	always”	in	5	steps.		
Body	Esteem	
Scale	
Generic	
to	women	
1	 30	 A	measure	of	“overall”	body	image.	Divided	into	3	
categories	–	appearance,	weight	and	attribution	with	
12,	9	and	9	items	respectively.	The	items	are	graded	
in	5	steps	from	“never”	to	“always”.			
The	Body	Image	
Quality	of	Life	
Inventory	
Generic	
to	women	
1	 19	 Assesses	the	impact	body	image	has	on	quality	of	life.	
It	uses	19	items	each	scored	from	-3	to	+3	giving	an	
overall	mark	between	-54	and	+54	with	a	higher	
score	indicating	a	higher	quality	of	life.		
Body	Image	in	
Pelvic	Organ	
Prolapse		
questionnaire	
Condition	
specific-	
prolapse	
1	 10	 A	10	item	questionnaire	that	assesses	how	pelvic	
organ	prolapse	directly	affects	how	women	perceive	
their	body	image.	5	step	grading	from	strongly	agree	
to	strongly	disagree.	
Vaginal	Changes	
Sexual	and	Body	
Esteem	
Generic	
to	women	
1	 10	 10	questions	with	Likert	scale	responses	ranging	
from	1	(strongly	agree),	to	5	(strongly	disagree).		
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Table	2:	Summary	of	the	psychometric	properties	reported	for	each	PROM	in	the	17	
included	studies	in	this	systematic	review		
	
Instrument/study	 Reliability	 Validity	
	 Cronbach’s	alpha	
Interclass	
correlation/Pearson’s	(r)	
Construct	validity	 Content/criterion	validity	 Responsiveness	
The	modified	Body	Image	Scale	(mBIS)	
Jelovsek	et	al	(2006)	
	
Cronbach’s	alpha	0.91	 Body	image	correlated	
moderately	(r=0.4)	with	
quality	of	life	and	prolapse	
(r=0.3)		and	urinary	(r=0.4)	
scores	of	the	PFDI-20	
Not	reported	
	
Not	assessed	
Barber	et	al	(2007)	 Not	reported	
	
Not	demonstrated	 Not	reported	
	
Not	demonstrated	
Lowenstein	et	al	(2009)	 Not	reported	
	
mBIS	scores	correlated	
moderately	with	POPDI	
scores	(r=0.37)	and	PISQ	
scores	(0.34)	
	
Not	reported	
	
Not	assessed	
Lowenstiein	et	al	(2010)	 Not	reported	
	
Improvement	in	mBIS	scores	
was	significantly	correlated	
with	improvement	in	
symptoms	of	prolapse	
(r=0.27)	
Patients	with	higher	body	
image	scores	also	had	higher	
sexual	function	scores.	
	
Not	reported	
	
Significant	change	in	mBIS	
scores	following	treatment	
Patel	et	al	(2010)	 Cronbach’s	alpha	0.89		
	
mBIS	scores	improved	
significantly	following	the	
use	of	pessary	for	prolapse	
management	
Not	reported	
	
Significant	change	in	mBIS	
scores	following	treatment	
Crisp	et	al	(2013)	 Not	reported	
	
mBIS	scores	significantly	
improved	post-surgical	
management	of	prolapse	
and	this	was	sustained	at	24	
weeks.		
Not	reported	
	
Significant	change	in	mBIS	
scores	following	treatment	
Levin	et	al	(2014)	 Not	reported	
	
Statistically	significant	
improvement	in	mBIS	scores	
following	treatment	of	OAB	
with	Interstim	
Not	reported	
	
Significant	change	in	mBIS	
scores	following	treatment	
Meriwether	et	al	(2015)	 Not	reported	
	
Changes	in	mBIS	scores	
were	significantly	associated	
with	BMI,	comorbidity	
indices	and	satisfaction	with	
pessary	for	management	of	
prolapse	
Not	reported	
	
Significant	change	in	mBIS	
scores	following	treatment	
Crisp	et	al	(2016)	
	
Not	reported	
	
mBIS	scores	showed	
significant	improvement	
post	op	
Not	reported	
	
Significant	change	in	mBIS	
scores	following	treatment	
Lucacz	et	al	(2016)	
	
Not	reported	
	
Statistically	significant	
improvement	in	mBIS	scores	
postoperatively	at	6,	12	and	
24	months.	
Not	reported	
	
Significant	change	in	mBIS	
scores	following	treatment	
Weidner	et	al	(2017)	
	
Not	reported	
	
Not	demonstrated	 Not	reported	
	
Not	demonstrated	
Genital	Self	Image	Scale–	20	(GSIS-20)	
Zielinski,	Kane-Low	et	al	
(2012)	
Cronbach’s	alpha	0.79-0.89	 Known	group	approach:	
significant	correlation	of	
GSIS-20	scores	with	
participants	considering	
genital	cosmetic	surgery	
User	group	involvement.	
Clincian	expert	panel.	
Content	validity	index	scores	
calculated.		
Pearson’s	correlation	for	
test-restest	reliability=	0.88	
Zielinski	et	al	(2012)	 Cronbach’s	alpha	0.89	
	
GSIS-20	scores	significantly	
lower	(worse)	than	patients	
not	diagnosed	with	prolpase	
Positive	correlation	with	
BES	scores	(r=0.38)	
	
Not	assessed	
Handezalts	et	al	(2017)	 Cronbach’s	alpha	0.85	 GSIS	scores	significant	
associated	with	sexual	
function	scores	(FSFI)	
Not	reported	
	
Not	assessed	
Body	Exposure	during	Sexual	Activities	Questionnaire	(BESAQ)		
Lowder	et	al	(2010)	
	
Cronbach’s	alpha	0.95	
	
Statistically	significant	
improvement	in	BESAQ	
scores	following	prolapse	
surgery	
Age	significantly	associated	
with	BESAQ	score	
Not	reported	
	
Significant	change	in	BESAQ	
scores	following	treatment	
Body	Esteem	Scale	(BES)	
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Zielinski	et	al	(2012)	
	
Not	reported	 Positive	correlation	between	
sexual	function	scores	(FSFI)	
and	BES	(r=0.34)	
Positive	correlation	with	
GSIS-20	(r=0.38)	
Not	assessed	
The	Body	Image	Quality	of	Life	Inventory	(BIQLI)	
Lowder	et	al	(2010)	
	
Cronbach’s	alpha	0.97	
	
No	statistically	significant	
change	in	BIQLI	scores		
Not	reported	
	
Not	demonstrated	
Body	Image	in	Pelvic	Organ	Prolapse	questionnaire	(BIPOP)	
	
Lowder	(2014)	 Cronbach’s	alpha	0.92	
Interclass	correlation	0.80	
Strong	correlation	(r=0.38	
and	r=	0.45)	with	scores	for	
pelvic	organ	prolapse	
symptoms	(PFDI-20,	PFIQ-7)	
Patient	user	group	
involvement	and	good	
evidence	of	face	validity	
Strong	correlation	(r=0.70	
and	r=0.36)	with	body	
exposure	during	sexual	
activity	(BESAQ)	and	Body	
image	quality	of	life	
inventory	(BIQLI)	
Not	assessed	
Vaginal	Changes	Sexual	and	Body	Esteem	(VSBE)	
Zielinski	(2009)	 Not	reported	 Strong	correlation	(r=0.59)	
between	severity	of	prolapse	
and	VSBE	
Not	reported	
	
Not	assessed	
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Table	3:	Summary	details	of	the	study	populations	for	each	included	study.	
	
Instrument/study	 Number	
of	
women	
in	study	
Study	population	
The	modified	Body	Image	Scale	(mBIS)	
Jelovsek	et	al	(2006)	 47	 Patients	with	advanced	pelvic	organ	prolapse	
Barber	et	al	(2007)	 70	 Patients	undergoing	surgery	for	pelvic	organ	prolapse	
Lowenstein	et	al	(2009)	 384	 Patients	with	stage	2	or	greater	pelvic	organ	prolapse	
Lowenstiein	et	al	(2010)	 239	 Patients	with	stage	2	or	greater	pelvic	organ	prolapse	
Patel	et	al	(2010)	 54	 Patients	with	pelvic	organ	prolapse	managed	by	pessary	
Crisp	et	al	(2013)	 87	 Patients	with	prolapse	undergoing	colpocliesis	
Levin	et	al	(2014)	 28	 Patients	with	overactive	bladder	
Meriwether	et	al	(2015)	 127	 Patients	with	pelvic	organ	prolapse	managed	with	a	pessary	
Crisp	et	al	(2016)	 81	 Patients	with	prolapse	undergoing	colpocliesis	
Lucacz	et	al	(2016)	 307	 Patients	undergoing	surgery	for	pelvic	organ	prolapse	
Weidner	et	al	(2017)	 283	 Patients	with	pelvic	organ	prolapse	stage	2	or	greater	
Genital	Self	Image	Scale–	20	(GSIS-20)	
Zielinski,	Kane-Low	et	al	(2012)	 277	 Patients	with	stage	2	or	greater	prolapse	(n=34).	Patients	
with	perineal	trauma(n=51)	
Zielinski	et	al	(2012)	 74	 Patients	with	prolapse	(n=13),,	surgery	for	prolapse	(n=24)	
and	controls	(n=37)	
Handezalts	et	al	(2017)	 107	 Patients	attending	a	urogynaecology	clinic	
Body	Exposure	during	Sexual	Activities	Questionnaire	(BESAQ)		
Lowder	et	al	(2010)	
	
	 Patients	with	pelvic	organ	prolapse	stage	2	or	greater	
Body	Esteem	Scale	(BES)	
	
Zielinski	et	al	(2012)	
	
74	 Patients	with	prolapse	(n=13),,	surgery	for	prolapse	(n=24)	
and	controls	(n=37)	
The	Body	Image	Quality	of	Life	Inventory	(BIQLI)	
Lowder	et	al	(2010)	
	
64	 Patients	with	pelvic	organ	prolapse	stage	2	or	greater	
Body	Image	in	Pelvic	Organ	Prolapse		questionnaire	(BIPOP)	
Lowder	(2014)	 201	 Patients	with	pelvic	organ	prolapse	symptoms	
Vaginal	Changes	Sexual	and	Body	Esteem	(VSBE)	
Zielinski	(2009)	 13	 Patients	with	pelvic	organ	prolapse	
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Table	4:	Psychometric	properties	of	PROMS	identified	by	the	systematic	review,	scored	
according	to	Preston	et	al	(2015).	Key	to	scoring:	0	not	reported,	-	no	evidence	in	favour,	+	
some	limited	evidence	in	favour,	++	some	good	evidence	in	favour,	+++	good	evidence	in	
favour.	
	
PROM	
Number	
of	
studies	
used	in	
Reliability	 Construct	Validity	
Content	
Validity	
Criterion	
Validity	 Responsiveness	 Acceptability	
The	modified	
Body	Image	
Scale	(mBIS)	
11	 ++	 ++	 0	 0	 ++	 ++	
Body	
Exposure	
during	Sexual	
Activities	
Questionnaire	
(BESAQ)	
1	 ++	 ++	 0	 0	 ++	 ++	
Body	Image	in	
Pelvic	Organ	
Prolapse		
questionnaire	
(BIPOP)	
1	 +++	 ++	 ++	 +++	 0	 0	
The	Body	
Image	Quality	
of	Life	
Inventory	
(BIQLI)	
1	 ++	 0	 0	 0	 0	 ++	
Genital	Self	
Image	Scale–	
20	(GSIS-20)	
3	 +++	 +++	 +++	 +++	 +++	 +++	
Vaginal	
Changes	
Sexual	and	
Body	Esteem	
(VSBE)	
1	 0	 ++	 0	 0	 0	 +	
Body	Esteem	
Scale	(BES)	
	
1	 0	 ++	 0	 ++	 0	 ++	
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Figure	1	
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7.3	Paper	3:	Gray	TG,	Alexander	C,	Jones	GL,	Tidy	JA,	Palmer	JE,	Radley	SC.	
Development	and	Psychometric	Testing	of	an	Electronic	Patient-Reported	Outcome	
Tool	for	Vulval	Disorders	(ePAQ-Vulva).	Journal	of	lower	genital	tract	disease.	
2017;21(4):319-26.		
Précis:	There	is	a	need	to	address	outcomes	assessment	for	patients	with	vulval	disorders.	
A	 PROM	 (ePAQ-Vulva)	 has	 been	 developed,	 initial	 psychometric	 testing	 shows	 good	
potential.	
	
Abstract	
Objective:	 Development	 of	 an	 electronic	 patient	 reported	 outcome	 measure	 (PROM)	
specifically	 designed	 for	 vulval-disorders.	 Psychometric	 testing	 of	 the	 components	 of	 the	
questionnaire	which	assess	vulval	symptoms,	sexual	function	and	quality	of	life	(QoL).	
Method:	Development	and	programming	of	the	instrument	(ePAQ-Vulva)	was	informed	by	
national	guidelines	for	the	assessment	of	vulval-disorders,	an	expert	panel	and	a	survey	of	
61	 vulval	 clinic	 patients.	 The	 PROM	 assesses	 frequency	 and	 impact	 of	 vulval	 symptoms,	
sexual	 function	 and	 QoL.	 It	 also	 records	 conditions	 and	 behaviours	 related	 to	 vulval-
disorders	and	patient	concerns/goals.		
Scale	generation	and	psychometric	testing	were	undertaken	for	the	vulval	symptoms,	sexual	
function	and	QoL	components	of	the	PROM	with	91	participants:	descriptive	statistics,	factor	
analysis	 and	 internal	 reliability	 of	 identified	 domains,	 agreement	 between	 free-text	 and	
multiple-choice	items	to	assess	convergent	validity	and	inter-rater	reliability	of	picture	items	
was	assessed.	
Results:	Descriptive	statistics	showed	high	floor	effects	for	seven	questionnaire	items.	
Factor	analysis	identified	five	principal	components.	These	were	reviewed	and	amended	to	
provide	a	putative	domain	structure	of	six	domains.	Internal	reliability	of	these	domains	
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was	assessed	using	Cronbach’s	alpha,	producing	values	of	0.715	to	0.917.	Inter-rater	
reliability	of	the	picture	items	produced	a	Kappa	statistic	of	0.405.	Spearman’s	rank	
showed	moderate	correlation	between	multiple	choice	answers	and	free-text	concerns	
(r=0.364	–	0.462)	in	three	of	the	six	domains	(Pain,	Sex	and	Dyspareunia).		
Conclusions:	 ePAQ-Vulva	 offers	 the	 first	 patient	 reported	 outcome	 tool,	 specifically	
designed	 for	 vulval-disorders.	 The	 instrument	 requires	 further	 validation	 and	 testing,	
including	evaluation	of	the	stability,	responsiveness	and	reliability.	
		
MeSH	 Keywords:	 Vulva,	 Genitalia-	 female,	 patient-reported	 outcome	 measures,	
surveys	and	questionnaires,	self	report,	telemedicine		
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Introduction:	
Vulval-disorders	encompass	a	diverse	group	of	conditions	affecting	the	visible	areas	
of	the	external	female	genitalia.1	Vulval-disorders	negatively	impact	on	quality-of-life,	body-
image,	 self-confidence,	 relationships	 and	 sexual	 function.2	 Adequate	 consultation	 time	 is	
essential	 to	enable	appropriate	assessment	of	women	with	vulval-disorders.	New-patient	
appointments	within	the	National	Health	Service	(NHS)	in	the	UK	are	restricted	to	twenty-
minutes.	 Taking	 a	 detailed	 history,	 physical	 examination,	 scheduling	 investigations,	
discussing	possible	diagnoses	and	treatment	options,	whilst	making	provision	for	women	to	
freely	express	themselves	about	such	intimate	conditions	is	challenging.				
Patient-reported	 outcome	 measures	 (PROMs)	 are	 questionnaires	 or	 instruments	
designed	 to	provide	means	of	measuring	 conditions,	 their	 impact	 and	outcome	 following	
intervention,	from	the	patient’s	perspective.	The	use	of	PROMs	is	increasingly	widespread.	
Since	2009	the	NHS	has	made	it	a	requirement	to	collect	PROMs	data	from	patients	before	
and	after	surgery	for	hip	and	knee	replacements,	varicose	veins	and	groin	hernias.3	In	2013	
The	British	Society	for	the	Study	of	Vulval	Disease	(BSSVD)	published	‘Standards	of	Care	for	
Women	 with	 Vulval	 Conditions.’4	 These	 standards	 recommend	 the	 routine	 collection	 of	
PROMs	for	all	women	with	vulval	conditions.	However,	despite	this,	there	is	no	nationally	
recommended	vulva-specific	instrument	for	the	collection	of	outcomes	data.		
A	variety	of	PROMs	have	been	described	for	use	in	women	with	vulval-disorders.	
These	include	three	instruments	specific	to	vulval	cancer;	Vulval	Intra-epithelial	Neoplasia	
Questionnaire	(VIN-Q),	5	Functional	Assessment	of	Cancer-Vulvar	(FACT-V)	6	and	Sexual	
Function	Vaginal	Changes	Questionnaire	(SVQ).,7	Examples	of	generic	instruments	used	to	
assess	components	of	vulval	disorders	include	the	McGill	Pain	Questionnaire	(MPQ),	8	
Dermatology	Specific	Quality-of-life	(DSQL),	9	Dermatology	Life	Quality	Index	(DLQI),	10		
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Female	Sexual	Distress	Scale	(FSDS)	11,	Female	Sexual	Function	Index	(FSFI)12	and	Patient-
Reported	Outcomes	Measurement	Information	System	Sexual	Function	and	Satisfaction	
measure	(PROMIS	SexFS).	13	
The	 available	 instruments	 are	 therefore	 either	 specific	 to	 vulval	 cancer	 or	 non-
specific	 to	 the	 vulva	 itself.	 The	 now	 archived	 Royal	 College	 of	 Obstetricians	 and	
Gynaecologists	(RCOG)	Guideline	on	the	Management	of	Vulval	Skin	Disorders	included	an	
example	of	 a	pre-clinic	 vulval-disorders	questionnaire.14	This	 explores	behaviors	 and	 co-
morbidities	that	relate	to	vulval-disorders,	but	does	not	include	assessment	of	symptoms,	
sexual	function	or	quality-of-life.		
The	 first	 aim	of	 this	 study	was	 to	develop	 a	PROM	 instrument	 specific	 for	 vulval-
disorders,	utilizing	 the	potential	benefits	of	an	 interactive	electronic	 format	 in	evaluating	
intimate	 and	 sensitive	 conditions,	 enhancing	 patient	 assessment	 and	 addressing	 the	
collection	 of	 PROMs	 data.	 The	 second	 aim	was	 to	 undertake	 psychometric	 testing	 of	 the	
components	 of	 this	 instrument	 designed	 to	 assess	 vulval	 symptoms,	 sexual	 function	 and	
quality	of	life	in	this	context.	
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Methods:	
Ethical	approval	was	obtained	from	the	University	of	Sheffield	University	Research	
Ethics	Committee	(Project	Number	001980).		
	
	
Patient	Survey	
To	assess	women’s	perspectives	regarding	the	concept	of	an	electronic	PROM,	and	
inform	the	questionnaire	content	that	would	be	important	to	women	with	vulval	disorders,	
a	survey	of	vulval	clinic	patients	was	undertaken	over	three	weeks	 in	 January	2013.	This	
survey	 included	 an	 explanation	 of	 the	 planned	 development	 of	 the	 PROM	 to	 help	 in	 the	
assessment	of	vulval	conditions	and	included	six	free-text	questions.	(Table	1).		
	
Platform	technology	
The	 platform	 technology	 used	 was	 first	 developed	 in	 urogynaecology	 to	 assess	
women	 with	 pelvic-floor	 disorders	 (ePAQ-Pelvic	 Floor),	 which	 has	 been	 extensively	
validated	and	used	in	clinical	practice.15-17		
Key	elements	of	 the	system	 include	 introductory	pages,	explaining	how	to	use	 the	
‘Help’,	‘Back’,	‘Next’	and	‘Skip’	navigation	functions.	This	eliminates	accidental	non-response	
to	 items,	as	progression	 is	only	enabled	once	a	 response	has	been	selected.	 Items	can	be	
skipped	 automatically,	 depending	 upon	 responses	 to	 earlier	 screening	 questions.	 Sub-
questions	 regarding	 the	 impact	 of	 symptoms	 are	 displayed	 if	 the	 particular	 symptom	 is	
reported.	Responses	from	completed	questionnaires	are	stored	as	numeric	code	in	a	secure	
central	database,	located	behind	a	firewall	on	an	NHS	N3	server.	
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Item	Generation	 	
Design	features	of	ePAQ-Pelvic	Floor	were	incorporated	in	ePAQ-Vulva	with	entirely	
new	content.	Initial	drafting	of	items	was	undertaken	by	a	specialty	trainee	(TG)	following	
Food	 and	 Drug	 Administration	 (FDA)	 guidance	 on	 PROM	 development.18	 Content	 was	
informed	 by	RCOG	 guidelines	 for	 the	management	 of	 vulval-disorders,	 findings	 from	 the	
literature	review	and	responses	 from	the	62	women	attending	 the	specialist	vulval	 clinic	
who	took	part	 in	the	survey.	An	expert	panel	consisting	of	three	consultant	gynecologists	
(JAT/SCR/JEP)	reviewed	the	items	and	further	advised	on	content.	An	interactive	pictorial	
item,	using	an	image	of	the	vulval	area	was	also	developed,	enabling	women	to	select	areas	
of	the	vulva	affected	by	pain	and	skin	changes.	Advanced	prototypes	of	the	instrument	were	
prepared	 across	 six	 drafts,	 before	 converting	 to	 electronic	 format	 using	 the	 ePAQ	
questionnaire	builder	 software.	The	first	 electronic	prototype	was	again	 reviewed	by	 the	
expert	panel	and	refined	across	two	further	versions.	The	final	version	contained	64	items,	
of	which	28	related	to	vulval	symptoms,	sexual	function	and	associated	quality	of	life	issues.	
These	items	were	subject	to	factor	analysis	in	order	to	evaluate	the	domain	structure	of	the	
instrument.	The	other	 items	concerned	conditions	related	to	vulval	disorders,	behaviours	
potentially	affecting	vulval	disorders,	demographic	details,	the	interactive	picture	item	and	
free	text	concerns	and	goals.	Items	assessing	conditions,	behaviours	and	demographics	were	
not	subjected	to	psychometric	assessment	as	part	of	this	study.		
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Scale	generation	
	
To	identify	scales	and	evaluate	psychometric	properties	for	the	items	assessing	vulval	
symptoms,	 sexual	 function	 and	 quality	 of	 life;	 the	 instrument	 was	 administered	 to	
consenting	 patients	 attending	 the	 vulval	 clinic	 at	 Sheffield	 Teaching	 Hospitals	 NHS	
Foundation	 Trust	 between	December	 2013	 and	 January	 2015.	 Data	 collected	 during	 the	
study	period	were	analyzed	using	SPSS	(IBM	SPSS	Statistics	for	Windows,	Version	22.0,	IBM	
Corporation,	2013,	Armonk,	New	York).	
During	the	study	period,	all	women	scheduled	to	attend	the	Vulval	Clinic	received	a	letter	
providing	 them	with	details	 of	 their	 appointment,	 inviting	 them	 to	 complete	 ePAQ-Vulva	
prior	to	attending.	The	letter	included	details	about	the	nature	and	purpose	of	ePAQ-Vulva,	
along	with	a	unique	16-digit	voucher	code	which	enables	secure	on-line	completion.	Subjects	
unable	to	complete	on-line	were	invited	to	do	so	in	clinic,	using	a	touch	screen	kiosk	in	a	
private	 room.	 Data	 from	 each	 subject	 automatically	 populates	 a	 one-page	 summary	 and	
three-page	detailed	 report,	which	 can	be	viewed	or	printed	 for	 inclusion	 in	patient	 case-
notes.			
Factor	analysis	is	a	statistical	procedure	which	enables	the	underlying	domains,	or	
scales,	of	a	patient-reported	outcome	measure/patient	questionnaire	to	be	determined.19	
In	order	to	identify	the	domains	of	ePAQ-Vulva,	factor	analysis	using	varimax	rotation	was	
carried	out.	There	is	no	consensus	on	the	sample	size	required	to	carry	out	factor	analysis.	
It	has	been	recommended	that	five	to	ten	times	the	number	of	subjects	to	items	in	the	
instrument	is	required.	However,	it	has	been	shown	that	a	ratio	of	2:1	of	respondents	and	
variables	is	satisfactory	and	can	produce	the	same	results.	20	Therefore,	instead	of	a	power	
calculation,	following	a	conservative	pragmatic	approach	we	aimed	to	recruit	as	many	
	
144	
women	as	possible	to	the	study	within	the	study	time	frame.	19	Of	the	64	items	in	ePAQ-
Vulva,	28	items	were	suitable	for	factor	analysis.	Not	all	items	from	ePAQ-Vulva	were	
included,	as	each	of	the	28	items	contained	sub-questions,	which	explore	the	impact	of	each	
symptom/problem.	Each	of	these	items	consisted	of	responses	on	a	four-point	scale,	which	
were	scored	0-3,	giving	continuous	data	suitable	for	factor	analysis.	
Descriptive	statistics	provided	a	baseline	understanding	of	the	data	set	generated	
from	ePAQ-Vulva.	This	included	the	mean,	median	and	floor/ceiling	effects	for	each	item.	
Floor	and	ceiling	effects	help	assess	content	validity	and	show	the	proportion	of	individuals	
who	score	the	greatest	or	least	possible	numeric	value	of	a	score/scale,	and	are	considered	
present	when	more	than	15%	of	participants	score	these	values.	High	ceiling	effects	
indicate	that	it	will	be	difficult	to	measure	changes	in	patients	after	an	intervention	has	
been	undertaken.	21		
Internal	reliability	is	the	extent	to	which	items	within	an	instrument	measure	the	
same	concepts.22	It	also	ensures	that	no	two	items	are	measuring	exactly	the	same	concept	
and	may	therefore	be	used	as	a	tool	for	item	reduction;	with	the	aim	of	reducing	the	burden	
of	completing	the	instrument.	Cronbach’s	α	was	used	to	measure	this.	Scores	greater	than	
0.7	usually	indicate	that	scale	items	are	measuring	related	constructs,	scores	greater	than	
0.94	suggest	a	degree	of	item	redundancy,	and	provide	a	basis	for	item	reduction.	This	was	
considered	for	all	items	that	did	not	statistically	or	intuitively	fit	into	any	of	the	domains	
identified	from	factor	analysis	and	those	that	did	not	show	good	internal	reliability.		
Inter-rater	 reliability	 was	 assessed	 for	 picture	 items.	 This	 assesses	 the	 level	 of	
agreement	between	two	or	more	raters	assessing	the	same	variable.23	In	order	to	establish	
whether	the	pictures	items	were	useful	for	recording	symptoms	of	vulval	disease,	a	subgroup	
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of	data	from	17	women	completing	ePAQ-Vulva	was	assessed.	The	clinician	reviewing	the	
patient	(JEP)	completed	a	paper	version	of	the	picture	item	in	the	patient’s	notes,	indicating	
where	they	considered	the	symptoms	to	be	located	after	examination.	The	picture	item	was	
split	into	six	fields,	so	that	for	17	women	there	were	102	possible	sites	of	agreement.	For	
each	site	a	binary	score	of	either	agreement		“1”	or	disagreement		“0”	was	given	and	Cohen’s	
Kappa	statistic	was	used	to	analyze	the	data.	Disagreement	was	deemed	to	occur	if	a	site	was	
selected	by	the	patient,	but	not	by	the	clinician	and	vice	versa.	
Convergent	validity	is	the	degree	to	which	two	measures	of	constructs	that	should	be	
related,	 are	 in	 fact	 related.	This	was	partially	 assessed	by	 comparing	 the	multiple-choice	
responses	with	 the	 free-text	 items	 recording	 subject’s	 concerns	 and	 goals.	 The	 free	 text	
comments	were	each	reviewed	to	assess	if	the	concern	recorded	by	the	patient	was	assessed	
by	 a	 questionnaire	 item	 in	 a	 particularly	 domain.	 Free-text	 data	 for	 concerns	were	 then	
categorized	 according	 to	 domain	 and	 the	 rank	 correlation	 coefficient	 with	 the	 relevant	
domain	scores	for	quality	of	life	calculated	(Spearman's	rank	correlation).	
	
Results	
a. Patient	Survey.	
A	total	of	62	women	completed	 the	survey	over	 the	 three-week	period	 (Table	1).	
Altogether	91	women	attending	the	clinic	were	invited	to	complete	the	questionnaire,	giving	
a	response	rate	of	68%.	
Of	women	completing	the	survey,	75%	were	positive	about	the	idea	of	an	electronic	
online	questionnaire	to	assess	women	with	vulval	disorders,	74%	listed	advantages	of	this	
and	26%	listed	disadvantages.	Two	key	themes	that	emerged	related	to	advantages	of	being	
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able	to	express	their	feelings	or	concerns	(35%)	and	receiving	information	and	knowledge	
about	 vulval-disorders	 (33%).	 When	 asked	 about	 possible	 advantages	 of	 an	 electronic	
questionnaire	 to	 clinic	 staff,	 56%	 of	 respondents	 answering	 the	 question	 reported	
advantages	of	improved	clinic	staff	communication	with	patients	and	their	partners.		
	
Table	1	-	Survey	questions	and	summary	of	results	
	
	
b.	ePAQ	Vulva	Structure	and	Dimensions	
ePAQ	Vulva	comprises	of	3	dimensions.	The	full	structure	and	questions	comprising	
ePAQ-Vulva	as	tested	can	be	viewed	as	supplementary	material	online	as	an	appendix	to	this	
paper.	
	
	
	
1. Vulval	Symptoms	dimension.		
Items	 assessing	 severity,	 frequency	 and	 impact	 of	 symptoms,	 including	 pain,	 soreness,	
itching,	skin	changes,	effects	on	sexual	function	and	activities	of	daily	living	(quality	of	life)	
(Figure	1).		
	
Figure	 1:	 Example	of	 item	 in	 the	 Vulval	 Symptoms	Dimension,	 assessing	 symptom	
frequency	and	impact,	in	this	case	itching.	
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Within	this	dimension	are	two	items	which	present	an	interactive	picture	of	the	vulva	
to	allow	women	to	record	both	the	loci	of	any	vulval	pain	or	soreness	and	vulval	skin	changes	
(Figure	2).	
	
Figure	2:	Vulval	image	allowing	women	to	indicate	areas	affected	by	discomfort	or	
pain.	
	
2. Activities	and	conditions	that	may	affect	the	vulva.		
These	 items	relate	 to	activities	and	behaviors	such	as	vulval	washing	regimens,	as	
well	as	dermatological,	rheumatological	and	inflammatory	disorders	associated	with	vulval	
conditions.	This	did	not	undergo	psychometric	testing.	
		
	
3.	Personal	Data	Dimension	
Comprising	of	six	items,	recording	age,	body	mass	index	(BMI),	current	medications	
and	obstetric	history.	Within	this	dimension	are	two	free-text	 items	that	allow	women	to	
record	their	personal	concerns,	goals	and	questions.	The	final	‘consent’	item	asks	whether	
the	 subject	 is	 willing	 to	 allow	 confidential	 use	 of	 their	 anonymised	 data	 for	 approved	
research.		
	
c. Initial	psychometric	testing	
Of	the	153	women	who	were	posted	a	voucher	to	complete	ePAQ-Vulva,	98	(64%)	
completed	the	instrument	either	on-line	prior	to	clinic	attendance	or	in	the	vulval	clinic	at	a	
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touch	screen	computer	in	a	private	room.	The	age	range	of	the	cohort	was	22	–	89,	with	a	
mean	age	of	38.	The	average	time	to	complete	the	questionnaire	was	32	minutes	(range	22	
–	57	minutes).	
Initially,	 factors	 (groups	 of	 items)	 which	 gained	 an	 Eigen	 value	 (raw	 sum	 of	 the	
squares)	of	1	or	more	were	retained.	Factor	analysis	(principle	component	analysis	using	
Varimax	rotation)	indicated	the	presence	of	five	components	or	domains.	These	accounted	
for	42.0%,	11.8%,	7.6%,	5.7%	and	3.6%	of	the	variance.	The	expert	panel	(SCR,	JEP,	GJ	and	
JAT)	reviewed	and	intuitively	amended	these	components	to	provide	a	putative	structure	
comprising	of	six	clinically	meaningful	domains.	
Descriptive	statistics	showing	the	mode,	median	and	floor/ceiling	effects	of	28	items	
from	ePAQ-Vulva,	including	the	frequency	that	each	question	was	answered,	can	be	seen	in	
table	two.		Descriptive	statistics	of	the	28	items	found	that	some	had	large	floor	and	ceiling	
effects	and	non-specificity,	meaning	that	many	women	completing	the	questionnaire	
recorded	a	similar	score	and	there	was	a	lack	of	variance;	these	items	were	considered	for	
modification	or	reduction	when	the	PROM	was	revised.	Internal	reliability	of	the	six	
domains	was	assessed	using	Cronbach’s	α;	all	six	domains	achieving	an	alpha	level	of≥	0.7	
(Table	3).			
	
Table	2:	Descriptive	statistics	for	the	28	assessed	items	in	ePAQ-Vulva:	Mean,	
Standard	Deviation,	Floor	and	Ceiling	effects.	Items	are	scored	from	0	to	3	(0=	best	
possible	health	status,	3=	worst	possible	health	status)	
	
Table	3:	Internal	reliability	assessment	of	the	six	domains	identified	in	ePAQ-Vulva:	
The	 six	 components	 resulting	 from	Factor	Analysis,	 Internal	 reliability	 testing	 and	
discussion	 with	 an	 expert	 panel.	 Showing	 items	 and	 resulting	 Cronbach's	 alpha	
statistic.	
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Inter-rater	reliability	of	the	picture	items	showed	agreement	between	clinician	and	
patient	54%	of	the	time	regarding	the	presence	of	symptoms.		Agreement	regarding	absence	
of	symptoms	was	85%.	The	Cohen’s	Kappa	measure	of	agreement	was	moderate	at	0.405.		
Spearman’s	rank	showed	significant	moderate	correlation	between	multiple-choice	
components	and	free-text	items	in	three	of	the	five	domains.	These	were;	vulval	pain	and	
soreness	(r=0.364,	p<0.005),	dyspareunia	(r=0.394,	p<0.005)	and	vulval	 itching	(r=0.462,	
p<0.005).	Correlation	between	the	other	two	domains	(quality	of	life	(r=0.022,	p=0.84)	and	
skin	changes	(r=0.071,	p=0.50)	was	non-	significant.		
	
Discussion		
ePAQ-Vulva	combines	detailed	assessment	of	vulval	symptoms,	sexual	dysfunction,	
quality-of-life,	associated	activities	and	medical	conditions,	as	well	as	relevant	issues	such	as	
BMI,	parity,	personal	goals	and	patient	questions.	This	presents	 the	clinician	with	a	 large	
amount	of	information	about	both	frequency	and	bothersomeness	of	symptoms,	presence	of	
conditions	or	behaviours	related	to	vulval	disorders	and	relevant	demographic	details.	This	
information	can	enhance	the	acuity	of	a	consultation	as	most	components	of	the	history	will	
be	included	in	the	ePAQ-Vulva	report.	It	is	not	intended	to	be	a	tool	which	gives	a	clinician	a	
diagnosis,	but	rather	an	accurate	and	detailed	assessment	of	symptoms	and	behaviours.	
	The	instrument	is	designed	to	be	completed	prior	to	clinical	consultation,	to	facilitate	
communication	and	enable	women	to	feel	more	confident	in	exploring	intimate	conditions	
and	concerns.	Evidence	suggests	that	electronic	questionnaires	can	increase	discussion	rates	
in	 sensitive	 conditions	 and	 that	 patients	 may	 feel	 more	 comfortable	 exploring	 sensitive	
medical	 problems	 via	 electronic	 questionnaire	 than	 during	 face-to-face	 consultation.24,25	
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ePAQ-Vulva	can	also	be	completed	prior	to	subsequent	consultations,	allowing	comparisons	
with	previous	completions	to	assess	treatment	response	and	patient	outcomes.		
The	 initial	 testing	 and	 validation	 of	 ePAQ-Vulva	 has	 provided	 some	 evidence	 of	
reliability	 and	 validity.	 However,	 the	 data	 analysed	 thus	 far	 represent	 a	 relatively	 small	
sample	in	a	single-centre	specialist	vulval	clinic.	The	instrument	therefore	requires	further	
testing,	including	confirmatory	factor	analysis	of	its	domain	structure	in	larger	numbers	of	
women,	with	a	wider	variety	of	vulval	conditions.	Although	the	age	range	of	the	cohort	was	
22	–	89,	with	a	mean	age	of	38,	many	women	attending	vulval	clinics	are	elderly,	which	may	
affect	 compliance	 with	 questionnaire	 completion.	 25	 Important	 psychometric	 properties,	
including	 test-retest	 reliability	 (stability),	 local	 dependency,	 item	 discrimination	 and	
responsiveness	of	the	instrument	have	yet	to	be	evaluated.		
Of	 the	 six	 domains	 in	 the	 vulval	 symptoms	 dimension	 of	 ePAQ-Vulva,	 both	 skin	
changes	and	quality	of	life	did	not	reach	statistical	significance	in	this	study.	This	could	be	
due	to	a	lack	of	direct	patient-involvement	in	the	construction	of	the	questionnaire	items.	
Whilst	 some	 patient	 involvement	 supported	 initial	 development	 and	 testing	 of	 the	
instrument,	due	to	the	limited	time-frame	of	the	study,	qualitative	in-depth	interviews	with	
patients	were	not	carried	out.3	Further	work,	such	as	cognitive	interviewing	with	patients	is	
proposed,	 gathering	 feedback	 on	 the	 current	 item	 pool,	 considering	 new	 items	 and	
strengthening	the	content	validity.		
Following	the	initial	psychometric	testing,	changes	will	be	made	to	the	instrument	to	
remove	redundant	items,	though	with	some	caution	to	ensure	that	clinical	detail	is	not	lost	
through	item	reduction;	prioritising	statistical	significance	over	clinical	detail	may	result	in	
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the	loss	of	important	information	needed	for	in-depth	assessment.26	Further	psychometric	
testing	will	then	be	undertaken.	
Inter-rater	 reliability	 for	 the	 picture	 items,	 was	 not	 shown	 to	 be	 statistically	
significant,	using	Cohen’s	Kappa.	However,	a	measure	of	sensitivity	may	be	reflected	in	the	
proportion	of	cases	where	there	was	agreement	between	clinician	and	patient	(54%)	and	
cases	when	both	clinician	and	patient	agreed	regarding	absence	of	symptoms	(85%).	This	
suggests	that	self-completed	vulval	image	items	may	have	high	specificity	but	low	sensitivity.	
Further	 research	 is	 required	 to	 better	 understand	 their	 reliability	 and	 value	 in	 clinical	
practice.		Only	fair	inter-rater	reliability	was	demonstrated	in	this	initial	study.	
Completion	 times	 for	 ePAQ-Vulva	 are	 generally	 around	30	minutes	which	may	be	
unacceptable	for	some	users,	particularly	in	busy	under-resourced	clinics	and	when	patients	
fail	to	pre-complete	the	questionnaire	at	home.	ePAQ-Vulva	is	shorter	than	its	predecessor,	
ePAQ-Pelvic	Floor,	which	has	been	found	to	be	acceptable	and	valuable	in	clinical	practice,	
though	the	potential	older	age	of	patients	with	vulvar	disorders,	with	attendant	lower	levels	
of	computer	literacy	and	internet	access	may	affect	compliance.15,17,		
The	detail	recorded	in	ePAQ-Vulva	aims	to	form	part	of	routine	clinical	assessment	
and	a	baseline	for	future	comparison.	A	graphic	illustration	of	changes	across	its	component	
domains	 may	 be	 particularly	 helpful	 in	 monitoring	 long-term	 vulval	 conditions	 when	
reviewing	patients	at	follow-up	appointments.	
The	 instrument	 aligns	 with	 BSSVD	 recommended	 standards	 of	 care	 through	 the	
routine	 collection	of	PROMS	data,	 enabling	 subsequent	 interrogation	of	 datasets	 through	
appropriately	approved	and	regulated	audit,	service	evaluation	and	research.4	This	may	take	
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the	form	of	local,	as	well	as	multi-center	studies,	when	the	analysis	of	larger	volumes	of	data	
may	be	valuable.	
	
Conclusions:	
	An	 individual’s	beliefs	and	perspective	on	his	or	her	condition,	 including	personal	
goals	and	concerns	are	important	to	understand	in	any	medical	field.	This	is	particularly	true	
for	intimate	urogenital	disorders,	which	may	be	taboo,	embarrassing	and	have	significant	
psychological	and	psychosocial	components.	ePAQ-Vulva	is	the	first	instrument	specifically	
designed	 for	use	 in	women	with	vulval-disorders.	Although	more	 testing	 is	 required,	 the	
instrument	shows	potential	as	a	clinical	tool.	ePAQ-Vulva	also	has	the	potential	to	be	used	in	
providing	objective	patient-based	data	for	service	evaluation	and	research.	The	next	step	is	
to	undertake	wider	psychometric	testing	of	a	revised	instrument	in	larger	samples	and	in	
different	 settings,	 including	 further	 assessments	 of	 its	 domain	 structure,	 responsiveness,	
reliability	and	validity.	
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Figure	1:	Example	of	item	in	the	Vulval	Symptoms	Dimension,	assessing	symptom	frequency	
and	impact,	in	this	case	itching		
	
Figure	2:	Vulval	image	allowing	women	to	indicate	areas	affected	by	discomfort	or	pain.	
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Table	1:	Survey	Questionnaire	and	summary	of	results	
	
Survey	Question	
	
Summary	of	responses	
1.	 What	do	you	think	about	the	idea	of	a	computerised	
online	questionnaire	to	help	assess	women’s	feelings	
and	concerns	about	their	vulval	condition	and	clinical	
care?	
Responses:	n=60	
• Positive	response	-75%	
• Ambivalent	response-	8%	
• Negative	response-	17%	
2.	 What	key	areas	or	issues	do	you	think	such	a	
questionnaire	should	cover?	
	
	
	
	
	
	
	
	
	
	
	
Responses:	n=52		
The	answers	were	split	into	six	categories	based	on	the	main	themes	covered	by	the	
various	answers.		
Some	patient	answers	included	several	themes.	
• 22.6%	-symptoms/investigations/diagnosis.		
• 37.7%	-	addressing	feelings/concerns.		
• 15.1%	-	management	of	their	vulval	disease.		
• 24.5%	-	information	about	their	condition	to	be	given	through	using	the	
electronic	questionnaire.	
• 15.1%	-	ability	to	record	demographic	information	about	themselves	though	
the	electronic	questionnaire.	
• 20.8%	said	the	electronic	questionnaire	should	cover	‘all	areas’	and	didn’t	
define	anything	more	specific.		
• 5.7%-	said	that	they	‘did	not	know’	or	were	‘not	keen’	on	the	questionnaire.	
3.	 What	do	you	think	might	be	the	advantages	or	
disadvantages	of	this	questionnaire	to	patients?	
	
	
	
	
	
	
	
	
	
Responses:	n=51		
The	answers	were	split	into	six	categories	based	on	the	main	themes	covered	by	the	
various	answers.	Some	patient’s	answers	included	several	themes.		
Advantages	listed	included:	
• Providing	information/knowledge	to	patients	(33%),	
• Expressing	their	feelings	or	concerns	(35%),	
• Confidentiality	(2%),		
• Improved	accessibility	to	the	vulval	clinic	(20%).	
Disadvantages	listed	included	
• Providing	too	much	information	(10%),		
• Confidentiality	concerns	(4%),		
• Worsening	access	to	vulval	clinic	(i.e.	doing	an	electronic	questionnaire	
instead	of	seeing	a	doctor/nurse)	(10%).		
4.	 What	do	you	think	might	be	the	advantages	or	
disadvantages	of	this	questionnaire	to	the	health	care	
team?	
	
	
	
	
	
	
	
	
	
Responses:	n=43		
89%	of	responses	regarded	advantages;	11%	regarded	disadvantages.	
Advantages	listed	included:	
• Improve	staff	training	(7%),		
• Provide	more	accurate	information	to	women	based	on	the	answers	provided	
in	the	questionnaire	(14%),		
• Improve	clinic	staff’s	communication	with	patients	and	their	partners	(56%),		
• Improve	quality	of	care	provided	to	patients	(19%),		
• Help	to	collect	information	which	can	be	used	to	improve	the	clinic	service	
(14%).	
Disadvantages	listed	included:	
• Create	extra	work	for	clinic	staff	(12%),		
• Some	patents	wouldn’t	use	the	electronic	questionnaire	(2%).		
5.	 What	sort	of	research	studies	do	you	feel	might	be	
carried	out	in	relation	to	this	project?	
	
	
	
	
	
Responses:	n=24		
• 42%	felt	that	communication	would	be	a	suitable	topic	for	research	carried	
out	in	relation	to	the	electronic	questionnaire.	
• 41%	felt	that	treatment/cures/prognosis	would	be	a	potential	research	topic	
in	relation	to	the	electronic	questionnaire.	
• 21%	felt	that	a	research	on	the	epidemiology	of	patients	with	vulval	disease	
could	be	carried	out	using	the	electronic	questionnaire.		
• 4%	felt	that	research	into	the	diagnosis	of	vulval	disease	could	be	carried	out	
using	the	electronic	questionnaire.	
6.	 Do	you	have	any	comments	or	suggestions	about	this	
project?	
	
	
	
	
	
	
• Six	patients	(50%)	said	they	wanted	the	questionnaire	to	help	them	get	access	
to	information	about	vulval	disease.	
• One	patient	(8.3%)	said	they	wanted	the	questionnaire	to	cover	sexual	
function		
• Two	patients.	(16.7%)	raised	concerns	about	the	questionnaire	being	
electronic	and	the	effect	this	would	have	on	provision	of	face	to	face	
consultations.	
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Responses:	n=12		 • Four	patients	(33%)	made	comments	stating	that	they	felt	that	the	
questionnaire	project	was	advantageous	for	them.	
 
 
 
 
Table	2:	Descriptive	statistics	summary	for	the	28	items	in	ePAQ-Vulva:	Mean,	Standard	Deviation,	Floor	
and	Ceiling	effects.	Items	are	scored	from	0	to	3	(0=best	possible	health	status,	3=	worst	
possible	health	status)	
 
 
Item	 	 	
n.	
Mode	 Median	 Mean	 	
Floor		0	
(%)	
	
	
1	
(%)	
	
	
2	
(%)	
	
Ceiling	
3	
(%)	
DOMAIN	1	VULVAL	PAIN	
	
V2a	–	Pain	soreness	frequency	
	
	
	
	
	
98	
	
	
2	
	
	
2	
	
	
1.64	
	
	
11	
30	 39	
	
17	
V3a	–	Pain/	soreness	affecting	sleep	 	 98	 0	 1	 	
.81	 40	 40	
	
15	
	
3	
V4a	-	Painkiller	use	 	 97	 0	 0	 .46	 63	 25	 7	 2	
V5a	–	Micturition	pain	 	 97	 1	 1	 .85	 33	 51	 8	 5	
V6a	–	Pain	on	defecation	 	 97	 0	 0	 .52	 58	
30	
7	 2	
DOMAIN	2	–	VULVAL	ITCHING	
	
V9a	–	Itching:	frequency	
	
	
	
	
	
95	
	
	
1	
	
	
1	
	
	
1.27	
	
	
22	
	
	
34	
30	
	
	
9	
V10a	–	Itching	and	excoriation	 	 95	 1	 1	 1.03	 31	 39	 15	 9	
V11a	–	Itching:	scratching	and	
bleeding	
	 95	 0	 0	 .41	 63	 26	 5	 1	
V12a	–	Itching:	sleep	disturbance	 	 95	 0	 1	 .69	 44	 39	 10	 2	
DOMAIN	3	–	VULVAL	SKIN	CHANGES	
	
V13a	–	Skin	pigmentation	
	
	
	
	
95	
	
	
1	
	
	
1	
	
	
1.28	
	
	
25	
	
	
31	
	
	
19	
	
	
15	
V14a	–	Skin	dryness	 	 95	 0	 1	 1.33	 34	 15	 27	 19	
V15a	–	Skin	tightness	 	 95	 0	 1	 1.13	 41	 21	 12	 20	
V16a	–	Skin	thickening	 	 94	 0	 0	 .48	 63	 15	 6	 5	
V17a	–	Skin	thinning	 	 94	 0	 0	 .77	 56	 9	 13	 11	
DOMAIN	4	–	DYSPAREUNIA:	
FREQUENCY	
	
V23a	–	Dyspareunia:	frequency	
	
	
	
	
	
	
93	
	
	
	
3	
	
	
	
3	
	
	
	
1.98	
	
	
	
12	
	
	
	
13	
	
	
	
4	
	
	
	
37	
V25a	–	Dyspareunia:	post	coital	 	 92	 1	 1	 1.49	 15	 19	 12	 17	
V26a	–	Dyspareunia:	dryness	 	 92	 0	 1	 1.46	 21	 13	 8	 21	
V27a	–	Dyspareunia:	reduced	
sensation	
	 92	 0	 1	 1.08	 23	 12	 8	 13	
V28a	Dyspareunia:	tightness	 	 92	 0	 1	 1.24	 26	 14	 8	 16	
V29a	Dyspareunia:	obstruction	 	 91	 0	 0	 .72	 39	 10	 5	 8	
DOMAIN	5	–	VULVA	&	SEX	
	
V30a	Vulva	and	sex	overall	
	
	
	
	
	
91	
	
	
3	
	
	
3	
	
	
2.15	
	
	
11	
	
	
7	
	
	
6	
	
	
39	
V31a	Vulva	and	sex	avoidance	 	 91	 3	 2	 1.91	 9	 16	 12	 29	
V32a	Vulva	and	sex	partner	avoids	 	 91	 0	 1	 1.27	 26	 12	 10	 16	
V33a	Vulva	and	sex	anxiety	 	 91	 3	 2	 1.79	 16	 8	 12	 28	
DOMAIN	6	–	ACTIVITIES	OF	DAILY	
LIVING	
	
V34	Vulval	condition	and	enjoyment	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
160	
of	life	 91	 3	 2	 1.83	 15	 19	 18	 35	
V35	Vulval	condition	and	physical	
activities	
	 	
91	
	
0	
	
1	
	
1.11	
	
37	
	
20	
	
18	
	
14	
V36	Vulval	condition	and	
responsibilities	
	 	
91	
	
0	
	
0	
	
.57	
	
61	
	
14	
	
6	
	
8	
V37	Vulval	condtion	and	social	
activities	
	 	
91	
	
0	
	
0	
	
.66	
	
55	
	
17	
	
10	
	
7	
 
 
 
Table 3: Internal reliability assessment of the six domains on ePAQ-Vulva:	The	
6	 components	 resulting	 from	 Factor	 Analysis,	 Internal	 reliability	 testing	 and	
discussion	 with	 an	 expert	 panel.	 Showing	 items	 and	 their	 Cronbach's	 alpha	
statistic.	
 
Item	 Cronbach’s	α	
DOMAIN	1	VULVAL	PAIN	
V2a	–	Pain	soreness	frequency	
	
0.786	
	
V3a	–	Pain/	soreness	affecting	sleep	
V4a	-	Painkiller	use	
V5a	–	Micturition	pain	
V6a	–	Pain	on	defecation	
DOMAIN	2	–	VULVAL	ITCHING	
V9a	–	Itching:	frequency	
	
0.850	
	
V10a	–	Itching	and	excoriation	
V11a	–	Itching:	scratching	and	bleeding	
V12a	–	Itching:	sleep	disturbance	
DOMAIN	3	–	VULVAL	SKIN	CHANGES	
V13a	–	Skin	pigmentation	
	
0.715	
	
V14a	–	Skin	dryness	
V15a	–	Skin	tightness	
V16a	–	Skin	thickening	
V17a	–	Skin	thinning	
DOMAIN	4	–	DYSPAREUNIA:	FREQUENCY	
V23a	–	Dyspareunia:	frequency	
	
0.878	
	
V25a	–	Dyspareunia:	post	coital	
V26a	–	Dyspareunia:	dryness	
V27a	–	Dyspareunia:	reduced	sensation	
V28a	Dyspareunia:	tightness	
V29a	Dyspareunia:	obstruction	
DOMAIN	5	–	VULVA	&	SEX	
V30a	Vulva	and	sex	overall	
	
0.929	
	
V31a	Vulva	and	sex	avoidance	
V32a	Vulva	and	sex	partner	avoids	
V33a	Vulva	and	sex	anxiety	
DOMAIN	6	–	ACTIVITIES	OF	DAILY	LIVING	
V34	Vulval	condition	and	enjoyment	of	life	
	
0.881	
	
V35	Vulval	condition	and	physical	activities	
V36	Vulval	condition	and	responsibilities	
V37	Vulval	condition	and	social	activities	
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ABSTRACT		
Objective	
Menstrual	 disorders,	 pelvic-pain	 and	 gynaecological	 hormonal	 conditions	 in	 women	 can	
have	 a	 significant	 impact	 on	 quality-of-life.	 Reliable	 assessment	 and	monitoring	 of	 these	
intimate	 conditions	 is	 challenging.	 Patient	 reported	 outcome	 measures	 (PROMs)	 can	 be	
invaluable	in	providing	objective	assessment,	but	no	comprehensive	PROM	assessing	all	of	
these	conditions	and	their	impact	on	quality	of	life	is	currently	available.	The	purpose	of	this	
study	 was	 to	 develop	 and	 undertake	 initial	 psychometric	 testing	 of	 a	 comprehensive	
interactive	electronic	patient	reported	outcome	measure	for	these	conditions.	
	
Study	design	
A	prototype	electronic	PROM	(ePAQ-MPH)	was	developed	 following	systematic	 literature	
review,	semi	structured	interviews	with	25	patients	and	expert	panel	review.	Exploratory	
factor	 analysis	 was	 undertaken	 in	 291	 women	 attending	 a	 menstrual-disorders	 clinic;	
establishing	 a	 domain	 structure	 and	 enabling	 item	 reduction.	 Two	 validated	 PROMS	
(Women’s	Health	Questionnaire	and	Menstrual	Distress	Questionnaire)	were	completed	to	
assess	criterion	validity	in	213	patients.	Test-retest	reliability	was	carried	out	in	30	women	
completing	ePAQ-MPH	at	least	one	week	apart.	Patients'	views	on	‘Value’	and	‘Burden’	were	
assessed	 in	278	women	using	a	validated	10-item	survey	measuring	questionnaire	utility	
(QQ-10).	Confirmatory	factor	analysis	(CFA)	of	the	revised	version	of	ePAQ-MPH	following	
item	reduction	was	undertaken	in	a	different	sample	of	254	women.	
	
Results	
Exploratory	 factor	 analysis	 identified	18	domains	 (Cronbach’s	α	>0.7)	 and	30	 redundant	
items.	 Test-retest	 analysis	 found	 acceptable	 intra-class	 correlations	 of	 0.6–0.9	 (p<0.05).	
Eight	domains	were	compared	with	Menstrual	Distress	Questionnaire	showing	moderate	or	
strong	 correlation	 in	 seven	domains.	Ten	domains	were	 compared	with	Women’s	Health	
Questionnaire,	six	of	which	showed	moderate	correlation.	Mean	QQ-10	Value	and	Burden	
scores	were	 76	 and	 25,	 respectively	 (SD=15.8	 and	 15.5).	 The	mean	 completion	 time	 for	
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ePAQ-MPH	 was	 31	 minutes.	 CFA	 of	 the	 revised	 version	 2	 instrument	 with	 15	 domains	
showed	good	model	fit.	
	
Conclusions	
Whilst	wider	psychometric	testing	of	the	revised	version	of	ePAQ-MPH	is	required,	including	
in	different	settings	and	in	assessments	of	data	quality	and	responsiveness,	initial	analysis	
provides	some	evidence	for	reliability,	validity	and	acceptability	of	this	multi-dimensional	
electronic	 PROM.	 ePAQ-MPH	 shows	 potential	 for	 both	 patient	 assessment	 and	 roles	 in	
service	evaluation	and	research.	
	
	
	
	
	
KEYWORDS	
Patient	 reported	 outcome	 measures,	 Menstruation,	 Pelvic	 Pain,	 Pre-menstrual	
syndrome,	Quality-of-life	
	
	
Condensation	
ePAQ-MPH	is	a	multi-dimensional	electronic	PROM.	Initial	psychometric	testing	shows	some	
evidence	for	potential	use	for	patient	assessment,	service	evaluation	and	research.	
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INTRODUCTION	
	
Menstrual	disorders	and	associated	pelvic	pain	and	gynaecological	hormonal	symptoms	are	
common	and	 can	have	a	profound	and	debilitating	 effect	 on	health-related	quality	of	 life	
(HRQoL)	[1-5].	There	is	often	an	overlap	between	heavy	menstrual	bleeding,	pelvic	pain	and	
gynaecological	hormonal	symptoms	such	as	premenstrual	syndrome	and	perimenopausal	
symptoms	[6].		
The	main	aim	of	treatment	for	menstrual	disorders	is	to	improve	HRQoL	and	therefore	it	is	
important	that	valid	and	reliable	patient	reported	outcome	measures	(PROMs)	are	available	
to	measure	both	symptoms	and	their	impact	on	HRQoL.		
PROMs	are	instruments	designed	to	provide	means	of	measuring	conditions,	their	 impact	
and	outcome	following	intervention,	from	the	patient’s	perspective.	[7]	The	use	of	PROMs	in	
all	areas	of	healthcare	has	become	increasingly	widespread	[8,	9]	and	their	use	in	sensitive	
conditions,	 where	 patients	 may	 not	 disclose	 embarrassing	 symptoms	 is	 potentially	
invaluable	[10-12].	
A	number	of	PROMs	have	been	described	for	use	in	women	with	menstrual,	pelvic	pain	and	
gynaecological	 hormonal	 disorders.	 However,	 existing	 instruments	 are	 either	 condition	
specific	 [13-15]	 or	 limited	 to	 one	 symptom	 area	 of	 menstrual	 disorders;	 specifically	
assessing	heavy	menstrual	bleeding,	 [16-18]	pelvic	pain,	 [19]	sexual	 function,	 [20]	health	
related	 quality-of-life	 [21-24]	 or	 premenstrual	 syndrome	 alone.	 [25-28].	 The	majority	 of	
instruments	 are	 paper-based,	 adding	 a	 significant	 administrative	 burden	 to	 their	 use	 in	
clinical	practice	[29].	
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The	 objective	 of	 this	 study	 was	 to	 develop	 and	 undertake	 psychometric	 testing	 of	 a	
comprehensive	electronic	PROM	instrument	for	women	with	menstrual	symptoms,	pelvic	
pain	and	gynaecological	hormonal	symptoms,	including	assessments	of	HRQoL	and	sexual	
function.	The	context	of	use	(COU)	for	this	PROM	would	be	for	both	baseline	assessment	of	
women	referred	to	secondary	care	in	gynaecology	with	these	conditions	and	when	they	are	
reviewed	for	follow	up.		
	
	
MATERIALS	AND	METHODS	
	
Ethical	 approval	 was	 obtained	 from	 the	 Sheffield	 Local	 Research	 Ethics	 Committee	
(Reference	number	09/H1308/21).	
	
Instrument	development	
The	platform	technology	(ePAQ)	used	to	create	this	electronic	PROM	was	first	developed	in	
urogynaecology	[30].	Design	features	of	ePAQ	were	incorporated	into	the	new	instrument,	
but	with	entirely	new	content.	
To	form	a	basis	for	sound	content	and	face	validity,	development	of	the	PROM	started	with	a	
systematic	 literature	 review	 of	 existing	 women’s	 health	 PROMs	 and	 semi-structured	
interviews	 with	 25	 patients	 conducted	 by	 a	 social	 scientist	 experienced	 in	 PROM	
development,	 these	 were	 voice-recorded,	 transcripts	 made	 and	 subjected	 to	 thematic	
content	analysis	[31].	
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Drafting	of	items,	identified	as	relevant	from	both	the	systematic	review	and	the	content	of	
the	semi-structured	interviews,	was	then	undertaken	following	Food	and	Drug	
Administration	(FDA)	guidance	on	PROM	development	[32]	and	an	initial	paper-based	
prototype	PROM	was	developed	by	an	expert	panel	(two	gynaecologists,	social	scientist	
and	specialist	nurse)	before	converting	to	a	first	electronic	prototype	comprising	of	102	
scored	items.	This	PROM	is	called	electronic	Personal	Assessment	Questionnaire-	
Menstrual,	Pain	and	Hormonal	(ePAQ-MPH).		
Eligible	patients	(female,	age	over	18,	able	to	understand	written	English	and	attending	the	
menstrual	disorder	outpatient	clinic)	were	recruited	into	the	study	between	August	2015-
June	2016	and	formal	written	consent	was	taken.	Participants	were	asked	to	complete	ePAQ-
MPH	followed	by	three	paper	based	questionnaires	which	would	assess	acceptability	and	
criterion	validity.	Table	1	presents	a	flow	chart	detailing	recruitment	and	completion	rates.	
	
	
Scale	generation	and	internal	reliability		
ePAQ	MPH	was	 administered	 to	308	 consenting	 female	patients	 attending	 the	menstrual	
disorders	gynaecology	clinics	at	Sheffield	Teaching	Hospitals.	Data	collected	were	analysed	
using	SPSS	(IBM,	Version	22.0,	IBM	Corporation,	2013,	Armonk,	New	York).	
Psychometric	testing	consisted	of	exploratory	factor	analysis	with	Varimax	rotation.	Factor	
analysis	is	a	statistical	procedure	which	enables	the	underlying	domains	or	scales	of	an	
instrument	to	be	determined.	Initially,	factors	(groups	of	items)	which	gained	an	Eigen	
value	(raw	sum	of	the	squares)	of	>0.5	were	considered	as	constituting	potential	domains,	
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each	of	which	contained	a	minimum	of	three	items	[33].	A	potential	domain	structure	and	
redundant	items	were	thereby	identified.		
Internal	 reliability	 is	 the	 extent	 to	which	 items	within	 an	 instrument	measure	 the	 same	
concepts	[34].	It	also	ensures	that	no	two	items	are	measuring	exactly	the	same	concept	and	
may	be	used	as	a	 tool	 for	 item	reduction.	Cronbach’s	α	was	used	 to	measure	 this;	 scores	
greater	 than	0.7	usually	 indicate	 that	scale	 items	are	measuring	related	constructs.	 Items	
failing	to	be	included	in	any	domain	were	reviewed	by	the	expert	panel	regarding	their	value	
and	possible	removal.		
	
	
Criterion	validity	
Two-hundred	and	thirteen	participants	also	completed	the	Women’s	Health	Questionnaire	
[35]	(WHQ)	and	the	Menstrual	Distress	Questionnaire	[36]	(MDQ).	These	two	PROMs	were	
used	as	there	is	evidence	for	their	validity	and	both	instruments	cover	almost	all	the	
content	incorporated	in	ePAQ-MPH.	Scores	from	ePAQ-MPH	were	compared	with	salient	
domain	scores	from	WHQ	and	MDQ	using	rank	correlation	to	assess	the	degree	of	
association.	
		
Stability	
Test-retest	reliability	to	evaluate	stability	over	time	was	undertaken	with	30	participants	
who	completed	ePAQ-MPH	on	two	occasions,	at	least	one	week	apart.	Wilcoxon	signed-
rank	test	was	used	to	measure	differences	between	Cronbach’s	alpha	values	for	the	two	
completions	and	inter-class	correlations	were	calculated.	
	
167	
	
Patient	experience	and	acceptability	
Patients'	views	of	ePAQ-MPH	were	evaluated	for	279	participants	using	QQ-10,	a	validated	
10-item	instrument	which	measures	face	validity,	feasibility	and	utility	of	PROM	use	during	
their	clinical	episode	[37].	The	established	QQ-10	scoring	algorithm	for	measuring	value	and	
burden	in	was	used	[37].		
	
Instrument	modification	and	confirmatory	factor	analysis	
Following	revision	of	the	instrument	and	item	reduction,	to	confirm	the	conceptual	model	of	
ePAQ-MPH,	a	confirmatory	factor	analysis	(CFA)	using	Mplus	version	8.0	(Muthen	&	Muthen,	
2017,	 Los	 Angeles,	 CA)	 was	 undertaken	 on	 254	 completed	 questionnaires	 (ePAQ-MPH	
Version	 2)	 from	 patients	who	 had	 given	 consent	 for	 the	 use	 of	 their	 data	 via	 the	 PROM	
between	January	2017-January	2018.	Given	the	nature	of	the	scales	used	in	ePAQ-MPH	the	
estimator	chosen	was	weighted	least	squares	means	and	variance	adjusted	(WLSMV).	This	
estimator	does	not	assume	normally	distributed	variables	and	therefore	has	been	argued	as	
providing	the	best	estimator	 for	modelling	categorical	or	ordered	data	 [38].	A	number	of	
model	fit	indices	were	evaluated	for	confirmation	of	the	CFA	which	included	a	chi-square,	
root	mean	 square	 error	 of	 approximation	 (RMSEA),	 comparative	 fit	 index	 (CFI)	 and	 the	
Tucker–Lewis	index	(TLI).	We	should	expect	a	non-significant	chi-square	for	confirmation	
of	the	CFA	(p	>	0.05)	[39].	The	RMSEA,	is	a	measure	of	fit	[40];	a	value	<	0.05	suggests	good	
model	fit,	although	values	<	0.08	are	considered	reasonable.	The	CFI	ranges	from	0	for	a	poor	
fit	to	1	for	a	good	fit.	The	TLI	is	another	index	for	comparative	fit.	It	can	be	interpreted	in	a	
similar	fashion	as	CFI,	but	it	can	have	a	value	outside	of	the	range	of	0	to	1.	We	should	expect	
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good	fit	statistics	for	CFI	and	TLI	to	be	>	0.95	although	values	exceeding	0.90	are	considered	
acceptable.	
	
RESULTS	
ePAQ-MPH	
ePAQ-MPH	 is	 completed	 online;	 patients	 use	 a	 unique	 16-digit	 voucher	 code	 which	 is	
automatically	generated	and	embedded	in	a	posted	clinic	letter.	This	code	is	entered	by	the	
patient,	 along	 with	 their	 date	 of	 birth	 to	 log-in	 and	 pseudonymously	 complete	 the	
questionnaire	on-line.	Patients	unable	to	complete	the	PROM	at	home	can	complete	it	in	the	
menstrual	disorders	clinic	using	a	touch-screen	or	tablet	computer	in	a	private	room,	with	
the	support	of	a	nurse	 if	needed.	Key	elements	of	ePAQ-MPH	include	 introductory	pages,	
explaining	how	to	use	the	‘Help’,	‘Back’,	‘Next’	and	‘Skip’	navigation	functions.		
	
Each	 item	 is	 presented	 on	 one	 screen	 and	 presents	 stem	questions	 relating	 to	 symptom	
frequency	and	severity,	sub-questions	regarding	the	impact	of	symptoms	are	displayed	if	the	
particular	 symptom	 is	 reported.	 Each	 item	 offers	 a	 four-point	 response	 scale	 (Figure	 1).	
Domain	scores	are	computed	using	a	standard	algorithm	used	in	the	urogynaecology	version	
of	ePAQ,	providing	scales	from	0	(best	health	status)	to	100	(worst	heath	status).	Responses	
from	 completed	questionnaires	 are	 stored	 as	 numeric	 code	 in	 a	 secure	 central	 database,	
located	behind	a	firewall	on	a	secure	NHS	N3	server.	
	
Version	one	of	ePAQ-MPH	comprised	four	symptom	dimensions:		Menstruation,	Pelvic	Pain,	
Hormonal	Conditions	and	Non-Menstrual	Bleeding	&	Discharge.	The	PROM	also	included	a	
	
169	
fifth	non-scored	Personal	Data	dimension,	 recording	additional	 information,	 such	as	 self-
reported	height	and	weight	 (computed	BMI),	previous	hysterectomy,	parity	and	 free-text	
items	relating	to	patient	concerns	and	treatment	goals.	Each	symptom	dimension	contains	
screening	questions,	identifying	whether	the	participant	is	affected	by	symptoms	from	the	
relevant	dimension.	Therefore,	the	PROM	only	presents	questions	relevant	to	the	symptoms	
the	patient	will	be	suffering	from.	For	example,	if	a	participant	does	not	have	periods,	they	
will	not	be	presented	with	questions	about	how	heavy	their	periods	are,	how	many	days	they	
bleed	for	etc.	Data	from	each	patient	automatically	populates	a	one-page	summary	(Figure	
2)	and	detailed	ePAQ-MPH	report,	with	one	page	each	for	the	raw	data	from	each	symptoms	
dimension	which	can	be	viewed	on	screen	or	printed	for	inclusion	in	patient	case-notes.	
	
Domain	structure,	internal	reliability	and	item	reduction	
Complete	 questionnaire	 data	 were	 obtained	 from	 291	 of	 the	 308	 women	 in	 the	 study	
(94.5%).		The	age	range	was	22–63	years	(mean	43).	Mean	completion	time	was	31	minutes.		
Eighteen	domains	of	ePAQ-MPH	with	Cronbach’s	alpha	values	of	>0.7	were	identified.	These	
domains	each	contained	between	3–7	items	and	Cronbach’s	alpha	values	ranged	from	0.70–
0.96.	 	A	summary	of	internal	reliability	statistics	for	the	18	domains	is	shown	in	Table	2.	
Factor	analysis	demonstrated	that	the	Menstrual	dimension	had	two	redundant	items	and	
identified	 six	 domains;	 the	 Pelvic	 Pain	 dimension	 had	 four	 redundant	 items	 and	 five	
domains;	the	Hormonal	dimension	had	seven	redundant	items	and	four	domains.	Within	the	
hormonal	dimension	a	putative	polycystic	ovary	syndrome	domain	including	items	relating	
to	hair	loss,	acne	and	hirsutism	was	evaluated;	these	items	were	tested	for	internal	reliability	
and	produced	a	Cronbach’s	alpha	value	of	0.42	suggesting	that	this	was	not	a	reliable	domain.	
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The	final	dimension	of	Non-menstrual	Bleeding	&	Discharge	(NMBD)	had	5	redundant	items	
and	 three	 domains	 were	 identified.	 A	 putative	 vaginal	 discharge	 domain	 within	 this	
dimension	produced	a	Cronbach’s	alpha	value	of	0.46,	again	suggesting	that	this	was	not	a	
reliable	domain.	All	redundant	items	were	removed	from	version	1	of	ePAQ-MPH	(102	items	
reduced	to	72	items).	
	
Test	retest	reliability	
Test	 retest	 reliability	was	undertaken	with	30	participants	using	version	1	of	ePAQ-MPH	
(Table	3).	Intra-class	correlation	coefficient	values	ranged	from	0.45	to	0.9;	the	minimum	
accepted	value	of	0.5,	was	not	achieved	in	the	hormonal	/	sexual	 function	domain	(0.45).	
Interclass	correlation	>0.5	was	seen	in	all	other	domains.	
	
Criterion	validity	
Of	the	308	participants	completing	version	1	of	ePAQ	MPH,	in	order	to	assess	criterion	
validity,	180	(58%)	completed	MDQ	and	213	(69%)	completed	WHQ.	No	corresponding	
domains	could	be	identified	for	two	of	the	18	ePAQ-MPH	domains	(Dyspareunia	and	
Intermenstrual	Bleeding),	two	of	the	18	domains	had	a	relevant	domain	in	both	MDQ	and	
WHQ.	Eight	domains	were	compared	with	MDQ	showing	moderate	or	strong	correlation	in	
seven	domains.	Ten	domains	were	compared	with	WHQ,	six	of	which	showed	moderate	
correlation	(Table	4).		
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PROM	Acceptability	
A	total	of	279	(91%)	women	completed	the	QQ-10	instrument.	Summary	statistics	for	value	
and	burden,	as	measured	by	QQ-10,	are	shown	in	Table	5.	Mean	scores	for	Value	and	Burden	
were	76	(SD	=	15.8)	and	25	(SD	=	15.5),	respectively,	suggesting	high	Value	and	low	Burden	
for	 the	majority	of	patients.	Of	 the	six	 items	relating	 to	Value,	 ‘ease	of	use’	and	 ‘happy	to	
complete	again’	were	the	most	highly	rated	responses	(92%	and	90%,	respectively).	Of	the	
four	 Burden	 items;	 ‘The	 questionnaire	 is	 too	 long’	 was	 the	 most	 frequently	 reported	
response	(25%	of	subjects).		
	
Revised	instrument	and	confirmatory	factor	analysis	
The	revised	version	2	of	ePAQ-MPH	(Table	6)	consisted	of	four	dimensions	and	fifteen	
domains	containing	72	items,	30	redundant	items	having	been	removed	and	domain	
structure	modified.	The	mean	completion	time	of	the	revised	instrument	was	22	minutes.	
Table	6	shows	the	fit	indices	for	the	CFA	model	for	each	ePAQ-MPH	dimension.	
For	all	dimensions,	the	p-value	for	the	χ2	goodness	of	fit	test	was	p<0.001	indicating	that	the	
overall	model	did	not	 fit	 the	data	well;	as	should	be	expected	 from	this	 test	 for	CFA.	The	
RMSEA	was	 small	 (p<0.005)	 suggesting	 good	model	 fit	 for	 the	Menstrual,	Hormonal	 and	
NMBD	dimensions.	The	RMSEA	was	0.086	for	the	pain	domain	suggesting	a	reasonable	fit.	
The	CFI	and	TFI	values	were	>	0.95	for	all	dimensions	indicating	good	model	fit.	Therefore,	
overall,	the	findings	suggest	that	that	the	ePAQ-MPH	structure	fits	the	data	moderately	well.	
Having	confirmed	the	conceptual	framework	for	ePAQ-MPH,	the	PROM	structure	for	patient	
administration	was	reorganised.	The	single	NMBD	domain	(intermenstrual	bleeding)	was	
relocated	 into	 the	Menstrual	 dimension	 and	 the	 five	 domains	 relating	 to	 sexual	 function	
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(menstruation	and	sexual	function,	dyspareunia,	pain	and	sexual	function	and	hormones	and	
sexual	function)	were	moved	into	a	new	Sexual	dimension	(Table	7).		
	
Comment	
	
ePAQ-MPH	 is	 a	 condition-specific	 ePROM	 which	 provides	 comprehensive	 assessment	 of	
symptomatology	 associated	 with	 menstrual	 disorders,	 pelvic	 pain	 and	 gynaecological	
hormonal	conditions	and	their	associated	impact	on	sexual	function	and	quality	of	life.		
ePAQ-MPH	 combines	 detailed	 assessment	 of	 menstrual	 disorders,	 including	 heavy	
menstrual	bleeding,	cycle	regularity,	 intermenstrual	bleeding,	dysmenorrhea,	menopausal	
symptoms	and	pre-menstrual	syndrome.	The	PROM	also	assesses	non-cyclical	pelvic	pain	
and	 hormonal	 symptoms.	 For	 each	 dimension	 of	 ePAQ-MPH	 the	 impact	 of	 symptoms	 on	
HRQoL	and	sexual	function	is	assessed.	Due	to	the	significant	overlap	between	menstrual,	
pelvic	pain	and	gynaecological	hormonal	conditions,	the	ability	to	assess	for	symptoms	and	
their	impact	on	HRQoL	in	all	of	these	conditions	simultaneously	is	potentially	valuable.		
The	instrument	aims	to	process,	with	graphic	and	concise	presentation,	a	large	volume	of	
information	regarding	both	frequency	and	bothersomeness	of	symptoms.	This	can	then	be	
used	 to	 enhance	 the	 acuity	 of	 a	 consultation	 through	 the	 inclusion	 of	 self-reported	 key	
components	of	a	patient’s	presenting	complaint	and	her	perspective	of	her	condition.	This	
PROM	is	not	intended	to	replace	clinical	consultation,	but	to	assist	and	objectively	augment	
the	clinical	assessment	and	diagnosis.	The	PROM	could	also	be	used	in	ethically	approved	
research	 projects	 to	 assess	 both	 baseline	 symptoms	 and	 impact	 on	 HRQoL	 and	 change	
following	intervention.		
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Initial	 psychometric	 testing	 of	 ePAQ-MPH	has	 shown	 good	 internal	 reliability,	 test-retest	
reliability	and	criterion	validity.	The	results	of	the	initial	psychometric	testing	has	enabled	
remodelling	of	the	instrument.	The	confirmatory	factor	analysis	of	the	revised	instrument	
has	 shown	 that	 the	 domain	 structure	 of	 ePAQ-MPH	 fits	 the	 data	 it	 is	 intended	 to	 collect	
moderately	 well	 and	 good	 model	 fit	 was	 also	 demonstrated,	 confirming	 the	 conceptual	
framework	of	the	instrument.		
	
The	burden	of	ePAQ-MPH	was	low	when	assessed,	despite	the	length	of	the	PROM,	for	which	
the	first	iteration	(version	1,	prior	to	item	reduction)	was	reported	as	being	‘Too	long’	by	
25%	of	patients.	Completion	times	of	twenty	minutes	may	be	unacceptable	for	some	users,	
particularly	 in	 under-resourced	 clinics	 when	 patients	 have	 failed	 to	 pre-complete	 the	
questionnaire	 at	 home.	However,	 ePAQ-MPH	 is	 considerably	 shorter	 than	 the	 previously	
developed	132	item	urogynaecology	PROM	(ePAQ-Pelvic	Floor),	which	has	been	found	to	be	
acceptable	and	valuable	in	clinical	practice	[30,	41-42].	ePAQ-MPH	may	be	similarly	useful	
as	a	clinical	and	research	tool.	Barriers	to	completing	PROMs	in	clinical	practice	can	include	
licensing	costs	and	additional	staff	training	needed	to	set	such	tools	up.	However,	once	in	
place	they	are	often	cheap	and	reduce	consultation	burden.		
	
Limitations	of	this	study	are	the	lack	of	detailed	demographic	data	for	the	308	participants	
including	race/ethnicity,	first	language	spoken	and	educational	level.	A	further	limitation	is	
whether	the	patients	recruited,	presented	with	a	full	range	of	the	conditions	that	ePAQ-MPH	
aimed	to	address,	including	pre-menstrual	syndrome,	perimenopausal	symptoms	and	non-
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menstrual	pelvic	pain.	The	two	PROMS	used	to	assess	criterion	validity	focus	principally	on	
HRQoL	 rather	 than	 symptomology	 [35,	 36]	 therefore	 the	 domains	 compared	 were	 not	
directly	measuring	an	identical	concept.	As	this	was	a	research	project,	requiring	consent,	
women	who	were	 participants	may	have	 been	more	motivated	 to	 provide	 questionnaire	
responses	 and	have	 a	more	positive	 attitude	 towards	questionnaire	 completion.	Another	
limitation	is	that	women	unable	to	understand	written	English	were	excluded	from	the	study	
as	were	those	lacking	basic	computer	literacy	and	willingness	complete	the	instrument	in	
the	electronic	format.		
	
Whilst	this	paper	reports	the	development	of	version	3	of	ePAQ-MPH	in	order	to	allow	other	
research	groups	to	scrutinize	and	review	the	data	generated	thus	far,	wider	evaluation	and	
psychometric	testing	of	this	latest	and	current	version	of	the	instrument	is	now	required	in	
larger	 samples	 and	 in	 different	 settings,	 including	 tests	 of	 stability,	 tests	 of	 data	 quality,	
sensitivity	and	responsiveness	to	change.		
Cognitive	interviewing	will	provide	further	assessment	of	content	and	face	validity.	So	far,	
ePAQ-MPH	shows	good	potential	as	a	PROM;	providing	objective	patient-based	data	which	
could	be	utilised	for	assessment,	service	evaluation	and	research.		
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Table	1:	Recruitment	into	study	and	completion	rates	for	ePAQ-MPH	and	study	questionnaires  
 
 
Completion	rates	for	each	of	the	study	questionnaires
1.	ePAQ-MPH	(n=291,94	%)
2.	QQ-10	(n=279,	91%)
3.	Menstrual	Distress	Questionnaire	(MDQ)	(n=213,	69%)
4.	Women's	Health	Questionnaire	(WHQ)	(n=180,	58%)
Participants	consenting	(formal	written	consent)	to	complete:	
1.	ePAQ-MPH
2.	QQ-10
3.	Menstrual	Distress	Questionnaire	(MDQ)
4.	Women's	Health	Questionnaire	(WHQ)
(n=308)
Participants	approached	for	recruitment	into	study	(n=356)
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Table	2:	Domain	structure	and	internal	reliability	of	ePAQ-MPH	Version	1	
	
Menstrual	dimension	
Domains	 Summary	of	items	 Cronbach’s	α	
Regularity	 Irregularity,	Regularity,	Predictability	 0.87	
Cycle	length		 Length	of	period,	Stop	&	start,	Post-menstrual	spotting,	Bleed	free	days	 0.78	
Heavy	Menstrual	Bleeding	
(HMB)		
HMB,	Days	heavy	bleeding,	Clots,	Clots/day,	Clot	size	 0.83	
Protection	 Leak	onto	clothes,	Leak	onto	bedding,	Pad	change,	Tampon	change,	Double	protection	 0.77	
Menstruation	&	Sexual	
Function	
Impact	on	sex,	Sex:	avoids,	Sex:	partner	avoids,	Sex:	anxiety	 0.86	
Menstruation	&	Quality	of	
Life	(QoL)	
QoL	overall	impact,	QoL	physical	impact,	QoL	social	impact,	QoL	responsibilities	impact	 0.94	
Pain	dimension	
Domains	 Summary	of	items	 Cronbach’s	α	
Dysmenorrhoea		 Dysmenorrhoea	presence,	Dysmenorrhoea	days/month,	Dysmenorrhoea	severity,	
Dysmenorrhoea	nausea,	Bladder	pain	menstrual,	Bowel	pain	menstrual,	Fails	to	relieve	
0.84	
Non-cyclical	pain		 Non-cyclical	pain,	NCP	days	per	month,	Duration	of	NCP,	NCP	severity,	NCP	bladder,	
NCP	bowel	
0.79	
Dyspareunia		
	
Dyspareunia,	Post	coital	pain,	Dyspareunia:	dryness,	Dyspareunia:	sensation,	
Dyspareunia:	tightness,	Dyspareunia:	obstruction	
0.80	
Pain	&	Sexual	Function		 Impact	on	sex,	Sex:	avoids,	Sex:	partner	avoids,	Sex:	anxiety	 0.92	
Pain	&	Quality	of	Life	(QoL)		
	
QoL	overall	impact,	QoL	physical	impact,	QoL	social	impact,	QoL	responsibilities	impact	 0.96	
Hormonal	dimension	
Domains	 Summary	of	items	 Cronbach’s	α	
Hypo-oestrogenism	 Mood	swings,	Concentration,	Hot	flushes,	Night	sweats,	Loss	of	libido,	Vaginal	dryness	 0.70	
Pre-	Menstrual	Syndome	
(PMS)		
	
Cyclical	mood	changes,	Aggression,	Cyclical	concentration,	Bloating,	Breast	tenderness,	
Cyclical	irritability	
0.85	
Hormones	&	Sexual	
Function		
Impact	on	sex,	Sex:	avoids,	Sex:	partner	avoids,	Sex:	anxiety	 0.90	
Hormones	&	Quality	of	Life	
(QoL)		
QoL	overall	impact,	QoL	physical	impact,	QoL	social	impact,	QoL	responsibilities	impact	 0.95	
Non-menstrual	bleeding	and	Discharge	(NMBD)	dimension	
Domains	 Summary	of	items	 Cronbach’s	α	
Inter	Menstrual	Bleeding	
(IMB)	
	
Intermenstrual	bleeding,	IMB	heaviness,	IMB	duration,	Post	coital	bleed	 0.88	
	
NMBD	&	Sexual	Function		
	
Impact	on	sex,	Sex:	avoids,	Sex:	partner	avoids,	Sex:	anxiety	 0.93	
NMBD	&	Quality	of	Life	
(QoL)		
QoL	overall	impact,	QoL	physical	impact,	QoL	social	impact,	QoL	responsibilities	impact	 0.95	
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Table	 3:	 Test	 retest	 reliability:	 ePAQ	 domains	 with	 first	 and	 second	 completion	 Cronbach’s	 alpha,	
Wilcoxon	signed	rank	test	and	intra-class	correlations	
	
Domain	 First	completion	
(Cronbach’s	
alpha(number	of	
completions))	
Second	completion	
(Cronbach’s	
alpha(number	of	
completions))	
Intra-class	correlation	
(2-tailed	significance)	
Menstrual	dimension	
Regularity		 0.87	(280)	 0.87	(27)	 0.87	
Cycle	length	 0.78	(273)	 0.64	(26)	 0.80	
Heavy	Menstrual	
Bleeding		
0.83	(275)	 0.92	(28)	 0.81	
Protection		 0.77	(129)	 0.90	(16)	 0.92	
Menstruation	 &	
Sexual	Function	
0.86	(266)	 0.89	(24)	 0.76	
Menstruation	 &	
Quality	of	Life	
0.94	(281)	 0.95	(27)	 0.86	
Pain	dimension	
Dysmenorrhoea	 0.83	(249)	 0.82	(26)	 0.80	
Non-cyclical	pain	 0.79	(210)	 0.73	(19)	 0.88	
Dyspareunia		 0.80	(263)	 0.74	(25)	 0.84	
Pain	&	Sexual	
Function	
0.92	(262)	 0.91	(24)	 0.75	
Pain	&	Quality	of	
Life		
0.96	(281)	 0.95	(29)	 0.88	
Hormonal	dimension	
Hypo-oestrogenism	 0.70	(266)	 0.72	(27)	 0.90	
Pre-Menstrual	
Syndrome	
0.87	(264)	 0.84	(28)	 0.83	
Hormones	&	Sexual	
Function	
0.90	(235)	 0.92	(23)	 0.45		
Hormones	&	
Quality	of	Life	
0.95	(271)	 0.96	(29)	 0.76	
Non-menstrual	bleeding	&	Discharge	dimension	
Intermenstrual	
bleeding		
0.88	(235)	 0.89	(25)	 0.68	
NMBD	 &	 Sexual	
Function	
0.93	(238)	 0.94	(23)	 0.70	
NMBD	 and	 Quality	
of	Life	
0.95	(263)	 0.85	(29)	 0.58	
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Table	 4:	 Criterion	 Validity	 for	 Salient	 ePAQ-MPH	 and	 Menstrual	 Distress	 Questionnaire	
(MDQ)/Women’s	Health	Questionnaire	(WHQ)	domains	and	the	Spearman’s	rank	correlations	
	
ePAQ-MPH	domain	 Related	MDQ	domain	 Spearman’s	rank	
(2-tailed	significance)	
Menstrual	Quality	of	Life	 Behaviour	Change	Menstrual	 0.46	(<0.001)	
Dysmenorrhoea	 Pain	Menstrual	 0.52	(<0.001)	
Non-cyclical	pain	 Pain	Postmenstrual	 0.34	(<0.001)	
Pain	&	Quality	of	Life	 Behaviour	Change	Menstrual	 0.42	(<0.001)	
Hypo-oestrogenism	 Autonomic	Reactions	Menstrual	 0.40	(<0.001)	
Pre-Menstrual	Syndrome	 Water	Retention	Premenstrual	 0.38	(<0.001)	
Hormones	&	Quality	of	Life	 Behaviour	Change	Menstrual	 0.48	(<0.001)	
NMBD	&	Quality	of	Life	 Behaviour	Change	Menstrual	 0.12	(0.153)	
ePAQ-MPH	domain	 Related	WHQ	domain	 Spearman’s	rank	
(2-tailed	significance)	
Regularity	 Menstrual	 0.15	(0.041)	
Cycle	Length	 Menstrual	 0.24	(0.001)	
Heavy	Menstrual	Bleeding	 Menstrual	 0.39	(<0.001)	
Protection	 Menstrual	 0.27	(<0.001)	
Menstruation	&	Sexual	Function	 Sex	 0.36	(<0.001)	
Hypo-oestrogenism	 Vasomotor	 0.49	(<0.001)	
Pre-Menstrual	Syndrome	 Menstrual	 0.47	(<0.001)	
Hormones	&	Sexual	Function	 Sex	 0.50	(<0.001)	
Pain	&	Sexual	Function	 Sex	 0.38	(<0.001)	
NMBD	&	Sexual	Function	 Sex	 0.26	(0.001)	
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Table	5:	QQ-10	results	for	face	validity/patient	experience	of	ePAQ-MPH	(version	1)	including	
percentage	and	count	for	each	response	
	
Statement	 %	Strongly	
disagree		
(n)	
%	Mostly	
disagree		
(n)	
%	Neither	agree	
or	disagree	(n)	
%	Mostly	
agree			
(n)	
%	Strongly	
agree		
(n)	
Value	
1.	Improved	
communication		
1.4	
(4)	
6.1	
(17)	
14.0	
(39)	
57.9	
(161)	
20.5	
(57)	
2.	Relevance	
	
1.4	
(4)	
5.0	
(14)	
10.4	
(29)	
52.2	
(145)	
30.9	
(86)	
3.	Ease	of	use	 2.2	
(6)	
2.2	
(6)	
3.9	
(11)	
37.3	
(104)	
54.5	
(152)	
4.	Comprehensive	 1.1	
(3)	
6.8	
(19)	
12.6	
(35)	
47.1	
(131)	
32.4	
(90)	
5.	Enjoyable	 1.8	
(5)	
5.0	
(14)	
42.1	
(117)	
36.7	
(102)	
14.4	
(40)	
6.	Happy	to	
complete	again	
2.2	
(6)	
2.9	
(8)	
5.8	
(16)	
39.6	
(110)	
49.6	
(138)	
Burden	
7.	Too	long	 10.9	
(30)	
24.3	
(67)	
40.2	
(111)	
18.5	
(51)	
6.2	
(17)	
8.	Too	embarrassing	 43.5	
(120)	
30.4	
(84)	
23.9	
(66)	
2.2	
(6)	
0.0	
(0)	
9.	Too	complicated	 41.1	
(113)	
42.2	
(116)	
14.5	
(40)	
1.8	
(5)	
0.4	
(1)	
10.	Upsetting		 68.1	
(188)	
17.4	
(48)	
13.0	
(36)	
1.1	
(3)	
0.4	
(1)	
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Table	6:	Dimensions	and	domain	structure	ePAQ-MPH	Version	2	with	associated	fit	indices	for	each	
dimension	derived	from	confirmatory	factor	analysis	
	
Menstrual	dimension	
X2	 df	 RMSEA	 CFI	 TFI	
818.402	 165	 0.001	 0.970	 0.965	
	
Domains	 Summary	of	items	
Regularity	 Irregularity,	Regularity,	Predictability	
Cycle	length		 Length	of	period,	Stop	&	start,	Post-menstrual	spotting,	Bleed	free	days	
Heavy	Menstrual	Bleeding	
(HMB)		
HMB,	Days	heavy	bleeding,	Clots,	Clots/day,	Clot	size	
Menstruation	&	Sexual	
Function	
Impact	on	sex,	Sex:	avoids,	Sex:	partner	avoids,	Sex:	anxiety	
Menstruation	&	Quality	of	
Life	(QoL)	
QoL	overall	impact,	QoL	physical	impact,	QoL	social	impact,	QoL	responsibilities	impact	
Pain	dimension	
X2	 df	 RMSEA	 CFI	 TFI	
920.172	 319	 0.086	 0.982	 0.980	
	
Domains	 Summary	of	items	
Dysmenorrhoea		 Dysmenorrhoea	presence,	Dysmenorrhoea	days/month,	Dysmenorrhoea	severity,	
Dysmenorrhoea	nausea,	Bladder	pain	menstrual,	Bowel	pain	menstrual,	Fails	to	relieve	
Non-cyclical	pain		 Non-cyclical	pain,	NCP	days	per	month,	Duration	of	NCP,	NCP	severity,	NCP	bladder,	NCP	bowel	
Dyspareunia		
	
Dyspareunia,	Post	coital	pain,	Dyspareunia:	dryness,	Dyspareunia:	sensation,	Dyspareunia:	
tightness,	Dyspareunia:	obstruction	
Pain	&	Sexual	Function		 Impact	on	sex,	Sex:	avoids,	Sex:	partner	avoids,	Sex:	anxiety	
Pain	&	Quality	of	Life	(QoL)		
	
QoL	overall	impact,	QoL	physical	impact,	QoL	social	impact,	QoL	responsibilities	impact	
Hormonal	dimension	
X2	 df	 RMSEA	 CFI	 TFI	
889.560	 168	 0.001	 0.963	 0.958	
	
Domains	 Summary	of	items	
Hypo-oestrogenism	 Mood	swings,	Concentration,	Hot	flushes,	Night	sweats,	Loss	of	libido,	Vaginal	dryness	
Pre-	Menstrual	Syndome	
(PMS)		
	
Cyclical	mood	changes,	Aggression,	Cyclical	concentration,	Bloating,	Breast	tenderness,	Cyclical	
irritability	
Hormones	&	Sexual	
Function		
Impact	on	sex,	Sex:	avoids,	Sex:	partner	avoids,	Sex:	anxiety	
Hormones	&	Quality	of	Life	
(QoL)		
QoL	overall	impact,	QoL	physical	impact,	QoL	social	impact,	QoL	responsibilities	impact	
Non-menstrual	bleeding	and	Discharge	(NMBD)	dimension	
X2	 df	 RMSEA	 CFI	
15.250	 2	 0.005	 0.998	
	
Domains	 Summary	of	items	
Inter	Menstrual	Bleeding	
(IMB)	
Intermenstrual	bleeding,	IMB	heaviness,	IMB	duration,	Post	coital	bleed	
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Table	7:	Dimensions	and	domain	structure	ePAQ-MPH	Version	3	following	development	of	conceptual	
framework	
	
Menstrual	dimension	
	
Domains	 Summary	of	items	
Regularity	 Irregularity,	Regularity,	Predictability	
Cycle	length		 Length	of	period,	Stop	&	start,	Post-menstrual	spotting,	Bleed	free	days	
Heavy	Menstrual	
Bleeding	(HMB)		
HMB,	Days	heavy	bleeding,	Clots,	Clots/day,	Clot	size	
Inter	Menstrual	
Bleeding	(IMB)	
Intermenstrual	bleeding,	IMB	heaviness,	IMB	duration,	Post	coital	bleed	
Menstruation	&	
Quality	of	Life	(QoL)	
QoL	overall	impact,	QoL	physical	impact,	QoL	social	impact,	QoL	
responsibilities	impact	
Pain	dimension	
	
Domains	 Summary	of	items	
Dysmenorrhoea		 Dysmenorrhoea	presence,	Dysmenorrhoea	days/month,	Dysmenorrhoea	
severity,	Dysmenorrhoea	nausea,	Bladder	pain	menstrual,	Bowel	pain	
menstrual,	Fails	to	relieve	
Non-cyclical	pain		 Non-cyclical	pain,	NCP	days	per	month,	Duration	of	NCP,	NCP	severity,	NCP	
bladder,	NCP	bowel	
Pain	&	Quality	of	Life	
(QoL)		
	
QoL	overall	impact,	QoL	physical	impact,	QoL	social	impact,	QoL	
responsibilities	impact	
Hormonal	dimension	
	
Domains	 Summary	of	items	
Hypo-oestrogenism	 Mood	swings,	Concentration,	Hot	flushes,	Night	sweats,	Loss	of	libido,	
Vaginal	dryness	
Pre-	Menstrual	
Syndome	(PMS)		
	
Cyclical	mood	changes,	Aggression,	Cyclical	concentration,	Bloating,	Breast	
tenderness,	Cyclical	irritability	
Hormones	&	Quality	
of	Life	(QoL)		
QoL	overall	impact,	QoL	physical	impact,	QoL	social	impact,	QoL	
responsibilities	impact	
Non-menstrual	bleeding	and	Discharge	(NMBD)	dimension	
	
Domains	 Summary	of	items	
Menstruation	&	
Sexual	Function	
Impact	on	sex,	Sex:	avoids,	Sex:	partner	avoids,	Sex:	anxiety	
Dyspareunia		
	
Dyspareunia,	Post	coital	pain,	Dyspareunia:	dryness,	Dyspareunia:	
sensation,	Dyspareunia:	tightness,	Dyspareunia:	obstruction	
Pain	&	Sexual	
Function		
Impact	on	sex,	Sex:	avoids,	Sex:	partner	avoids,	Sex:	anxiety	
Hormones	&	Sexual	
Function		
Impact	on	sex,	Sex:	avoids,	Sex:	partner	avoids,	Sex:	anxiety	
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Figure	2	
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7.4:	Paper	5:	Gray	T,	Li	W,	Campbell	P,	Jha	S,	Radley	S.	Evaluation	of	coital	
incontinence	by	electronic	questionnaire:	prevalence,	associations	and	outcomes	in	
women	attending	a	urogynaecology	clinic.	International	Urogynecology	Journal.	
2018;29(7):969-78.	
Abstract 
Introduction 
Coital incontinence is the involuntary leakage of urine during sexual intercourse and is divided 
into that occurring with penetration or orgasm. Mechanisms of coital incontinence are poorly 
understood. The aim of this retrospective study was to measure the prevalence of coital 
incontinence and evaluate the association between different types of coital incontinence with stress 
urinary incontinence (SUI), overactive bladder (OAB) and impact on quality-of-life in women 
attending a urogynaecology clinic.  
 
Methods 
2312 women completed ePAQ-PF in advance of their urogynaecology consultation. Logistic 
regression and Spearman’s rank correlation evaluated associations between types of coital 
incontinence and OAB and SUI. Mann-Witney test evaluated the relationship between coital 
incontinence and self-reported quality-of–sex-life and self -avoidance and partner-avoidance of 
sex. Subgroup analysis analysed outcomes in 84 women with coital incontinence undergoing 
TVT.  
 
Results  
Prevalence of coital incontinence in the cohort was 30%. Symptoms of OAB (p<0.005) and SUI 
(p<0.005) were significantly and independently associated with both types of coital incontinence 
(orgasm & penetration). In women with coital incontinence compared with those without, there 
	
191	
was significant self-avoidance of sex (p<0.0005), partner-avoidance of sex (p<0.0005) and 
impaired quality-of-sex-life due to sexual problems (p<0.005). The impact of this was significant 
in each group. Subgroup analysis of 84 women undergoing TVT showed significant 
improvement in all coital incontinence symptoms three months post-operatively. 
 
Conclusion Using an electronic questionnaire prior to consultation has identified coital 
incontinence as a prevalent symptom, having a significant impact on sexual life. Coital 
incontinence at orgasm and penetration are both significantly associated with SUI and OAB. 
 
Keywords: coital incontinence, ePAQ-PF, questionnaire, computer interviewing, TVT, orgasm 
 
Brief Summary:  
Orgasm and penetration coital incontinence are prevalent complaints in women attending 
urogynaecology clinics and are both associated with OAB, SUI and impaired sexual function.  
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Introduction 
Coital incontinence is a symptom occurring within the spectrum of urinary incontinence in 
women and is defined as the complaint of involuntary loss of urine associated with coitus. This 
can be further divided into coital incontinence occurring with penetration and that occurring at 
orgasm[1]. 
Coital incontinence is prevalent in women attending urogynaecology clinics [2, 3, 4] and has 
been shown to affect up to 60% of women with urinary incontinence [5]. Coital incontinence has 
been shown to have a negative impact on quality of life [6]. 
 The precise mechanism and aetiology of coital incontinence remains incompletely understood, 
with conflicting evidence presented in previous studies regarding the association between coital 
incontinence and stress urinary incontinence (SUI) and detrusor overactivity (DO). Previously, it 
has been observed in urodynamic studies that coital incontinence with orgasm was more strongly 
associated with detrusor overactivity (DO), whereas coital incontinence with penetration more 
strongly associated with urodynamic stress incontinence (USI)  [2, 7]. However, larger studies 
have suggested that urodynamic findings do not correlate well with orgasm or penetration coital 
incontinence [5, 8]. 
 
The objective of this study was to evaluate the prevalence of coital incontinence in women 
attending a urogynaecology clinic in a tertiary teaching hospital in the UK, and evaluate the 
association between different types of coital incontinence and SUI, OAB and quality of life. The 
impact of treatment with tension-free vaginal tape (TVT) on coital incontinence will be assessed 
as part of a subgroup analysis. 
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Methods 
Women attending the urogynaecology unit at Sheffield Teaching Hospitals, UK, between 
January 2012 and September 2015 who had completed the electronic Personal Assessment 
Questionnaire-Pelvic Floor (ePAQ-PF) as part of their routine clinical care, prior to first 
assessment in the urogynaecology clinic, were included in the study. Ethical approval for this 
study was obtained from the University of Sheffield (Registration Number 011338) 
 
ePAQ-PF is a web-based instrument, in the form of an electronic questionnaire, which provides a 
detailed assessment of a woman’s pelvic floor symptoms and their impact [9-11]. The 
questionnaire can be completed online, prior to clinic attendance, or using a touch-screen 
computer terminal in a private room in the clinic. Computer interviewing using ePAQ-PF 
provides women with an opportunity to report symptoms of an intimate and sensitive nature, 
which may be difficult to express in a face-to-face consultation [12, 13].  
 
The questionnaire comprises of four dimensions (areas of the questionnaire which assess different 
types of symptomatology): Urinary, Bowel, Vaginal and Sexual. Within each dimension are four 
to five scored domains. Domain scores are derived by dividing the sum of all item scores in that 
domain by the total possible item score and multiplying this by 100 to produce a scale ranging 
from 0 (best possible) to 100 (worst possible health status). Data for the present study were used 
anonymously from women who answered ‘Yes’ to the final item of the questionnaire, which seeks 
consent to allow confidential use of their answers for approved research projects. 
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Between January 2012 and September 2015, 2,905 women completed ePAQ-PF as part of their 
routine clinical care, prior to their first consultation in the urogynaeoclogy clinic. Two hundred 
and thirty two women (8%) declined consent for the use of their data for research, and a further 
361 women did not complete the consent question. Therefore, data from 2,312 women were 
anonymised and transferred to SPSS (version 22) for analysis. 
 
Table 1 shows the ePAQ-PF items included in the analyses of this study. Response options for all 
these items are on a four-point scale ‘Never’, ‘Occasionally’, ‘Most of the time’ or ‘All of the 
time’ and scored 0, 1, 2 or 3 respectively. The impact attributed to each of these symptoms is also 
recorded, using a standard sub-question ‘How much of a problem is this for you?’ and graded as 
‘Not a problem’, ‘A bit of a problem’, ‘Quite a problem’ or ‘A serious problem’ and scored 0, 1, 
2 and 3 respectively. Frequency and bothersomeness are thereby assessed for each symptom. 
Figure 1 shows the ePAQ-PF item relating to coital incontinence. The domain score for OAB is 
derived from items 21 to 24 and that for SUI from items 28-32 (Table 1).  
Both Spearman’s rank and logistic regression were used to measure the association between 
coital incontinence symptoms (items Q101, Q102 and Q103) with symptoms of OAB and SUI 
(items Q21-32). Mann-Whitney Test was used to compare self-avoidance of sex, (Q98) partner-
avoidance of sex (Q99) and interference of sex with enjoyment of life (Q122) in women with and 
without CI. 
 
ePAQ-PF also includes a free-text question which asks: ‘Considering the issues that currently 
concern you the most, what do you hope to achieve from any help, advice or treatment?’. All free 
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text responses were reviewed to evaluate self-reporting of sexual concerns and goals, including 
free-text responses specifically related to coital incontinence.  
  
Subgroup analysis was undertaken in 84 women who underwent tension-free vaginal tape (TVT) 
procedure, in order to evaluate whether treatment of SUI is associated with changes in coital 
incontinence. Data from consenting patients who underwent TVT between 2012 and 2015 and 
completed ePAQ-PF both pre- and three-months post operatively were included in the study. All 
women reported stress urinary incontinence and underwent urodynamics in line with ICS 
guidelines [14]. It is the usual practice at Sheffield Teaching Hospitals to complete urodynamic 
studies before undertaking surgery for stress urinary incontinence. Paired Student t Test was used 
to compare the pre- and post-operative OAB and SUI domain scores in women reporting coital 
incontinence pre-operatively. Wilcoxon signed ranks test was used to compare pre- and post-
operative symptoms of CI.   
Demographic details for consenting patients undergoing TVT were collected from the 
standardised anaesthetic pre-operative assessment and include body mass index (BMI), smoking 
status, hypertension, sleep apnoea, depression or anxiety, diabetes and American Society of 
Anesthesiologists (ASA) grade. Demographic data and co-morbidities were compared between 
patients reporting pre-operative coital incontinence and those who did not. BMI was compared 
using student t test. The proportion of hypertension, smoking, diabetes, sleep apnoea, depression 
and anxiety in patients reporting coital incontinence and those who did not was compared with 
Pearson Chi-Square and Fisher’s Exact tests, depending on the prevalence of the co-morbidities. 
ASA scores were compared using the Mann-Whitney U test. The reasons for the four different 
statistical tests for demographic features, were the different data types: BMI was of continuous 
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data type, (student T test), ASA score was of ordinal data type (Mann-Whitney U test) and co-
morbidity and smoking status of categorical data type (Pearson Chi-Square test or Fisher Exact 
test, depending the prevalence of each item). 
Results 
Prevalence of coital incontinence 
Between January 2012 and September 2015, 2,312 women completed ePAQ-PF and gave 
consent for the use of their data. Of these, 1,573 completed Q101 regarding coital incontinence, of 
whom 477 (30.3%) reported the presence of this symptom.  The overall prevalence of coital 
incontinence was 21% (477 of 2,312). The question on orgasm coital incontinence was answered 
by 1,533 women, of whom 369 (24.1%) reported the presence of this symptom (16% overall). 
The question of penetration coital incontinence was answered by 1,532 women, of whom 230 
(15.0%) reported the presence of this symptom (10% overall).  
The item on urinary incontinence was answered by 2,294 women, of whom 1,438 reported this 
symptom. Amongst those women reporting urinary incontinence, 946 answered the question on 
coital incontinence, of whom 451 (47.7%) reported the presence of the symptom. Of the women 
without urinary incontinence, 26 reported coital incontinence (1%). 
 
Association between coital incontinence, SUI and OAB scores 
Three binomial logistic regression models were used to explore the relationship between SUI and 
OAB symptoms with coital incontinence, orgasm incontinence and penetration incontinence. 
Symptoms of OAB (p<0.005) and SUI (p<0.005) were shown to be significant and independent 
predictors of coital incontinence.  
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Increasing OAB domain scores were associated with increasing odds of coital incontinence 
(OR=1.042 95%CI, 1.035 to 1.050, p <0.0005), orgasm incontinence (OR=1.035 95%CI, 1.028 
to 1.042, p <0.001) and penetration incontinence (OR=1.038 95%CI, 1.030 to 1.045, p <0.001). 
Increasing SUI domain scores were associated with increasing odds of coital incontinence 
(OR=1.017 95%CI, 1.009 to 1.024, p <0.0005), orgasm incontinence (OR=1.011 95%CI, 1.004 
to 1.019, p =0.003) and penetration incontinence (OR=1.024 95%CI, 1.015 to 1.033, p <0.001). 
These data are all statistically significant, but the magnitude of the effect is relatively low, 
possibly due to the large sample size. 
 
Spearman’s Rank Order Correlation showed similar results of moderate statistically significant 
association between coital incontinence symptom score with both SUI (Rs=0.410, p<0.001) and 
OAB (Rs=0.540, p<0.001); orgasm incontinence with SUI (Rs=0.339, p<0.001) and OAB 
(Rs=0.462, p<0.001); penetration incontinence with SUI (Rs=0.361, p<0.001) and OAB 
(Rs=0.443, p<0.001). These results are displayed as product plots in figure 2.  
 
Coital incontinence with impact on sex 
Mann-Whitney Test was used to compare reported self-avoidance of sex due to bladder 
problems, partner-avoidance of sex due to bladder problems and overall interference of sex with 
enjoyment of life and the impact of each of these in women who reported coital incontinence 
compared with those who did not. This showed significant self-avoidance of sex (p<0.0005), 
partner avoidance of sex (p<0.0005) and lower quality of life due to sexual problems (p<0.0005), 
compared with those without coital incontinence  (Table 2).  
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Pre-operative symptom profiles in women undergoing TVT 
Pre and post operative ePAQ-PF data were available for 84 women who gave consent for the use 
of their data. Coital incontinence was reported by 45 (54%). Table 3 shows a comparison of pre-
operative symptom profiles between women with and without coital incontinence. 
This analysis found that women reporting coital incontinence were significantly younger than 
those who did not (Mean age 48 vs. 55) (t(67)= 3.448, p= 0.001). The BMI of women reporting 
orgasm incontinence (t(56)= -2.750, p=0.008) and penetration  incontinence (t(57)= -3.205, 
p=0.002) was significantly higher than that of patients without coital incontinence.  
 
TVT outcome 
Paired t test was used to compare pre-operative and post-operative OAB and SUI domain scores 
in all 84 women undergoing TVT and found significant improvement in all the symptoms 
analysed (Table 4). Wilcoxon signed rank test was used to conduct sub-group analysis in the 45 
women undergoing TVT who reported coital incontinence  pre-operatively (55%).  This found 
significant improvement in the reporting of any coital incontinence, orgasm incontinence and 
penetration incontinence following TVT (table 5). Of the 45 patients with coital incontinence, 37 
completed follow up at three months. Of these, 27 (72%) had improved nine (20%) reported no 
change and one (3%) worsened (p<0.001).  
The association between cure of SUI following TVT and the presence of pre-operative coital 
incontinence (coital incontinence, orgasm incontinence and penetration incontinence) was 
analysed using Pearson Chi-Square test and Fisher’s Exact test. The presence of coital 
incontinence  pre-operatively was not associated with the outcome in terms of SUI (X2= 1.001, 
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p=0.317); neither was pre-TVT orgasm incontinence status (X2= 2.745, p=0.098) or pre-TVT 
penetration incontinence status (X2= 1.983, p=0.159).  
 
 
 
Free-text analysis 
The free-text item relating to ‘Greatest concerns’ was completed by 1,261 women (55%), 24 of 
whom used free-text to report concerns regarding sexual function (1%). Four women explicitly 
reported coital incontinence, five said that they wanted to improve or resolve problems in their 
sex life, but did not detail the specific problem. Three women reported reduced sensation during 
sex and twelve reported painful sexual intercourse.  
 
Discussion 
 
The primary objective of this study was to investigate the prevalence of coital incontinence and 
its association with SUI, OAB and sexual function in women attending a urogynaecology clinic. 
 
The main findings are that coital incontinence is reported by approximately one in five women 
attending urogynaecology clinics and is associated with avoidance of sexual activity. Coital 
incontinence is associated with both SUI and OAB, regardless of whether this occurs at orgasm 
or on penetration. Following TVT, 60% of women reported cure in coital incontinence. 
 
The main weakness of this study is its observational nature and that data on other aspects of 
sexual function, sexuality and relationship status were not available. We are therefore unable to 
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comment on other factors which may affect sexual function and coital incontinence; including 
menopausal status and other physical and mental health issues. Detailed demographic data for 
the 2312 women are also lacking, including parity and ethnicity. 
 
This is however the largest study to-date relating to coital incontinence in women attending a 
urogynaecology clinic, which has found a prevalence of 21% overall, 30% in women willing to 
answer questions about sexual function and 47% in women reporting urinary incontinence. The 
results are comparable to a previous study in an earlier cohort of women in our unit, which found 
a coital incontinence prevalence of 60% in women undergoing urodynamic studies for urinary 
incontinence [5]. 
 
Previous studies have shown rates of coital incontinence in women attending urogynaeoclogy 
clinics of up to 24%[2, 4] If the prevalence of coital incontinence is assessed only in women with 
urinary incontinence the rates have been shown to vary between 10% - 66% 
[5][6][15][16][17][18].  
Including this study, three studies have assessed coital incontinence in women attending a 
urogynaecology clinic. The prevalence was 10% [15] when direct questioning was used to assess 
prevalence and 36% [6] and 47% when a validated questionnaire (KHQ or ePAQ-PF) was used. 
Four studies assessed the prevalence of coital incontinence in women undergoing urodynamics. 
Two of these studies used direct questioning to assess this and both found a prevalence of 11% 
[8][18]. The other two studies used validated (ePAQ-PF) or non-validated (author’s own) 
questionnaires to assess prevalence and found it to be 60% [5] and 66% [17] respectively. The 
substantially higher prevalence of coital incontinence in women undergoing urodynamics, 
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compared with women attending a urogynaecology clinic, is likely to be a reflection of more 
severe symptoms in women undergoing urodynamics.  
It is apparent that using a questionnaire, substantially increases disclosure and therefore the 
reported prevalence of coital incontinence, compared with direct questioning. This may be due to 
embarrassment and the taboo nature of this intimate problem.  
 
Using ePAQ-PF to assess coital incontinence has the advantage of specifically enquiring about 
urinary coital incontinence and when it occurs- with orgasm or penetration. Other questionnaires 
used widely within urogynaecology do not assess coital incontinence as comprehensively. The 
Pelvic organ prolapse urinary Incontinence Sexual Questionnaire (PISQ) doesn’t differentiate 
between faecal and urinary incontinence during intercourse and doesn’t assess if the incontinence 
occurs with orgasm or penetration, the International Consultation on Incontinence modular 
Questionnaire- Short Form (ICIQ-SF) does not ask about coital incontinence or sexual issues at 
all and the Kings Health Questionnaire (KHQ), whilst it does assess the prevalence of coital 
urinary incontinence, doesn’t distinguish between orgasm incontinence and penetration 
incontinence. 
 
We found that orgasm coital incontinence was significantly associated with the reporting of both 
symptoms of both SUI and OAB. Likewise, penetration incontinence was also significantly 
associated with symptoms of both SUI and OAB. Studies have previously linked orgasm 
incontinence to OAB, demonstrating higher rates of detrusor overactivity during urodynamics in 
women with orgasm incontinence than in women with penetration incontinence [2, 7, 18]. 
Penetration incontinence has similarly been linked to stress urinary incontinence [15, 17]. 
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However, larger and more recent studies have found no significant relationship between 
urodynamic diagnosis and penetration or orgasm incontinence [5]. It has also been shown that 
both Urodynamic Stress Incontinence (USI) and Detrusor overactivity (DO), but not DO 
incontinence, are both significantly associated with coital incontinence [8]. As seen in table four, 
both orgasm incontinence and penetration incontinence were significantly improved following 
TVT, suggesting a similar aetiology for coital incontinence in women with these symptoms. 
  
There is a significant overlap between women who have coital incontinence at penetration and 
coital incontinence at orgasm, with 26% of women in our study group reporting both symptoms. 
Therefore, attempting to separate orgasm and penetration coital incontinence into different 
diagnostic groups may not be helpful or meaningful; many women have elements of both and the 
symptoms may not be indicative of distinct pathophysiological entities.  
A previous anatomical study used MRI to measure the pubococcygeal line, hiatal width and 
levator descent to assess pelvic organ prolapse in 60 women with coital incontinence, compared 
with a control group of 30 women with urinary incontinence but no coital incontinence. No MRI 
features were identified that were significantly associated with coital incontinence in that 
study[17]. Proposed mechanisms for coital incontinence include increased abdominal pressure 
during intercourse, which may vary depending on position; increased abdominal pressure due to 
contraction of abdominal muscles during orgasm and straightening of the urethra during deep 
penetration [19]. The precise mechanism is however not fully understood.  
 
Urinary incontinence is well known to cause sexual dysfunction [20-22]. It is clear from the 
present study that women with coital incontinence commonly avoid sex, their partners 
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commonly avoid sex with them and they have a significantly impaired sexual function compared 
with women without coital incontinence. In a study of 633 women with urinary incontinence, 
assessed using the King’s Health Questionnaire (KHQ), women with coital incontinence were 
observed to have significantly worse scores in all KHQ dimensions and global score [6]. A 
logistic regression model in the study found that the only variable which demonstrated 
independent association with the KHQ global score was coital incontinence (B=10.1, 95% 
CI=1.7-18.5). A further study of 180 women using the Bristol Female Lower Urinary Tract 
Symptoms questionnaire and the Medical Outcomes Study Short Form (SF-36) questionnaire 
observed that women with coital incontinence had more health-related quality of life impairment 
than those without coital incontinence [23]. A qualitative study of 37 women scheduled for 
pelvic floor surgery using semi-structured interviews found that nine of the 37 women had 
experienced coital incontinence [24]. These women tried to avoid coital incontinence by 
emptying their bladders before intercourse and also avoided certain sexual positions, hurried 
through sex so that it would be over quicker, avoided orgasm and did self-directed pelvic floor 
muscle training. These measures were reportedly successful in four of the nine patients.  
 
It is clear that coital incontinence causes embarrassment to women [25] and leads to avoidance 
of sex which in turn affects quality of life. Previous studies addressing the prevalence of coital 
incontinence  and its associations have shown that coital incontinence  is a rarely volunteered 
symptom. Only two of 400 women in Hilton’s study paper [2] and one of 100 in Gordon’s study 
[4] volunteered that they had coital incontinence prior to questioning. Urinary symptoms may be 
the presenting complaint in women who have an underlying sexual problem [25], it is therefore 
important to routinely enquire about coital incontinence in women attending the urogynaecology 
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clinic. In our study, of 2,312 women completing ePAQ-PF, only 1% used the free-text items to 
report a sexual problem, and only four recorded that they had coital incontinence using free text. 
It is also clear from the differing prevalence rates of coital incontinence  in women with urinary 
incontinence observed in previous studies that using an appropriate questionnaire will help 
identify women experiencing this symptom. There is evidence that patients may feel more 
comfortable disclosing embarrassing or intimate issues through use of a computer questionnaire 
than during a conventional consultation [26]. By using a validated questionnaire to identify 
women experiencing coital incontinence, a more open and honest consultation can be afforded 
and more appropriate treatment planned. It has been shown that electronic questionnaires can 
increase discussion rates in women with urinary incontinence [8] and seems likely that this is 
also the case for coital incontinence.  
 
Our study found significant improvement in SUI and OAB at three months follow-up in women 
undergoing TVT. There was also a statistically significant improvement in coital incontinence at 
penetration, orgasm and overall. Coital incontinence was not shown to be a predictor for poorer 
outcome at TVT in this study. 
In previous studies, TVT has been shown to improve sexual function.  In 2007 Jha et al reported 
improved sexual function at six months post-operatively in 54 women assessed using PISQ-12 
[27]. The study showed that coital incontinence was significantly reduced after TVT, with 38 
women being affected pre- and 15 post-operatively (p<0.002). In 2009 Bekker et al showed that 
women with coital incontinence show a significantly higher improvement in sexual function at 
three to twelve months post-op (61 TVT, 32 TVT-O and 43 TOT), compared with those without 
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coital incontinence [16]. The authors concluded that coital incontinence is a prognostic factor for 
improvement in sexual function after incontinence surgery.  
Glavind et al in 2014 observed that in 51 women undergoing TVT, sexual function significantly 
improved and coital incontinence  assessed by PISQ-12 was significantly reduced (p<0.005) at 
six months post-operatively [28]. The same authors subsequently published a follow-up study in 
this group, with 44 patients followed up at both at six months post TVT and again at a mean of 
four years and nine months [29], showing that sexual function and coital incontinence  remained 
significantly improved at long-term follow-up, with no significant differences between six month 
and long term follow up. 
In a previous study, Serati et al used antimuscarinics (tolteridine 4mg) to treat women with coital 
incontinence at orgasm, and observed inferiority in the treatment of OAB, compared with 
women without orgasm CI, supporting the view that incontinence at orgasm is either a marker of 
more severe detrusor overactivity or that it is more of a marker for SUI [18]. The improvement in 
coital incontinence post TVT lends support to this latter theory.  
 
The demographics of the patients with coital incontinence in our study group undergoing TVT 
showed that younger age was a significant co-factor for coital incontinence, which is likely to be 
related to higher levels of sexual activity in this age group. Raised BMI was also a risk factor for 
both penetration and orgasm coital incontinence. This was also demonstrated in the study by 
Madhu et al [8], which also observed a significant association between coital incontinence and 
cigarette smoking and antidepressant use. High BMI is an established risk factor for urinary 
incontinence [30] and this is thought to be due to increased intra-abdominal pressure and 
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increased stress on the pelvic floor. This again points towards a stress related mechanism rather 
than a detrusor over activity mechanism for coital incontinence. 
 
In conclusion, the present study has found coital incontinence  to be highly prevalent and affects 
more than half of women with urinary incontinence. It is also a rarely volunteered symptom and 
even on direct questioning, women may not admit to coital incontinence. The value of 
questionnaires to help in the assessment of women in this context cannot be underestimated. 
Coital incontinence has a significant negative impact on sexual function and results in avoidance 
by both partners. Both coital incontinence at orgasm and penetration are significantly associated 
with both SUI and OAB. and should not be considered completely separate entities.  TVT results 
in a significant improvement in coital incontinence symptoms and improves sexual function for 
women with SUI. Further studies, including multiple centres using ePAQ-PF, are needed to 
confirm and develop these findings. Further research into the precise mechanisms of coital 
urinary incontinence are required. 
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Table 1: The items of ePAQ-PF included in this study  
Urinary dimension 
• Q21	Do	you	suddenly	get	a	strong	urge	to	rush	to	the	toilet	to	pass	urine?	
• Q22	When	you	get	the	urge	to	go,	does	urine	start	to	leak	before	you	can	make	it	to	the	toilet?	
• Q23 Does urine leak when you wash your hands or hear the sound of running water? 
• Q24 Does urine leak when you are opening or unlocking your door to your home? 
• Q28 Does urine leak when you cough? 
• Q29 Does urine leak when you sneeze? 
• Q30 Does urine leak when you exercise, lift things, jump or run? 
• Q31 Does urine leak with movements such as standing up, bending down or getting dressed? 
• Q32 Does urine leak when you are walking? 
 
Sexual dimension 
• Q98 Do you avoid sexual activity because of your bladder or urinary problems? 
• Q99 Do you feel that your partner avoids sexual activity with you because of your bladder or urinary 
problems? 
• Q101 Does urine leak when you have sexual intercourse? 
• Q102 Do you leak urine when you have an orgasm? 
• Q103 Does urine leak at the start of sexual intercourse? 
(i.e. on penetration) 
• Q122 Overall, how much do sexual problems interfere with your enjoyment of life? 
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Table two 
The frequency and impact of coital incontinence on self-avoidance and partner avoidance of sex 
and interference with enjoyment of life. 
 
 
 Coital incontinence 
positive 
Coital incontinence 
negative 
p-value 
Self-avoidance 365.74 586.34 p <0.0005 
Impact of self-
avoidance 
356.22 596.77 p <0.0005 
Partner-avoidance 411.92 515.84 p <0.0005 
Impact of partner-
avoidance 
407.53 520.74 p <0.0005 
Overall enjoyment of 
life  
338.08 610.44 p <0.0005 
Impact of overall 
enjoyment of life 
332.65 616.40 p <0.0005 
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Table	three:	Comparison	of	pre-operative	symptom	profiles	between	women	with	coital	
incontinence	and	without	coital	incontinence,	with	details	of	statistical	test	used	and	
significance	level.	Complete	demographic	details	were	available	for	56	participants,	36	with	
coital	incontinence	and	23	without.	
 
a. Coital incontinence 
 Coital 
incontinence 
positive (n) 
Coital 
incontinence 
negative (n) 
Statistical 
test used 
Significance 
Age 48.3± 8.0 55.46± 8.8 Student t Test t(67)= 3.448,  
p= 0.001 
BMI 30.4± 5.6 28.0± 5.7 Student t test t(57)= -1.616,  
p= 0.112 
Hypertension 10/36 7/23 Pearson Chi 
Squared Test 
Χ2(1)= 0.48, 
p=0.826 
Smoking 6/36 2/23 Fisher exact 
test 
p=0.464 
ASA (Mean 
rank) 
29.13 31.37 Mann Witney 
test 
U=382.500, 
p=0.580 
Diabetes 0/36 2/23 Fisher exact 
test 
p=0.516 
Sleep apnoea 5/36 2/23 Fisher exact 
test 
p=0.694 
Depression 5/36 3/23 Fisher exact 
test 
p=1.000 
Anxiety 1/36 2/23 Fisher exact 
test 
p=0.554 
 
b. Orgasm coital incontinence 
 Orgasm 
coital 
incontinence 
positive (n) 
Orgasm 
coital 
incontinence 
negative (n) 
Statistical 
test used 
Significance 
Age 49.0± 8.2 52.9± 9.3 Student t 
Test 
t(66)= 1.824,  
p= 0.073 
BMI 31.6± 5.9 27.7± 5.1 Student t 
test 
t(56)= -2.750,  
p= 0.008* 
Hypertension 10/28 7/30 Pearson 
Chi 
Squared 
Test 
Χ2(1)= 1.071, 
p=0.301 
Smoking 5/28 2/30 Fisher exact test 
p=0.246 
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ASA (Mean 
rank) 
31.23 27.88 Mann 
Witney test 
U=371.500, 
p=0.394 
Diabetes 1/28 1/30 Fisher 
exact test 
p=1.000 
Sleep apnoea 3/28 3/30 Fisher 
exact test 
p=1.000 
Depression 6/28 3/30 Fisher 
exact test 
p=0.290 
Anxiety 2/28 1/30 Fisher 
exact test 
p=0.605 
 
c. Penetration coital incontinence 
 Penetration 
coital 
incontinence 
positive (n) 
Penetration 
coital 
incontinence 
negative (n) 
Statistical 
test used 
Significance 
Age 50.2± 7.7 51.1± 9.6 Student t 
Test 
t(67)= 0.370, p= 
0.0713 
BMI 32.6± 6.1 27.9± 4.9 Student t 
test 
t(57)= -3.205, 
p= 0.002* 
Hypertension 8/20 9/39 Pearson 
Chi 
Squared 
Test 
Χ2(1)= 1.846, 
p=0.174 
Smoking 5/20 3/39 Fisher exact test 
p=0.106 
ASA (Mean 
rank) 
34.43 27.73 Mann 
Witney test 
U=301.500, 
p=0.109 
Diabetes 2/20 0/39 Fisher 
exact test 
p=0.111 
Sleep apnoea 4/20 3/39 Fisher 
exact test 
p=0.213 
Depression 4/20 4/39 Fisher 
exact test 
p=0.424 
Anxiety 0/20 3/39 Fisher 
exact test 
p=0.544 
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Table four: Paired t test was used to compare the pre-operative and post -operative OAB 
and SUI domain scores in all 84 women undergoing TVT.  
 
 
 Pre-operative 
domain score 
Post-operative 
domain score 
Significance 
OAB Domain of 
ePAQ-PF 
30.59±19.46/100 18.99±19.70/100 t(78)= 5.557,  
p< 0.001 
SUI Domain of 
ePAQ-PF 
58.72±23.42/100 14.70±27.04/100 t(77)= 12.032, p<0.001 
 
 
Table five 
 
Wilcoxon signed ranks test was used to compare the pre-operative and post-operative symptoms 
of coital incontinence, orgasmic coital incontinence and penetrative coital incontinence. It 
showed that there was significant improvement in all the symptoms analysed. 
 
 Positive 
pre-TVT 
Improveme
nt 
Worseni
ng 
No 
change 
Significance 
Coital 
Incontinence 
45/84 27/37 1/37 9/37 Z = -4.639, p < 
0.001 
Orgasm Coital 
Incontinence 
35/84 20/26 0/26 6/26 Z = -4.030, p < 
0.001 
Penetration 
Coital 
Incontinence 
25/84 14/19 0/19 5/19 Z = -3.402, p = 
0.001 
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Fig.1 The electronic Personal Assessment Questionnaire-Pelvic Floor item relating to coital incontinence 
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Figure 2: Product plots showing the correlation between domain scores for stress urinary incontinence 
(SUI) and overactive bladder (OAB) with overall reported coital incontinence, coital incontinence at 
orgasm and that at penetration. The shading of each square displayed varies depending on the number of 
patients reporting the specific frequency of coital incontinence symptoms (never, occasionally, most of 
the time, all of the time) and having a particular domain score (0–100)  
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7.6:	Paper	6:	Gray	T,	Money-Taylor	J,	Li	W,	Farkas	AG,	Campbell	P,	Radley	SC.	What	is	
the	effect	of	body	mass	index	on	subjective	outcome	following	vaginal	hysterectomy	
for	prolapse?	International	Neurourology	Journal.	2019;23(2):1-8.	
Abstract	
Purpose	
Obesity	is	a	significant	risk	factor	for	pelvic	organ	prolapse	(POP),	but	the	effects	of	obesity	
on	outcomes	of	surgery	for	POP	are	poorly	understood.	The	aim	of	this	study	was	to	assess	
the	relationship	between	POP	symptomatology,	subjective	outcomes	of	surgery	and	body	
mass	index	(BMI)	in	women	undergoing	vaginal	hysterectomy	for	POP.	
Methods	
Pre-	and	post-operative	data	 from	a	validated	pelvic	 floor	questionnaire	 (ePAQ-PF)	were	
collected	prospectively	from	60	women	undergoing	vaginal	hysterectomy	for	POP.	Of	these,	
20	were	normal	weight	(BMI	18.5	–	24.9),	20	were	overweight	(BMI	25	–	29.9)	and	20	were	
women	with	obesity	(BMI	30	–	34.9).		The	relationship	between	BMI	and	symptom	scores	
for	prolapse,	impact	on	vaginal	symptoms	on	quality	of	life	(VS-QoL)	and	‘overall	change	in	
condition’	 was	 assessed.	 Pre-	 and	 post-operative	 symptom	 scores	 were	 compared	 using	
repeated	 mixed	 ANOVA	 test	 for	 BMI	 as	 a	 categorical	 variable	 (Normal,	 Overweight	 and	
Obese).	 Spearman’s	 rank	 order	 correlation	 test	 was	 carried	 out	 to	 evaluate	 BMI	 as	 a	
continuous	 variable.	 All	 women	 underwent	 vaginal	 hysterectomy	 using	 a	 standardised	
technique.	
Results	
Overall,	93%	of	women	reported	improvement	in	their	condition.	The	main	finding	was	that	
‘Overall	 change	 in	 condition’	 was	 negatively	 correlated	 with	 increasing	 BMI	 (rs=	 -0.324,	
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p=0.028).	 Irrespective	 of	 BMI,	 significant	 improvements	 were	 observed	 in	 symptoms	 of	
prolapse	and	VS-QoL	at	three-months	post	operation.			
Conclusions		
With	 increasing	 BMI,	 women	 are	 likely	 to	 report	 lower	 levels	 of	 satisfaction	 following	
prolapse	surgery,	despite	reporting	equivalent	improvements	in	symptoms.	BMI	is	known	to	
affect	how	individuals	perceive	their	general	health	and	well-being	with	obese	individuals	
reporting	 poorer	 levels	 of	 subjective	 health	 status.	 	 Women	 with	 obesity	 may	 perceive	
change	 in	 their	 condition	 after	 prolapse	 surgery	 differently	 to	women	 of	 normal	weight.		
Reduction	 of	 weight	 prior	 to	 prolapse	 surgery	 could	 be	 considered	 in	 obese	 women	 to	
improve	subjective	outcomes	of	surgery.		
	
MeSH	Key	words	
Obesity,	Patient	outcome	assessment,	Pelvic	organ	prolapse,	Hysterectomy	
	
Highlights	
• Obesity	is	a	risk	factor	for	pelvic	organ	prolapse.	
• Data	on	impact	of	BMI	on	outcomes	of	prolapse	surgery	is	limited.			
• Impact	of	obesity	on	subjective	outcomes	following	hysterectomy	was	assessed.	
• Women	with	obesity	reported	less	impact	of	prolapse	on	quality	of	life	(p=0.032).			
• Increasing	BMI	is	associated	with	poorer	subjective	outcome	(p=0.028).			
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Introduction	
Pelvic	organ	prolapse	(POP)	is	a	common	condition	for	which	the	estimated	lifetime	risk	of	
undergoing	surgery	is	12.6%	[1].		Despite	the	global	rise	in	the	prevalence	of	obesity,	defined	
as	body	mass	index	greater	than	or	equal	to	30,	little	is	known	regarding	the	relationship	
between	obesity	and	surgical	outcomes	in	this	field	[2].			
An	association	between	increasing	obesity	and	prevalence	of	prolapse	has	been	reported	by	
several	 authors,	 including	 data	 from	 a	 number	 of	 large	 population-based	 surveys	 [3-8].		
Obesity	is	recognised	as	a	risk	factor	for	progression	of	pelvic	organ	prolapse	[9]	and	is	the	
strongest	identified	risk	factor	for	post-hysterectomy	vaginal	vault	prolapse	[10].			
The	impact	of	obesity	on	outcomes	of	prolapse	surgery	has	been	reported	in	relatively	few	
studies.	 	Anatomical	and	functional	outcomes	following	abdominal	sacrocolpopexy	do	not	
appear	 to	 be	 affected	 by	 obesity	 [11-13],	 whereas	 a	 study	 of	 women	 undergoing	
sacrospinous	 ligament	 fixation	 with	 anterior	mesh	 repair	 reported	 less	 improvement	 in	
prolapse	symptoms	in	the	obese	group	[14].			
The	increasing	prevalence	of	obesity	is	likely	to	lead	to	increasing	prevalence	of	symptomatic	
POP.	 	 Improving	our	understanding	of	how	obesity	relates	to	perception	and	reporting	of	
symptoms,	 impact	on	quality	of	 life	and	outcomes	of	surgery	will	help	to	 inform	decision	
making	and	ensure	that	both	clinicians	and	patients	have	a	good	understanding	and	realistic	
expectations	of	outcome.		To	our	knowledge,	the	relationship	between	obesity	and	outcome	
following	vaginal	hysterectomy	for	uterine	prolapse	has	not	been	reported.		The	aim	of	the	
present	study	was	to	compare	subjective	outcomes	of	surgery	in	women	of	normal	weight,	
overweight	 and	 obesity,	 undergoing	 vaginal	 hysterectomy	 for	 POP,	 using	 prospectively	
collected	data	from	a	validated	pelvic	floor	symptom	questionnaire	(ePAQ-PF)	[15].		
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Materials	and	methods	
The	 study	 included	 all	 women	 undergoing	 vaginal	 hysterectomy	 at	 Sheffield	 Teaching	
Hospitals	NHS	Foundation	Trust,	UK,	 during	 the	 three	 year	 study	period	who	 completed	
ePAQ-PF	pre-operatively	and	three	months	post-operatively,	with	documented	Body	Mass	
Index	(BMI)	and	patient	consent	for	their	data	to	be	used	for	research.		
Women	 who	 attend	 our	 unit	 complete	 the	 ePAQ-PF	 questionnaire	 as	 part	 of	 routine	
assessment.		This	provides	detailed	symptom	and	health-related	quality	of	life	(HRQoL)	data,	
as	well	as	recording	BMI	and	patient	consent	for	use	of	their	data	in	research	and	service	
evaluation.			
The	 electronic	 Personal	 Assessment	 Questionnaire-Pelvic	 Floor	 (ePAQ-PF)	 is	 a	 validated	
web-based	interactive	questionnaire	which	provides	an	in-depth	evaluation	of	a	woman’s	
pelvic	floor	symptoms	and	their	impact	upon	her	HRQoL	[15,	16].	The	questionnaire	can	be	
completed	online,	or	using	a	touch-screen	computer	terminal	in	clinic.	 	The	questionnaire	
presents	 up	 to	 132	 items	 and	 was	 designed	 to	 improve	 communication	 and	 detailed	
assessment	by	providing	patients	with	an	opportunity	to	report	symptoms	of	an	intimate	
and	sensitive	nature,	many	of	which	might	be	difficult	to	express	face-to	face	[17,	18].		The	
questionnaire	covers	dimensions	of	urinary,	bowel,	vaginal	and	sexual	function.			
For	this	study,	the	following	items	from	ePAQ-PF	questionnaire	were	assessed.		
Comparison	of	pre-	and	post-operative	vaginal	prolapse	domain	scores	and	impact.		Domain	
score	is	a	composite	of	responses	to	the	following	questions	on	the	ePAQ	questionnaire;	
• Q84	Do	you	feel	that	something	is	dropping	down	inside	your	lower	abdomen	
or	vagina?	
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• Q85	Do	you	feel	that	your	vagina	is	too	loose	or	too	lax?	
• Q86	Do	you	feel	a	lump	or	bulge	coming	down	in	your	vagina?	
• Q87	Do	you	feel	a	lump	or	bulge	that	comes	out	of	your	vagina	altogether,	so	
that	you	can	feel	it	or	see	it	on	the	outside?	
	
Response	options	are	‘Never’,	‘Occasionally’,	‘Most	of	the	time’	or	‘All	of	the	time’	and	scored	
0,	1,	2	or	3	respectively.	Symptom	impact	is	graded	as	‘Not	a	problem’,	‘A	bit	of	a	problem’,	
‘Quite	a	problem’	or	‘A	serious	problem’	and	scored	0,	1,	2	or	3	respectively.		Domain	scores	
are	calculated	by	dividing	the	sum	of	all	 item	scores	in	the	domain	by	the	maximum	total	
possible	score	and	multiplying	this	by	100,	to	produce	a	scale	ranging	from	0	to	100.		On	this	
scale,	a	score	of	0	indicates	the	best	and	100	indicates	the	worst	possible	health	status.			
	
Analysis	of	pre-	and	post-operative	responses	to	individual	POP	symptoms	relating	to;	
‘Awareness	of	something	coming	down	(SCD)’	(Q84	)	
‘Vaginal	laxity’	(Q85)	
‘Awareness	of	a	vaginal	lump	or	bulge’	(Q86)	
	
Comparison	 of	 pre-	 and	 post-operative	 vaginal	 symptoms	 quality	 of	 life	 scores	 (VS-QoL)	
generated	from	responses	to	three	questions;		
‘Overall,	how	much	do	vaginal	problems	interfere	with	your	enjoyment	of	life?’	
‘Do	you	have	any	vaginal	problems	that	interfere	with	physical	activity?’		
‘Do	you	have	any	vaginal	problems	that	interfere	with	social	activity?'	
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Assessment	of	overall	change	in	condition	based	on	a	validated	7-point	scale;	0	=	Very	much	
worse,	1	=	Much	worse,	2	=	A	little	worse,	3	=	No	change,	4	=	A	little	better,	5	=	Much	better,	
6	=	Very	much	better.	
Four	surgeons	carried	out	the	hysterectomies	included	in	this	study,	using	a	standardised	
technique.	 All	 women	 undergoing	 vaginal	 hysterectomy	 and	 vaginal	 wall	 repair	 had	 a	
procedure	using	absorbable	suture	materials	only.	No	mesh	inlays	or	non-absorbable	suture	
materials	were	used	as	part	of	 surgery.	All	women	had	Mc’Call’s	 culdoplasty	 to	unite	 the	
uterosacral	 ligaments	 in	 the	 midline	 and	 obliterate	 the	 deadspace	 where	 a	 potential	
enterocoele	 could	 form.	 The	 uterosacral	 ligaments	 were	 also	 fixed	 to	 the	 vault	 and	 tied	
across	the	midline.		Concomitant	native	tissue	anterior	vaginal	wall	repair	was	undertaken	
if	point	Aa	on	the	pelvic	organ	prolapse	quantification	grid	was	within	1cm	of	the	hymenal	
ring.	Likewise,	concomitant	native	tissue	posterior	wall	repair	was	undertaken	if	point	Ap	
on	 the	pelvic	organ	prolapse	quantification	grid	was	within	1cm	of	 the	hymenal	 ring.	All	
patients	who	had	a	sacrospinous	 fixation	had	this	undertaken	with	a	Capio	SlimTM	device	
(Boston	Scientific)	and	2.0	PDS	was	the	suture	material	used.		
Ethical	approval	was	obtained	from	The	University	of	Sheffield.		Data	were	anonymised	and	
statistical	 analysis	 was	 undertaken	 using	 SPSS	 (version	 22).	 	 Pre-	 and	 post-operative	
symptom	scores	were	compared	using	a	repeated	mixed	ANOVA	test	for	BMI	as	a	categorical	
variable	(Normal:	18-24.9,	Overweight:	25-29.9	and	Obese:	30-35).	Spearman’s	rank	order	
correlation	test	was	also	carried	out	to	evaluate	BMI	as	a	continuous	variable.	
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Results	
In	total	60	women	were	included	in	the	study	and	completed	ePAQ-PF	both	pre-operatively	
and	three	months	post	operatively	during	the	study	period.		Of	these	60	women,	20	were	of	
normal	weight,	20	were	overweight	and	20	were	women	with	obesity.	The	average	age	for	
the	cohort	was	63	(range	37	–	88	years).		The	average	age	in	the	normal	BMI	group	was	63.2,	
in	the	overweight	group	it	was	61.6	and	in	the	obese	group	it	was	64.8.	The	average	parity	
for	the	cohort	was	2.4.	The	average	parity	in	the	normal	BMI	group	was	2.4,	in	the	overweight	
group	it	was	2.5	and	in	the	obese	group	it	was	2.35.	When	assessed	by	student’s	t	test,	there	
was	no	significant	difference	in	age	for	women	with	normal	BMI	compared	with	overweight	
BMI	(p=	0.24),	normal	BMI	compared	to	obese	BMI	(p=	0.33)	and	overweight	BMI	compared	
with	obese	BMI	(p=	0.13).	There	was	also	no	significant	difference	in	parity	when	assessed	
by	Student’s	t	test	for	women	with	normal	BMI	compared	with	overweight	BMI	(p=	0.37),	
normal	BMI	compared	to	obese	BMI	(p=	0.42)	and	overweight	BMI	compared	with	obese	
BMI	(p=	0.30).	All	women	in	the	study	had	uterine	prolapse	grade	2	or	more	using	the	pelvic	
organ	prolapse	quantification	system.	There	was	no	statistically	significant	difference	in	age,	
parity	or	grade	of	prolapse	between	the	three	groups.	Characteristics	of	the	three	BMI	groups	
are	reported	in	Table	1.	
Fifty-six	women	underwent	vaginal	hysterectomy	with	anterior	or	posterior	repair,	two	of	
whom	 underwent	 concomitant	 sacrospinous	 ligament	 fixation.	 	 Four	women	 underwent	
vaginal	hysterectomy,	without	vaginal	wall	repair.		No	other	concomitant	procedures	were	
undertaken.	All	the	surgical	procedures	undertaken	are	reported	in	Table	1.		
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Vaginal	symptoms	quality	of	life	(VS-QoL)	scores	
The	 pre-operative	 impact	 of	 prolapse	 on	 vaginal	 symptoms	 quality	 of	 life	 (VS-QoL)	was	
significantly	 less	 in	women	with	obesity	when	 compared	with	women	 in	 the	overweight	
group	(p=0.026)	and	normal	weight	group	(p=0.032)	(Table	2).		Significant	improvements	
were	observed	in	VS-QoL	scores	post-operatively	in	all	BMI	groups	(Table	2).		There	was	no	
significant	difference	in	degree	of	improvement	between	different	BMI	groups	(p=0.102).		
	
Overall	change	in	condition	
Forty-six	women	 (77%)	 answered	 the	 global	 rating	 of	 outcome	 question,	 of	whom	 93%	
(n=43/46)	reported	 improvement	 in	 their	condition.	 	One	woman	 felt	 that	 there	was	 ‘No	
change’	and	two	women	felt	 that	 their	condition	was	 ‘A	 little	worse’.	 	Surgery	resulted	 in	
improvement	in	overall	condition	in	all	groups:	normal	weight	group	(4.9	±	0.3),	overweight	
group	(4.6	±	0.9)	and	obese	group	(4.5	±	0.8).		Analysing	BMI	as	a	continuous	variable,	BMI	
was	 significantly	 correlated	 with	 global	 rating	 of	 outcome;	 women	with	 the	 higher	 BMI	
reporting	poorer	overall	outcome	(Spearman’s	rank-order	correlation	rs=-0.324,	p=0.028).	
	
Prolapse	symptoms	domain	scores		
Significant	 improvement	 was	 seen	 in	 the	 prolapse	 symptoms	 domain	 score	 for	 all	 BMI	
groups	(Table	3).		Data	from	all	patients	combined	(n=60)	showed	91%	improvement,	from	
55	 ±	 18	 to	 6	 ±	 14	 (p<0.0005).	 	 There	 was	 no	 significant	 difference	 in	 the	 degree	 of	
improvement	 of	 prolapse	 symptoms	 with	 increasing	 BMI	 (repeated	 mixed	 ANOVA	 test,	
p=0.57,	 Spearman’s	 rank-order	 correlation	 test	 (rs=-0.104,	 p=0.44)).	 	 There	 was	 no	
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significant	 correlation	 between	 pre	 and	 post-operative	 prolapse	 impact	 scores	 and	 BMI	
(repeated	mixed	ANOVA	test,	p=0.223).	
	
Prolapse	symptom	scores	
The	 two	most	 commonly	 reported	 symptoms	of	 prolapse	were	 ‘Awareness	 of	 something	
coming	down’	and	‘Awareness	of	a	lump’,	reported	by	97%	and	95%	of	women	respectively.		
‘Vaginal	laxity’	was	reported	by	48%	of	women.		Data	from	all	patients	combined	showed	
significant	 improvement	 in	 all	 symptoms	 (Table	 4).	 Further	 analysis	 demonstrated	 no	
significant	difference	in	degree	of	improvement	of	individual	prolapse	symptoms	between	
different	BMI	groups	(repeated	mixed	ANOVA	tests,	p>0.05).	
	
	
Discussion	
The	aim	of	this	study	was	to	investigate	the	impact	of	BMI	on	subjective	outcomes	of	vaginal	
hysterectomy	 for	 POP.	 	 The	 main	 finding	 is	 that	 patient-reported	 perception	 of	 overall	
improvement	in	their	condition	following	hysterectomy	for	prolapse	is	negatively	correlated	
with	increasing	BMI.		
As	women	with	raised	BMI	appear	to	be	less	satisfied	with	subjective	outcome	of	surgery	for	
POP,	the	potential	merits	of	delaying	surgery	on	patients	with	significantly	raised	BMI	and	
POP	should	be	considered.	The	increased	intra-abdominal	pressure	associated	with	obesity	
which	 leads	 to	 associated	 pressure	 on	 the	 pelvic	 floor	 is	 the	 theoretical	 mechanism	
implicating	 obesity	 as	 a	 risk	 factor	 for	 POP.	 Therefore,	 weight	 loss	 should	 lead	 to	
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improvement	in	symptomatic	prolapse	and	as	this	study	shows,	may	also	lead	to	improved	
subjective	outcomes	following	surgery	after	weight	loss.			
However,	the	impact	of	weight	loss	on	POP	still	remains	unclear.	 	As	part	of	the	Women’s	
Health	 Initiative	 (WHI)	 trial,	which	 investigated	health	 issues	 in	women	 taking	hormone	
replacement	therapy;	16,608	women	were	followed	up	over	a	five-year	period	to	investigate	
the	 relationship	 between	weight	 change	 and	 POP	 [9].	 	 Although	 this	 study	 observed	 an	
association	between	weight	gain	and	POP	progression,	weight	loss	was	not	associated	with	
prolapse	regression	but	in	fact	with	borderline	worsening	of	uterine	prolapse	[9].		Likewise,	
the	impact	of	bariatric	surgery	on	POP	has	demonstrated	conflicting	results,	with	one	study	
reporting	significant	reduction	in	prevalence	of	symptoms	of	POP	from	54%	to	18%	at	1	year	
follow	up	[19],	while	other	studies	have	shown	no	effect	[20-22].		In	contrast,	a	weight	loss	
programme	for	women	with	stress	urinary	 incontinence	reported	(SUI)	 that	women	who	
lost	 5-10%	 of	 their	 body	 weight	 were	 significantly	 more	 likely	 to	 achieve	 substantial	
reduction	 in	 SUI	 symptoms	 than	 women	 in	 a	 control	 group	 [23].	 There	 is	 also	 strong	
evidence	that	bariatric	surgery	has	significantly	beneficial	effects	on	SUI	[24].	
A	common	rationale	for	delaying	surgery	in	morbidly	obese	patients	with	POP	whilst	they	
lose	weight	is	to	reduce	the	risk	of	intraoperative	complications.	However,	only	one	study	
has	 reported	 complications	 of	 prolapse	 surgery	 specifically	 related	 to	 BMI,	 finding	 that	
obesity	was	protective	against	blood	loss,	transfusion	and	long-term	urinary	retention	[25].		
The	retrospective	design	of	this	study	may	have	introduced	selection	bias	as	it	possible	that	
women	with	obesity	may	have	been	managed	differently.	Evidence	of	a	significant	increase	
in	risks	of	immediate	complications	during	prolapse	surgery	in	obese	patients	is	lacking.	
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A	further	potential	rationale	 for	recommending	weight	 loss	 to	patients	with	POP	prior	 to	
surgery,	is	to	reduce	the	risks	of	recurrence.	A	small	retrospective	study	of	69	women	found	
that	BMI	was	a	significant	risk	factor	for	surgical	failure	at	one	year	[26]	and	obesity	has	been	
associated	with	significant	risk	of	recurrent	anterior	vaginal	wall	prolapse	following	anterior	
colporrhaphy	 [27].	 	 Conversely,	 a	 five-year	 prospective	 study	 of	 376	women	undergoing	
prolapse	and	 incontinence	 surgery	 found	no	association	between	obesity	and	 recurrence	
[28].	 	 Moreover,	 a	 systematic	 review	 from	 2015	 found	 that	 though	 higher	 BMI	 was	 a	
significant	risk	factor	for	primary	pelvic	organ	prolapse,	it	was	not	a	significant	risk	factor	
for	recurrent	prolapse	[29].		Therefore,	delaying	surgery	for	POP	whilst	patients	lose	weight	
may	not	be	beneficial	for	reducing	complications	or	recurrence	of	the	prolapse.		
	
Comparison	of	our	findings	with	other	studies	is	limited,	as	only	a	few	papers	have	reported	
the	impact	of	obesity	on	outcomes	of	prolapse	surgery.	 	Obesity	does	not	appear	to	affect	
anatomical	or	 functional	outcomes	 in	women	undergoing	abdominal	sacrocolpopexy	[11-
13].	 	 A	 study	 involving	women	 undergoing	 sacrospinous	 ligament	 fixation	with	 anterior	
mesh,	employing	Asian	BMI	categories	(where	obesity	is	classed	as	BMI	>27.5),	reported	less	
symptomatic	improvement	in	women	with	obesity	[14].		Whereas	these	studies	involved	the	
use	of	synthetic	mesh	to	treat	vault	prolapse,	the	present	study	related	specifically	to	women	
undergoing	vaginal	hysterectomy	for	prolapse,	so	results	are	not	directly	comparable.			
Since	 increasing	 BMI	 was	 associated	 with	 a	 lesser	 degree	 of	 overall	 improvement	 in	
condition	and	improvement	in	POP	symptoms	was	not	related	to	BMI,	perception	of	outcome	
may	be	related	to	factors	other	than	impact	of	prolapse	surgery	on	prolapse	symptoms.		Body	
mass	 index	affects	how	 individuals	perceive	 their	general	health	and	well-being	 [30]	and	
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obesity	is	associated	with	impaired	health	related	quality	of	life	and	poor	levels	of	subjective	
health	 status	 [31].	 	 A	 population	 survey	 of	 2000	 people	 in	 America	 reported	 decreased	
HRQoL	with	increasing	obesity,	even	without	the	presence	of	chronic	disease	[31],	and	in	a	
population	 survey	 of	 almost	 10000	 people	 in	 Australia	 who	 completed	 the	 Short	 Form	
Health	Survey	(SF-36),	high	BMI	was	associated	with	reduced	levels	of	physical	and	mental	
well-being	[32].	 	The	assessment	of	 ‘overall	change	in	condition’	 in	the	present	study	is	a	
subjective	measure	of	treatment	outcome.	Women	with	obesity	may	perceive	change	in	their	
condition	differently	to	women	of	normal	weight.			
	
The	ePAQ	VS-QoL	score	is	generated	from	responses	to	questions	relating	to	the	impact	of	
vaginal	symptoms	on	physical	and	social	activity	and	enjoyment	of	life.		Women	with	obesity	
and	POP	reported	significantly	less	impact	of	prolapse	on	their	vaginal	symptoms	quality	of	
life	 (VS-QoL)	 pre-operatively	 than	 normal	 weight	 or	 overweight	 patients,	 a	 possible	
explanation	for	this	being	a	relationship	between	physical	activity	and	BMI.	 	Women	with	
obesity	may	be	less	likely	to	engage	in	physical	activity	than	women	of	normal	weight	and	
therefore	 report	 less	 impact	 of	 prolapse	 on	 their	 quality	 of	 life.	 	 This	 finding	may	 relate	
specifically	 to	 prolapse	 as	 it	 contrasts	with	 published	 reports	 of	 impaired	 health	 related	
quality	of	life	with	increasing	BMI.		
	
The	main	limitations	of	our	study	are	the	short	follow	up	period	(three	months)	and	lack	of	
pre-	and	post-operative	objective	data,	including	pelvic	organ	prolapse	quantification	(POP-
Q)	 scores.	 	 It	 is	possible	 that	patients	who	were	unsatisfied	with	 their	 surgery	may	have	
disengaged	from	the	follow	up	process	and	not	completed	the	post-op	questionnaire	that	
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was	requested,	thereby	introducing	reporting	bias.		However,	our	comprehensive	pre-	and	
post-operative	questionnaire	data	 from	60	patients	undergoing	 vaginal	 hysterectomy	 for	
prolapse	has	permitted	a	detailed	comparison	of	subjective	outcomes	between	different	BMI	
groups	in	this	small	study.			
	
In	 conclusion,	we	suggest	 that	with	 increasing	BMI,	women	are	 likely	 to	be	satisfied	 to	a	
lesser	degree	with	the	outcome	of	prolapse	surgery.		This	may	have	important	implications	
in	pre-operative	counselling	and	management	of	patients.		Future	studies	should	investigate	
the	 impact	 of	 obesity	 on	 outcomes	 of	 surgery	 for	 anterior	 and	 posterior	 compartment	
prolapse,	 assessing	 both	 subjective	 and	 objective	 outcomes,	with	 long	 term	 follow	 up	 to	
assess	the	impact	of	BMI	on	recurrence.			
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Table	legends	
Table	1:	Characteristics	of	patients	in	normal	BMI	group,	overweight	BMI	group	and	obese	
BMI	 group	 (VH=	 vaginal	 hysterectomy,	 AR=	 anterior	 vaginal	 wall	 repair,	 PR=	
posterior	vaginal	wall	repair	and	SSF=	sacrospinous	fixation).	
Table	2.	Pre	and	post-operative	vaginal	symptoms	quality	of	life	(VS-QoL)	scores.	
Table	3.	Pre	and	post-operative	prolapse	symptoms	domain	score	for	each	BMI	group.	
Table	4.	Pre	and	post-operative	prolapse	symptoms	(all	BMI	groups	combined,	n=60).		
(Score	0	=	Never,	1							
																	=	Occasionally	2	=	Most	of	the	time,	3	=	All	of	the	time)	
	
	
	
	
	
	
	
	
	
237	
Table	1.	Characteristics	of	patients	in	normal	BMI	group,	overweight	BMI	group	and	obese	BMI	group	(VH=	
vaginal	 hysterectomy,	 AR=	 anterior	 vaginal	 wall	 repair,	 PR=	 posterior	 vaginal	 wall	 repair	 and	 SSF=	
sacrospinous	fixation)	
Normal	group	(BMI	18-
24.9)	
	
	 BMI	 Age	 Parity	 Surgical	procedure	
	 21.5	 37	 2	 VH	+	AR	
	 22.4	 83	 3	 VH	+	AR	
	 23.3	 62	 2	 VH	+	AR	+	SSF	
	 24.2	 58	 3	 VH	+	AR	
	 24.2	 73	 3	 VH	+	AR	
	 24.3	 67	 2	 VH	+	AR	+PR	
	 21.2	 63	 2	 VH	+	AR	
	 23.5	 64	 3	 VH	+	AR	
	 21.2	 55	 2	 VH	+	PR	+	SSF	
	 22.5	 49	 2	 VH	+	AR	
	 18.5	 63	 1	 VH	+	AR	
	 21.2	 65	 2	 VH	+	AR	+	PR	
	 20.6	 66	 2	 VH	+	AR=	PR	
	 21.2	 72	 2	 VH	+	AR	
	 24.3	 63	 3	 VH	+	AR+	PR	
	 23.5	 61	 4	 VH	+	AR	
	 24.7	 56	 3	 VH	+	AR	
	 24.1	 62	 2	 VH	+	AR	+	PR	
	 24.2	 60	 1	 VH	+	AR	
	 21.8	 85	 4	 VH+	PR	
AVERAGE	 22.6	 63.2	 2.4	 	 	
Overweight	group	(BMI	25-
29.9)	
	
	 BMI	 Age	 Parity	 Surgical	procedure	
	 25.8	 62	 3	 VH	+	AR	
	 27.7	 48	 5	 VH	+	AR	
	 26.6	 52	 4	 VH	+	AR	
	 27.5	 56	 3	 VH	+	AR+	PR	
	 28.3	 67	 2	 VH	+	AR	
	 28.3	 68	 2	 VH	+	AR	
	 29.7	 63	 2	 VH	+	AR+	PR	
	 26.7	 68	 2	 VH	+	AR	
	 25.6	 58	 3	 VH	+	AR	
	 28.2	 56	 2	 VH	+	AR	
	 27.6	 57	 2	 VH	+	AR+	PR	
	 29.6	 63	 1	 VH	+	AR	+	PR	
	 27.5	 65	 2	 VH	+	AR	
	 28.4	 68	 2	 VH	+	PR+	SSF	
	 26.3	 60	 2	 VH	
	 29.7	 67	 3	 VH	+	AR	
	 26.6	 64	 3	 VH	+	AR+	PR	
	 28.5	 45	 1	 VH	+	AR	
	 26.2	 49	 2	 VH	+	AR	
	 28.6	 84	 4	 VH	+	AR	+PR	
AVERAGE	 27.67	 61	 2.5	 	 	
Obese	group	(BMI	30-35)	 	
	 BMI	 Age	 Parity	 Surgical	procedure	
	 30.6	 82	 2	 VH	+	AR	
	 33.7	 76	 3	 VH	+	AR	
	 34.9	 53	 2	 VH	+	AR+	PR+	SSF	
	 35.0	 62	 3	 VH	+	AR	
	 33.8	 67	 3	 VH	+	AR	+	PR	
	 32.1	 68	 2	 VH		
	 31.2	 49	 2	 VH	+	AR	
	 33.2	 62	 3	 VH	+	AR+	PR	
	 31.5	 73	 2	 VH	+	AR	+	PR	
	 33.8	 54	 2	 VH	+	AR	
	 34.3	 73	 1	 VH	+	AR	
	 34.9	 53	 2	 VH	+	AR	
	 33.5	 76	 2	 VH	
	 32.7	 42	 2	 VH	+	AR	
	 32.8	 50	 3	 VH	+	PR	
	 33.8	 64	 4	 VH	+	AR	
	 32.1	 74	 3	 VH	+	AR	
	 34.8	 63	 2	 VH	+	AR		
	 33.8	 67	 1	 VH	+	AR	+	PR	
	 34.7	 88	 3	 VH	+	PR	
AVERAGE	 33.36	 64.8	 2.35	 	
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Table	2.	Pre-	and	post-operative	vaginal	symptoms	quality	of	life	(VS-QoL)	scores.	
	
BMI	group	 n	 Pre-op	
score	
Post-op	
score	
Change	in	
score	
Percentage	
improvement	
	
Significance	
Normal	
weight	
20	 57	±	27	 10	±	24	 47	±	39	 82%	 (p<0.0005)	
Overweight	 20	 57	±	26	 10	±	22	 47	±	34	 82%	 (p<0.0005)	
Obese	 20	 31	±	26	 5	±	15	 26	±	29	 84%	 (p<0.0005)	
	
	
	
	
	
	
	
	
Table	3.	Pre-	and	post-operative	prolapse	symptoms	domain	scores	for	each	BMI	group.	
	
BMI	group	 n	 Pre-op	
score	
Post-op	
score	
Change	in	
score	
Percentage	
improvement	
	
Significance	
Normal	
weight	
	
20	 60	±	16	 6	±	18	 54	±	25	 90%	 (p<0.0005)	
Overweight	
	
20	 55	±	16	 5	±	13	 50	±	22	 91%	 (p<0.0005)	
Obese	 20	 51	±	21	 7	±	13	 45	±	25	 88%	 (p<0.0005)	
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Table	4.	Pre-	and	post-operative	prolapse	symptoms,	all	BMI	groups	combined	n=60		
(Score	0	=	Never,	1	=	Occasionally	2	=	Most	of	the	time,	3	=	All	of	the	time)	
	
Symptom	 Pre-op	
score	
Post-op	
score	
Change	in	
score	
Percentage	
improvement	
Significance	
‘Something	
coming	down’	
2	±	0.7	 0.3	±	0.7	 1.9	±	0.9		 95%	 (p<0.0005)	
‘Vaginal	lump’	 2	±	0.7	 0.3	±	0.8	 1.8	±	1		 90%	 (p<0.0005)	
‘Vaginal	laxity’	 1.04	±	1.15	 0.06	±	
0.23	
1	±	1.1		 96%	 (p<0.0005)	
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Abstract	
Introduction	
Understanding	patients’	concerns	and	goals	is	essential	for	providing	individualised	care	in	
urogynaecology.		
The	study	objectives	were	to	undertake	a	content	analysis	of	free-text	concerns	and	goals	
recorded	by	patients	using	an	electronic	pelvic-floor	questionnaire	(ePAQ-PF)	and	measure	
how	these	related	to	self-reported	symptom	and	health-related	quality-of-life	(HRQOL)	
data	also	recorded	using	ePAQ-PF.		
	
Methods	
1996	consenting	patients	completed	ePAQ-PF.	Content	analysis	was	undertaken	of	free-
text	responses	to	the	item:	‘Considering	the	issues	that	currently	concern	you	the	most,	what	
do	you	hope	to	achieve	from	any	help,	advice	or	treatment?’		Key	content	themes	were	
identified	by	the	lead	researcher,	and	three	researchers	read	and	coded	all	recorded	
responses.	Student’s	t	test	was	used	to	compare	ePAQ-PF	domain	scores	for	patients	
reporting	concerns	in	the	relevant	domain	with	those	who	did	not.	
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Results	
In	total,	63%	of	participants	who	completed	the	questionnaire,	recorded	at	least	one	free-
text	item.	Content	analysis	identified	1560	individual	concerns	coding	into	the	19	ePAQ-PF	
domains.	Symptom	scores	were	significantly	higher	for	patients	reporting	free-text	
concerns	in	18	domains	(p<0.05).	Additional	concerns	relating	specifically	to	body	image	
were	recorded	by	11%	of	patients.	Key	areas	of	importance	emerging	for	personal	goals	
included	cure/improvement,	better	understanding,	incontinence	pad	use,	sexual-function	
and	surgery.		
	
Conclusion	
Free-text	reporting	in	ePAQ-PF	is	utilised	by	patients	and	facilitates	self-expression	and	
discussion	of	issues	impacting	on	HRQOL.	The	significant	relationship	between	recorded	
free-text	concerns	and	ePAQ-PF	domain	scores	suggests	convergent	validity	for	the	
instrument.	Development	and	psychometric	testing	of	a	domain	to	assess	body	image	is	
proposed.	
	
Keywords:	patient	reported	outcome	measures,	prolapse,	incontinence,	body	image	
	
Brief	Summary:		
Free-text	reporting	in	ePAQ-PF	is	well	utilised	and	relates	significantly	to	the	quantitative	
data	recorded.	Development	of	a	domain	to	assess	body	image	is	required.	
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Introduction	
	
Understanding	patient’s	concerns	of	an	illness	and	its	treatment	and	their	personal	goals	in	
terms	of	achieving	a	good	health-related	quality	of	life	(HRQoL)	is	an	important	element	of	
clinical	management.	This	is	particularly	important	in	areas	concerning	sensitive	
conditions,	as	encountered	in	urogynaecology.	Patients	may	not	always	divulge	clear	
information	about	their	symptomatology	and	what	bothers	them	the	most,	particularly	
within	the	constraints	of	a	conventional	history	and	examination	[1].	
The	use	of	technology	has	been	shown	to	be	of	benefit	in	overcoming	this	problem.	For	
example,	computer	interviewing	in	urogynaecology	has	been	shown	to	provide	patients	
with	an	opportunity	to	report	symptoms	of	an	intimate	and	sensitive	nature,	which	may	be	
difficult	to	express	in	a	face-to-face	consultation	[2-4].	This	means	that	their	concerns	can	
be	more	objectively	assessed	and	appropriate	investigation	and	treatment	planned.		
The	use	of	patient	reported	outcome	measures	(PROMS)	in	urogynaecology	is	now	well-
established	and	their	use	is	advocated	in	clinical	practice	[5],	aiming	to	reliably	and	
objectively	quantify	HRQoL	and	assess	outcomes	[2].	Most	PROMS	used	in	urogynaecology	
use	multiple	choice	questions	(MCQs)	to	assess	symptoms	and	their	impact.	Data	collected	
using	these	tools	provides	quantitative	data	about	HRQOL	and	outcome,	but	may	lack	
sensitivity	and	acuity	required	to	individualise	patient’s	concerns	and	goals,	particularly	
with	regard	to	treatment	[6].	The	electronic	Personal	Assessment	Questionnaire-Pelvic	
Floor	(ePAQ-PF)	is	a	self-administered,	interactive,	web-based	questionnaire	which	
measures	urinary,	bowel,	vaginal	and	sexual	symptoms	and	their	related	impact	[7,8,9].	
The	instrument	is	interactive	and	presents	up	to	132	items,	depending	on	patients’	
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responses	to	screening	items,	providing	both	summary	and	detailed	reports,	reflecting	the	
4-dimensional	assessment	of	urinary,	bowel,	vaginal	and	sexual	conditions	and	their	
impact	on	HRQOL,	which	is	used	to	inform	and	support	healthcare	consultations,	document	
symptoms	and	monitor	outcomes	from	the	patient’s	perspective.		
The	penultimate	item	in	ePAQ-PF	is	a	free-text	question:	‘Considering	the	issues	that	
currently	concern	you	the	most,	what	do	you	hope	to	achieve	from	any	help,	advice	or	
treatment?’	(Figure	1).	Free-text	responses	to	this	question	appear	at	the	top	of	the	
structured	report	(Figure	2)	aiming	to	provide	an	additional	qualitative,	personalised	
component	to	patient	assessment,	alongside	quantitative	data	from	the	closed	MCQ	
elements	of	the	instrument.	
The	objective	of	this	study	was	to	analyse	themes	and	content	of	free-text	concerns	and	
goals	recorded	in	response	to	this	item,	from	new	patients	attending	a	urogynaecology	
clinic,	and	assess	how	these	responses	related	to	the	quantitative	data	recorded	in	MCQ	
items	in	ePAQ-PF	and	to	identify	any	elements	not	currently	addressed	by	the	
questionnaire.	
	
Methods	
The	principal	methodology	for	this	research	study	was	content	analysis	[10].	This	is	a	
social	science	methodology	used	to	examine	patterns	in	communication	in	a	systematic	and	
replicable	manner,	in	this	case	free	text	comments	from	a	validated	pelvic	floor	assessment	
questionnaire	(ePAQ-PF).	
Ethical	approval	for	the	study	was	obtained	from	the	University	of	Sheffield,	UK	(project	
number	015337).	Female	patients	attending	the	urogynaecology	unit	at	Sheffield	Teaching	
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Hospitals,	UK,	who	completed	ePAQ-PF	during	the	study	period	(October	2013-	September	
2016)	as	part	of	their	routine	clinical	care,	prior	to	first	assessment	in	the	urogynaecology	
clinic	and	gave	consent	for	use	of	their	data	for	approved	research,	were	included	in	the	
study.		
	
ePAQ-PF	is	a	web-based	instrument	that	provides	a	comprehensive	assessment	of	a	
patient’s	pelvic	floor	symptoms	and	their	impact	on	HRQOL	[7,9,11].	The	instrument	is	
completed	on-line,	prior	to	clinic	attendance	by	80%	of	users	[7],	or	alternatively,	using	a	
touchscreen-computer	or	tablet	in	a	private	room	in	the	urogynaecology	clinic.	Patients	
may	choose	to	have	their	partner/family	member	present	with	them	when	they	complete	
the	questionnaire	and	if	they	complete	it	in	the	hospital	a	nurse	can	sit	with	them	to	
support	them	if	they	wish.	The	great	majority	of	patients	complete	the	questionnaire	alone,	
unaided.	Previous	studies	have	shown	that	most	patients	find	the	questionnaire	easy	to	use	
and	a	useful	process	which	helps	them	to	reflect	and	prepare	for	their	consultation	[2].	The	
mean	completion	time	of	ePAQ-PF,	including	the	free-text	components,	is	26	minutes	[7].	A	
questionnaire	report	may	be	printed	or	viewed	electronically	for	use	by	the	attending	
clinician,	supporting	consultation,	diagnosis	and	management.		
	
The	core	element	of	ePAQ-PF	comprises	of	standardised	multiple-choice	questions,	which	
assess	 both	 the	 frequency	 and	 impact	 of	 pelvic	 floor	 symptoms	 across	 four	 dimensions:	
Urinary,	 Bowel,	 Vaginal	 and	 Sexual.	 Each	 item	 is	 presented	 on	 a	 separate	 screen,	 with	
individual	Help	page	and	navigation	buttons.		Response	options	for	all	these	items	are	on	a	
four-point	scale	‘Never’,	‘Occasionally’,	‘Most	of	the	time’	or	‘All	of	the	time’	and	scored	0,	1,	
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2	or	3	respectively.	The	impact	attributed	to	each	of	these	symptoms	is	also	recorded,	using	
a	 standard	 sub-question	 ‘How	 much	 of	 a	 problem	 is	 this	 for	 you?’	 and	 graded	 as	 ‘Not	 a	
problem’,	‘A	bit	of	a	problem’,	‘Quite	a	problem’	or	‘A	serious	problem’	and	scored	0,	1,	2	and	
3	respectively.	The	degree	of	frequency	and	bothersomeness	are	thereby	assessed	for	each	
symptom.		
	
The	 electronic	 instrument	 automatically	 generates	 scores	 across	 19	 validated	 domains,	
providing	 graphic	 representation	 of	 these	 both	 the	 severity	 and	 the	 impact	 for	 each	
condition.	Domain	scores	are	derived	by	dividing	the	sum	of	all	item	scores	in	that	domain	
by	the	total	possible	item	score	and	multiplying	this	by	100	to	produce	a	scale	ranging	from	
0	(best	possible	health	status)	to	100	(worst	possible	health	status).	[7,	8]	
	
In	addition	to	the	multiple-choice	items	within	ePAQ-PF,	the	instrument	also	includes	a	free-
text	question	(item	PD6	within	the	final	Personal	Data	Dimension)	which	asks:	‘Considering	
the	 issues	 that	currently	concern	you	the	most,	what	do	you	hope	to	achieve	 from	any	help,	
advice	or	treatment?’.	Patients	are	invited	to	record	up	to	three	free-text	responses,	each	of	
up	to	100	characters.	
	
Data	for	the	present	study	were	used	anonymously	from	women	who	answered	‘Yes’	to	the	
final	 item	 of	 the	 questionnaire,	 which	 seeks	 consent	 to	 allow	 confidential	 use	 of	 their	
answers	for	approved	research.	
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Data	were	anonymised	and	transferred	to	SPSS	(version	22)	for	analysis.	Free-text	data	
were	imported	into	Microsoft	Excel	(version	15.33).	Content	analysis	of	free-text	data	was	
conducted	[10].	This	approach	was	adopted	because	it	is	located	more	within	a	
quantitative	methodology	and	our	aim	was	to	count	and	record	the	number	of	concerns	
reported	by	the	women	and	compare	these	against	the	current	ePAQ-PF	domain	structure	
(e.g.	looking	at	where	there	was	convergence	and	divergence	between	the	datasets).	The	
lead	researcher	(TG)	read	and	became	thoroughly	familiar	with	the	comments	recorded	
throughout	the	free-text	data.	These	comments	were	then	coded	categorically	according	to	
the	19	domains	of	the	ePAQ-PF	instrument.	Content	not	fitting	into	these	categories,	and	
therefore	not	assessed	by	ePAQ-PF,	were	then	coded	separately.	
	
Free-text	comments	were	then	analysed	coded	independently	by	three	members	of	the	
research	team	(TG,	SS,	SP)	and	any	ambiguities	were	resolved	by	discussion.	A	similar	
approach	was	also	undertaken	by	the	lead	researcher	to	analyse	the	text	that	patients	had	
been	reported	for	patient	goals	(TG).	Again,	these	were	then	coded	independently	by	two	
members	of	the	research	team	(TG,	SP)	and	any	further	ambiguities	were	resolved	by	
discussion.	
	
Student’s	t	test	was	used	to	compare	ePAQ-PF	domain	symptom	frequency	scores	for	
patients	reporting	concerns	in	the	relevant	domains,	compared	with	those	who	did	not.	
Mann	Witney	test	was	used	to	compare	the	domain	impact	scores	in	the	same	manner.		
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Results	
	
During	the	three-year	study	period,	2,498	women	completed	ePAQ-PF	as	part	of	their	
routine	clinical	care	prior	to	their	first	consultation	in	the	urogynaecology	clinic.	One	
hundred	and	ninety-nine	women	(8%)	declined	consent	for	the	use	of	their	data	for	
research,	and	a	further	303	did	not	complete	the	consent	question.	Therefore,	data	from	
1,996	women	were	included	in	the	study.	Of	these,	1266	(63%)	recorded	one	or	more	
response	to	the	question:	‘Considering	the	issues	that	currently	concern	you	the	most,	what	
do	you	hope	to	achieve	from	any	help,	advice	or	treatment?’.	During	the	study	period,	
greater	than	90%	of	patients	attending	the	urogynaecology	outpatients	department	at	
Sheffield	Teaching	Hospitals,	UK	completed	ePAQ-PF.	Reasons	for	non-completion	have	not	
been	formally	recorded	or	studied,	but	often	relate	to	advanced	age,	computer	literacy	or	
lack	of	time	to	complete	during	the	clinic.	
	
	
Patient	concerns	
Five	hundred	and	thirty-one	patients	(42%)	recorded	one	concern,	472	(37%)	recorded	
two	concerns,	100	(8%)	patients	recorded	three	concerns	and	102	(8%)	recorded	more	
than	three.	Sixty-one	patients	(5%)	completing	this	item	recorded	free	text	content	which	
did	not	relate	to	a	concern	or	goal,	for	example,	writing	a	question	or	making	a	statement	
about	their	care.		
Content	analysis	identified	1560	components	from	recorded	concerns	which	all	coded	into	
the	19	domains	of	ePAQ-PF.		
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Domain	scores	were	significantly	higher	in	18	of	the	19	ePAQ-PF	domains	for	women	
reporting	concerns	in	the	salient	domain,	compared	with	those	who	did	not	(p<0.05)	(table	
1).	Domain	impact	scores	were	also	significantly	higher	in	all	19	ePAQ-PF	domains	for	
those	reporting	concerns	in	the	salient	domain,	compared	with	those	who	did	not	(p<0.05)	
(table	1).	
	
Additional	themes	not	coding	into	the	existing	ePAQ-PF	domain	structure	were	identified;	
160	specific	body	image	concerns	were	recorded	by	136	patients.	These	body	concerns	
were	grouped	into	themes	of	smell	(16.3%),	scarring	(6.9%),	appearance	(37.5%)	and	
emotions	(39.3%).	The	frequency	of	the	most	commonly	used	words	or	phrases	used	in	
relation	to	body	image	concerns	is	shown	in	Table	2.	
	
Table	3	provides	examples	of	some	of	the	intimate	concerns	and	goals	recorded	by	
patients	in	the	study;	102	patients	reported	faecal	incontinence,	23	reported	coital	urinary	
incontinence	and	5	reported	coital	faecal	incontinence.	A	word	cloud,	graphically	
illustrating	the	words	most	frequently	used	by	women	recording	concerns	about	their	
condition	was	created	(figure	3).	
	
Personal	goals	
Overall	85%	of	patients	completing	the	free-text	item	recorded	at	least	one	goal.	A	total	of	
596	patients	(47%)	recorded	one	goal,	332	(26%)	recorded	two	goals,	116	(9%)	patients	
recorded	three	goals	and	102	(3%)	recorded	more	than	three;	189	(15%)	did	not	record	a	
goal.	Content	analysis	identified	seven	key	themes	related	to	personal	goals:	(1)	Aiming	for	
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cure	or	improvement,	(2)	better	understanding	of	their	condition,	(3)	to	improve	physical	
activity,	(4)	reduced	use	of	incontinence	pads,	(5)	improved	sex	life,	(6)	reduction	in	pain	
and	(7)	to	undergo	surgery.	
	
Discussion	
	
The	primary	objective	of	this	study	was	to	undertake	a	content	analysis	to	assess	themes	
emerging	from	free-text	concerns	and	goals	recorded	in	ePAQ-PF.	The	secondary	objective	
was	to	assess	how	concerns	recorded	related	to	symptoms	and	HRQOL	recorded	in	
quantitative	components	of	ePAQ-PF	and	thereby	support	a	patient-focussed	approach	to	
updating	and	potentially	introducing	new	elements	to	the	questionnaire.		
	
The	main	findings	are	that	the	free-text	component	of	ePAQ-PF	was	used	by	over	60%	of	
patients	completing	the	instrument.	The	majority	(90%)	of	themes	identified	from	the	
content	analysis	fitted	into	the	existing	domain	structure	of	the	instrument.	Specific	body-
image	concerns	were	recorded	by	10%	(n=136)	of	patients	responding	to	the	free-text	
question,	which	are	not	currently	addressed	by	the	MCQ	items	of	ePAQ-PF.		The	most	
commonly	reported	goals	related	to	seeking	improvement	or	cure	of	conditions,	improved	
physical	and	sexual	function	and	to	undergo	surgical	treatment.		
	
Free-text	data	are	commonly	included	in	patient	reported	outcome	measures	alongside	
quantitative	components,	though	such	data	are	rarely	used	in	research	as	components	of	
free-text	responses	may	vary	in	relevance	to	the	research	question	posed	[12]	and	analysis	
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of	qualitative	data	presents	methodological	challenges.	As	such,	free-text	data	are	often	
neglected	as	a	potentially	rich	source	of	data,	which	can	supplement,	augment	and	
compliment	more	traditional	quantitative	data	[13].		
	
The	free-text	concerns	and	goals	questions	of	ePAQ-PF	are	presented	towards	the	end	of	
the	questionnaire.	This	aims	to	ensure	that	patients	have	first	completed	the	core	MCQ	
component	of	the	PROM,	giving	them	the	opportunity	to	reflect	on	their	condition	and	then	
provide	considered	responses	to	these	items.	A	previous	qualitative	study,	using	semi-
structured	interviews	with	20	women	completing	ePAQ-PF	observed	that	patients	found	
the	use	of	ePAQ-PF	helped	them	better	understand	and	have	further	insight	into	their	
condition	and	its	impact	on	their	HRQOL,	in	addition	to	giving	them	the	confidence	to	
disclose	embarrassing	personal	issues	[2].	Previous	studies	have	also	found	that	patients	
using	electronic	questionnaires,	feel	more	comfortable	when	reporting	embarrassing	or	
taboo	problems	with	this	approach	than	during	a	consultation	with	a	healthcare	
professional	[2,	9,	14].	The	content	analysis	of	the	concerns	in	this	study	recorded	included	
a	large	volume	of	personal	detail	including	faecal	incontinence,	coital	urinary	incontinence	
and	coital	faecal	incontinence.	All	these	symptoms	are	also	incorporated	in	the	MCQ	
component	of	ePAQ-PF.	The	fact	that	these	patients	felt	sufficiently	enabled	to	record	these	
intimate	symptoms	using	their	own	words,	suggests	that	these	symptoms	are	likely	to	be	
having	a	significant	impact	on	their	HRQOL	and	hence	are	seeking	to	ensure	these	concerns	
are	addressed	during	the	consultation	and	subsequent	treatment.	
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In	this	study,	we	undertook	a	deductive	approach,	hypothesising	that	there	would	be	
significantly	higher	domain	scores	in	ePAQ-PF	for	patients	reporting	a	free-text	concern	in	
the	salient	domain,	compared	with	those	who	did	not	which	was	observed	from	the	
analysis.	In	questionnaire	psychometrics,	convergent	validity	refers	to	the	degree	to	which	
two	different	measures	of	constructs	that	theoretically	should	be	related,	are	in	fact	related.	
This	translates	to	the	degree	to	which	an	instrument	measures	what	it	purports	to	measure	
[15]	and	is	one	component	in	establishing	the	overall	construct	validity	of	an	instrument.	
The	significant	differences	in	domain	scores	between	women	recording	free-text	concerns	
in	the	salient	domain	compared	with	those	who	did	not,	provides	evidence	of	convergent	
validity	for	ePAQ-PF	and	fulfils	the	objective	of	the	study.	We	found	that	women	reporting	
free-text	concerns	for	a	specific	domain	had	significantly	higher	domain	scores	than	those	
who	did	not	in	18	of	the	19	ePAQ-PF	domains.	The	only	domain	which	was	not	statistically	
significant	was	Sex	and	bowel	symptoms.	Only	five	women	recorded	a	concern	in	this	
domain,	and	therefore	the	lack	of	statistical	significance	in	this	instance	may	have	been	due	
to	the	small	sample	size	(Type	2	error)	with	effect	not	being	detected	due	to	very	small	
numbers	of	concerns	recorded	for	these	less	common,	but	intimate	and	taboo	symptoms.	
	
An	important	finding	of	this	study	was	that	10%	of	concerns	recorded	related	to	body	
image	issues,	which	are	not	currently	assessed	by	ePAQ-PF.		This	supports	previous	
research	suggesting	that	many	women	who	attend	urogynaecology	clinics	have	body	image	
concerns	[16,	17].	The	analysis	demonstrated	that	women	were	most	concerned	about	
smell,	the	presence	of	scars	and	the	appearance	of	their	pelvic	area;	often	using	emotive	
language	to	describe	and	express	these	concerns.		
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‘Body	image’	refers	to	the	mental	picture	that	an	individual	has	of	themselves,	which	depicts	
not	only	details	available	to	objective	investigation	by	others	(e.g.	height,	weight,	hair	colour	
etc.),	 but	 also	 details	 that	 have	 been	 learned	 about	 themselves,	 either	 from	 personal	
experiences	or	by	internalising	the	judgments	of	others	[18].	The	term	Genital	self-image	has	
also	been	used	to	describe	the	mental	picture	that	an	individual	has	of	his	or	her	external	
genitalia	 [18].	This	may	 include	 components	 such	as	 appearance,	 smell,	 function	and	 the	
perceptions	of	others	(including	partners	and	healthcare	professionals).		
	
Pelvic	floor	disorders	including	urinary	incontinence	and	pelvic	organ	prolapse	have	been	
shown	to	negatively	impact	on	body	image	[16,17].	A	previous	qualitative	study	of	patients	
completing	a	quantitative	urogynaecology	PROM	(King’s	Health	Questionnaire)	also	found	
that	women	reported	body	image	concerns	during	the	qualitative	analysis,	which	were	not	
covered	 by	 the	 quantitative	 components	 of	 the	 questionnaire	 [6].	 	 Currently	 there	 is	 no	
specific	instrument	available	which	assesses	body	image	exclusively	in	women	with	pelvic	
floor	 conditions.	 The	 definition	 of	 the	 female	 genitalia	 does	 not	 necessarily	 include	 the	
perineum,	vagina	and	perianal	region,	which	are	often	involved	in	pelvic	floor	conditions,	
including	 incontinence	 and	 pelvic	 organ	 prolapse.	 Therefore,	 a	 broader	 definition	 than	
genital	 self-image	 is	 required	 for	 the	assessment	of	body	 image	 concerns	experienced	by	
women	with	pelvic	floor	disorders	and	we	suggest	that	the	term	Pelvic	Body	Image	may	be	
more	appropriate.		Whilst	ePAQ-PF	provides	a	comprehensive	and	robust	assessment	of	a	
women’s	pelvic	floor	symptomatology,	it	does	not	specifically	address	related	body	image	
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concerns.	The	authors	propose	further	work	to	develop	items	in	a	new	domain	within	ePAQ-
PF,	evaluating	related	body	image	issues.	
	
The	content	analysis	of	goals	in	this	study	demonstrated	that	fewer	patients	mentioned	
cure	compared	with	improvement	in	symptoms	as	a	personal	goal	(29%	vs	40%).	This	may	
suggest	that	patients	do	have	realistic	expectations	about	their	treatment	outcomes	and	the	
higher	likelihood	of	improvement	as	compared	to	outright	cure	of	their	condition.	Previous	
studies	have	observed	that	the	majority	of	women	with	urinary	incontinence	and	
overactive	bladder	do	have	realistic	expectations	regarding	outcome	and	are	willing	to	
accept	improvement	and	tolerate	ongoing	minor	lower	urinary	tract	symptoms	[19].	
Previous	studies	have	also	identified	similar	themes	when	assessing	personal	goals	in	
semi-structured	interviews.	Srikrishna	et	al	(2009)	identified	goals	around	role	limitation,	
physical	activity,	sexual	function	and	less	frequent	use	of	incontinence	pads	[4].	Almost	
10%	of	patient’s	goals	recorded	referred	to	sexual	function,	again	confirming	the	impact	
that	pelvic	floor	conditions	have	on	sexual	function	and	patient’s	desires	for	interventions	
to	improve	this.	
	
The	use	of	patient-orientated	goals	has	been	described	as	a	more	sensitive	approach	to	
counselling	women	and	assessing	outcome	and	identifying	these	goals	via	a	PROM	prior	to	
initial	consultation	or	discussions	about	investigation	and	intervention	is	a	useful	way	to	
aid	counselling	and	enhance	shared	decision	making	[20].	Structured	questionnaires	
functioning	as	PROMS	may	lack	the	sensitivity	to	understand	and	individualise	a	patient’s	
expectations	with	regard	to	treatment	if	they	do	not	include	free-text	components	which	
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aim	to	enhance	self-expression.	Providing	an	individualised	summary	report	(Figure	2)	
which	headlines	personal	goals,	allows	the	consultation	to	focus	on	issues	of	greatest	
concern	to	the	patient	and	therefore	be	most	useful	clinically.	Electronic	data	capture	via	
instruments	such	as	ePAQ-PF	might	enable	the	development	of	personalised	decision	aids,	
using	individual	patient	data,	such	as	symptom	profile,	along	with	personal	circumstances,	
concerns	and	goals	to	model	information	relevant	and	meaningful	to	the	individual.	This	is	
important	as	women	affected	by	pelvic	floor	disorders,	including	urinary	incontinence	and	
pelvic	organ	prolapse	face	challenging	and	complex	decisions	about	their	treatment.		
The	main	limitations	of	this	study	are	that	not	all	patients	completing	ePAQ-PF	provided	a	
response	to	the	free-text	question.	The	length	and	quality	of	the	free-text	comments	
provided	was	also	variable.	Both	issues	are	likely	to	be	related	to	questionnaire	fatigue;	the	
time	taken	to	complete	the	up	to	132-item	questionnaire.	This	may	be	exacerbated	as	the	
free-text	item	is	positioned	at	the	end	of	the	instrument	and	this	may	have	had	an	impact	
on	data	quality.	Variation	in	literacy,	patient	engagement	or	a	lack	of	significant	ongoing	
concerns	or	goals	may	have	also	contributed	to	non-responses.	It	is	also	possible	that	
presenting	free-text	items	after	the	MCQ	component	of	the	questionnaire	may	have	
introduced	recall	bias	by	prompting	free-text	responses	related	to	the	most	recent	MCQ	
items.	For	example,	the	reporting	of	sexual	dysfunction	may	have	been	favoured	as	this	
dimension	immediately	precedes	the	personal	data	dimension	containing	free-text	items.		
In-depth	semi-structured	qualitative	interviews	would	provide	an	alternative	approach	to	
eliciting	information	regarding	concerns	and	goals,	though	face-to-face	interview	data	may	
also	prove	unreliable,	due	to	non-disclosure	of	sensitive	issues;	previous	studies	assessing	
both	urinary	incontinence	and	coital	urinary	incontinence	have	shown	patients	are	
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significantly	less	likely	to	disclose	sensitive	symptoms	to	an	interviewer,	as	compared	to	a	
questionnaire	[9,	1].		
Detailed	demographic	data	for	the	1996	women	are	also	lacking,	including	parity	and	
ethnicity,	menopausal	status,	prolapse	grade,	urodynamic	findings	and	other	physical	and	
mental	health	issues.	The	comparison	of	domain	scores	for	those	reporting	free-text	
concerns	for	the	stress	urinary	incontinence	(SUI)	and	overactive	bladder	(OAB)	domains	
of	ePAQ-PF	with	salient	domain	scores	for	patients	not	reporting	concerns	potentially	did	
not	include	a	number	of	patients	with	SUI	and	OAB	symptoms.	This	is	because	patients	
(n=451)	who	reported	urinary	incontinence,	did	not	report	specific	symptoms	of	
overactive	bladder	or	stress	urinary	incontinence.	The	authors	were	therefore	unable	to	
categorise	these	as	such,	so	the	numbers	of	patients	reporting	a	concern	for	the	stress	
urinary	incontinence	and	overactive	bladder	domains	of	ePAQ-PF	may	have	been	
underestimated.	Nonetheless	the	scores	in	these	two	domains	were	still	significantly	
different	for	both	symptom	frequency	and	impact	for	those	reporting	SUI	or	OAB	concerns.		
	
Despite	the	limitations	of	this	observational	study,	its	strengths	include	a	large	sample	size,	
subject	to	a	systematic	analysis.	This	is	the	first	paper	to	publish	an	in-depth	analysis	of	
free-text	data	from	an	electronic	questionnaire	used	in	routine	clinical	practice.	
	
Currently,	including	free-text	data	within	ePAQ-PF	is	a	helpful	way	to	provide	an	
individualised	qualitative	element	which	will	help	to	improve	the	acuity	of	the	PROM	when	
it	is	used	in	clinical	practice,	to	facilitate	discussion	and	aid	shared	decision	making	about	
treatment	[9].		The	patient’s	response	to	the	open	free-text	question	regarding	concerns	
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and	goals	in	ePAQ-PF	is	automatically	populated	in	the	summary	report	and	appears	as	
headline	information,	showing	the	clinician	clear	individual	qualitative	information	about	
what	is	most	concerning	the	patient	and	what	their	goals	are	regarding	their	condition.		
This	helps	to	ensure	that	these	concerns	and	goals	can	then	be	appropriately	addressed	
during	the	consultation,	as	the	report	draws	stark	attention	to	them.		
	
The	main	clinical	implication	of	this	study	is	that	validated	questionnaires	used	in	clinical	
practice,	including	ePAQ-PF,	can	help	to	identify	concerns	and	goals	which	relate	to	
symptoms.	Another	clinical	implication	is	that	a	significant	proportion	of	patients	attending	
a	urogynaecology	clinic	will	have	body	image	concerns	which	may	need	to	be	addressed	
and	development	and	use	of	questionnaires	to	identify	these	issues	and	their	impact	in	
urogynaecology	patients	needs	to	be	considered.		
	
Conclusions	
The	present	study	has	found	the	free-text	component	of	ePAQ-PF	to	be	well	utilised	by	
patients	and	the	concerns	and	goals	recorded	may	be	of	value	in	guiding	and	focussing	the	
subsequent	consultation.	Many	of	the	concerns	recorded	related	to	intimate	issues	and	
helped	to	highlight	the	issues	affecting	patients	HRQOL	the	most.	The	significant	
relationship	between	domain	symptom	frequency	scores	and	domain	impact	scores	with	
reporting	of	free-text	concerns	supports	convergent	construct	validity	of	the	instrument.	A	
significant	proportion	of	concerns	recorded	by	patients	related	to	body	image,	which	is	not	
currently	assessed	by	ePAQ-PF	and	is	an	area	of	further,	development	and	psychometric	
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testing.		An	individualised	electronic	patient	decision	aid	to	address	patient	goals	could	also	
be	of	value	and	is	worthy	of	further	research.	
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Figure 1 
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Figure 3 
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Table 1 
 
Domain Number	of	
controls	
(number	
of	patients	
not	
recording	
a	concern	
in	this	
domain)	
Number	
of	cases	
(patients	
recording	
a	concern	
in	this	
domain)																												
	
Mean	
symptom	
frequency	
score	±	2	
S.D		
(controls)	
Mean	
symptom	
frequency	
score	±	2	
S.D	
(cases)	
Domain	
score	p	
value		
(Student’s	t	
test)	
Modal	
symptom	
impact	
score	
(controls)	
Modal	
symptom	
impact	
score	
(cases)	
Impact	
score	p	
value	
(Mann-
Whitney)	
Urinary	dimension	
Stress urinary 
incontinence 1143	
122	 23.3±49.7	 47.5±43.3	 <0.005	 0	 3	 <0.005	
Overactive 
bladder 
1197	
68	 23.1±41.7	 41.7±39.2	 <0.005	 0	 3	 <0.005	
Voiding 
dysfunction 1212	
53	 16.6±38.3	 38.1±47.4	 <0.005	 0	 2	 <0.005	
Urinary pain 
and sensation 1213	
52	 12.3±33.4	 24.4±45.1	 <0.005	 0	 2	 <0.005	
QoL Urinary 
1132	
133	 33.0±66.12	 66.3±59.0	 <0.005	 -	 -	 	
Bowel	dimension	
Constipation 1206	 59	 21.2±40.7	 53.0±52.9	 <0.005	 0	 2	 <0.005	
Irritable 
Bowel 1237	
28	 27.7±41.9	 46.2±46.1	 <0.005	 0	 2	 <0.005	
Bowel 
evacuation 1194	
71	 20.8±38.2	 47.1±42.3	 <0.005	 0	 3	 <0.005	
Bowel 
continence 1163	
102	 16.3±33.0	 38.4±39.4	 <0.005	 0	 3	 <0.005	
QoL Bowel 1235	 30	 22.6±60.0	 53.7±71.5	 <0.005	 -	 -	 	
Vaginal	dimension	
Prolapse 857	 408	 16.5±45.4	 54.6±52.0	 <0.005	 0	 2	 <0.005	
Vaginal pain 
and sensation 1078	
187	 19.1±39.4	 33.1±43.0	 <0.005	 0	 2	 <0.005	
Vaginal 
capacity 1254	
11	 9.0±41.3	 34.3±61.1	 0.021	 0	 1	 <0.005	
QoL Vagina 1223	 42	 27.6±60.9	 63.3±60.6	 <0.005	 -	 -	 	
Sexual	dimension	
Sex and 
urinary 
symptoms 1242	
23	 25.7±63.4	 47.6±53.16	 <0.005	 0	 3	 <0.005	
Sex & bowel 
symptoms 1260	
5	 15.2±53.09	 36.6±19.2	 0.072	 0	 2	 0.001	
Sex & vaginal 
symptoms 1223	
42	 36.2±69.0	 64.4±46.6	 <0.005	 0	 3	 <0.005	
Dyspareunia 1189	 76	 23.3±49.7	 41.4±44.75	 <0.005	 0	 3	 <0.005	
General sex 
life QoL 1217	
48	 41.9±57.42	 66.1±52.0	 <0.005	 1	 3	 <0.005	
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Table	2	
	
Emotional	words	/phrases	used	in	
relation	to	body	self-image	
Number	of	times	repeated	
Embarrassment	 18	
Worry	 6	
Fear	 5	
Lack	of	confidence/	Self-conscious	 4	
Depression	 4	
Gets	me	down	 2	
Shame	 1	
Mortifying	 1	
Anxiety		 1	
Scared	 1	
Distress	 1	
Mental	effects	 1	
Feeling	low	 1	
Mentally	disturbing	 1	
Dirty	 1	
Ashamed	 1	
Paranoid	 1	
Miserable	 1	
Psychological	effect	 1	
Overall	unhappy	 1	
Annoying	 1	
Upsetting		 1	
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Table 3 
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8. Conclusions	and	areas	for	future	research	
	
Electronic	patient	reported	outcome	measures	in	gynaecology	have	an	important	role	in	
providing	patients	with	the	opportunity	to	report	their	symptoms	and	the	impact	they	may	
be	having	on	both	function	and	health	related	quality	of	life.	ePROMs,	such	as	ePAQ-Pelvic	
Floor,	ePAQ-MPH	and	ePAQ-Vulva	which	are	all	delivered	online	allow	patients	to	do	this	in	
the	comfort	of	their	own	surroundings;	supporting	self-	expression	and	increasing	
disclosure	of	potentially	taboo	or	embarrassing	symptoms.	Utilisation	of	these	tools	is	of	
particular	importance	in	gynaecology,	as	this	area	of	medicine	deals	with	sensitive	
conditions	which	often	have	a	profound	and	significant	impact	on	health-related	quality	of	
life.	It	can	be	well	argued	that	routine	use	of	ePROMs	such	as	ePAQ-Pelvic	Floor,	ePAQ-MPH	
and	ePAQ-Vulva	should	be	standard	practice	in	the	evaluation	of	both	new	and	follow	up	
patients,	such	is	the	level	of	evidence	for	their	value.	
It	is	clear	that	ePROMs	used	in	gynaecology	need	to	have	undergone	psychometric	testing	
and	have	good	evidence	for	their	reliability,	validity	and	functionality	in	clinical	practice	as	
well	as	in	research.	ePAQ-Pelvic	Floor	already	has	an	excellent	level	of	evidence	for	this	and	
is	widely	used	across	many	centres	in	the	UK	and	as	an	outcome	measure	in	research	studies.	
Papers	five,	six	and	seven	of	this	thesis	help	to	build	on	this.	The	levels	of	evidence	presented	
so	far	for	ePAQ-MPH	and	ePAQ-Vulva	provide	some	good	evidence	for	reliability,	validity	and	
functionality.	For	ePAQ-Vulva	further,	psychometric	testing	including	test-retest	reliability	
(stability),	local	dependency,	item	discrimination	and	responsiveness	of	the	instrument	have	
yet	to	be	evaluated.	The	instrument	requires	further	assessments	of	its	domain	structure,	
responsiveness,	reliability	and	validity.	For	ePAQ-MPH,	wider	evaluation	and	psychometric	
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testing	of	the	latest	and	current	version	three	of	the	instrument	is	required	in	larger	samples	
and	 in	 different	 settings,	 including	 tests	 of	 stability,	 tests	 of	 data	 quality,	 sensitivity	 and	
responsiveness	 to	 change.	Once	 these	psychometric	properties	of	 ePAQ-Vulva	and	ePAQ-
MPH	 have	 been	 assessed,	 there	will	 be	 further	 evidence	 to	 support	 their	 routine	 use	 in	
clinical	practice	and	research.		
	
Through	the	work	presented	here	in	paper	two	and	paper	six,	work	has	been	undertaken	to	
develop	and	test	a	new	domain	in	ePAQ-Pelvic	Floor	which	will	be	able	to	assess	body	image	
in	a	urogynaecology	setting.	This	will	be	the	first	ePROM	able	to	do	this.	Further	research	
will	evaluate	this	new	domain	of	the	ePAQ-Pelvic	Floor	ePROM	and	will	allow	the	routine	
assessment	 of	 body	 image	 in	 patients	 attending	 the	 urogynaecology	 clinic.	 This	will	 also	
allow	ethically	approved	research	studies	to	evaluate	the	relationship	between	body	image,	
urogynaecology	symptomatology	and	the	effect	of	interventions,	such	as	surgical	treatments	
for	incontinence	or	prolapse,	on	body	image.	
	
Likewise,	 the	work	undertaken	 in	paper	one	of	 this	narrative	 thesis	has	 led	 to	 testing	of	
ePAQ-Pelvic	 Floor	 in	 postnatal	women,	 in	 order	 to	 identify	 pelvic	 floor	 symptomatology	
including	 anal	 incontinence.	 Using	 an	 ePROM	 in	 this	 context	 is	 a	 novel	 concept	 and	 the	
ethically	approved	eQuiPP	study	(Electronic	Questionnaires	in	the	Postpartum	Period)	will	
help	to	investigate	and	test	this.	The	evidence	presented	in	paper	1	and	paper	5	regarding	
increased	 disclosure	 of	 embarrassing	 and	 taboo	 symptoms	 when	 PROMs	 are	 used	 has	
supported	this	next	phase	of	work.			
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It	 is	 essential	 that	 high	 quality	 research	 evaluating	 the	 use	 of	 ePROMs	 in	 gynaecology	
continues,	particularly	work	which	examines	the	financial	and	costing	benefits	of	using	such	
tools,	 as	well	 as	 assessments	 of	 psychometric	 properties,	 clinical	 outcomes	 and	 research	
outcomes.	The	NHS	Long	Term	plan81	states	that	ten	years	from	now	many	patients	will	be	
offered	a	‘digital	first’	option	for	assessment	when	they	have	a	healthcare	interaction.	It	is	
likely	that	the	remit	of	ePROMs	in	this	context	is	going	to	increase	exponentially.	Therefore,	
high	 quality	 research	 both	 for	 ePROM	 development,	 including	 systematic	 reviews	 of	
psychometric	properties	of	existing	measures	as	well	as	psychometric	testing	of	new	tools,	
and	research	using	data	from	ePROMs	will	similarly	increase.	The	body	of	work	presented	
in	 this	 thesis	 forms	a	 small	 part	 of	 this	 overall	 narrative	which	will	 become	 increasingly	
important	as	we	strive	to	delivery	high	quality	healthcare	for	all.			
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